最新主要文献でみる　脳神経外科学レビュー　2025-’26

I章 脳腫瘍

P.2 掲載の参考文献

1) Sahm F, Brandner S, Bertero L et al:Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors;an EANO guideline. Neuro Oncol 25:1731-1749, 2023

 

P.3 掲載の参考文献

2) Buckland ME, Sarkar C, Santosh V et al:Announcing the Asian Oceanian Society of Neuropathology guidelines for Adapting Diagnostic Approaches for Practical Taxonomy in Resource-Restrained Regions (AOSNP-ADAPTR). Brain Pathol 34:e13201, 2024

 

3) Torp SH, Solheim O, Skjulsvik AJ:The WHO 2021 Classification of Central Nervous System tumours:a practical update on what neurosurgeons need to know-a minireview. Acta Neurochir (Wien) 164:2453-2464, 2022

 

4) 小森隆司:WHO脳腫瘍分類2021第5版-主な変更点. Brain Nerve 74:803-809, 2022

 

P.4 掲載の参考文献

5) Jamshidi P, Brat DJ:The 2021 WHO classification of central nervous system tumors:what neurologists need to know. Curr Opin Neurol 35:764-771, 2022

 

6) McNamara C, Mankad K, Thust S et al:2021 WHO classification of tumours of the central nervous system:a review for the neuroradiologist. Neuroradiology 64:1919-1950, 2022

 

7) Joyner DA, Garrett J, Batchala PP et al:MRI features predict tumor grade in isocitrate dehydrogenase (IDH) -mutant astrocytoma and oligodendroglioma. Neuroradiology 65:121-129, 2023

 

8) Nishikawa T, Ohka T, Aoki K et al:Easy-to-use machine learning system for the prediction of IDH mutation and 1p/19q codeletion using MRI images of adult-type diffuse gliomas. Brain Tumor Pathol 40:85-92, 2023

 

9) Lasocki A, Buckland ME, Molinaro T et al:Correlating MRI features with additional genetic markers and patient survival in histological grade 2-3 IDH-mutant astrocytomas. Neuroradiology 65:1215-1223, 2023

 

10) van der Voort SR, Incekara F, Wijnenga MMJ et al:Combined molecular subtyping, grading, and segmentation of glioma using multi-task deep learning. Neuro Oncol 25:279-289, 2023

 

P.5 掲載の参考文献

11) Bouffet E, Hansford JR, Garre ML et al:Dabrafenib plus trametinib in pediatric glioma with BRAF V600 mutations. N Engl J Med 389:1108-1120, 2023

 

12) Brastianos PK, Twohy E, Susan Geyer MS et al:BRAF-MEK inhibition in newly diagnosed papillary craniopharyngiomas. N Engl J Med 389:118-126, 2023

 

13) Mellinghoff IK, van den Bent MJ, Blumenthal DT et al;INDIGO Trial Investigators:Vorasidenib in IDH1- or IDH2-mutant low-grade glioma. N Engl J Med 389:589-601, 2023

 

P.6 掲載の参考文献

14) Tini P, Yavoroska M, Mazzei MA et al:Low expression of Ki-67/MIB-1 labeling index in IDH wild type glioblastoma predicts prolonged survival independently by MGMT methylation status. J Neurooncol 163:339-344, 2023

 

15) Jusue-Torres I, Lee J, Germanwala AV et al:Effect of extent of resection on survival of patients with glioblastoma, IDH-wild-type, WHO grade 4 (WHO 2021):systematic review and meta-analysis. World Neurosurg 171:e524-e532, 2023

 

16) van der Meulen M, Ramos RC, Voisin MR et al:Differences in methylation profiles between long-term survivors and shortterm survivors of IDH-wild-type glioblastoma. Neurooncol Adv 6:vdae001, 2024

 

17) Kros JM, Rushing E, Uwimana AL et al:Mitotic count is prognostic in IDH mutant astrocytoma without homozygous deletion of CDKN2A/B. Results of consensus panel review of EORTC trial 26053 (CATNON) and EORTC trial 22033-26033. Neuro Oncol 25:1443-1449, 2023

 

18) Hervey-Jumper SL, Zhang Y, Phillips JJ et al:Interactive effects of molecular, therapeutic, and patient factors on outcome of diffuse low-grade glioma. J Clin Oncol 41:2029-2042, 2023

 

P.7 掲載の参考文献

19) Louis DN:A vade mecum for crossing the second translational "valley of death" in brain tumor classification. Brain Pathol 34:e13183, 2024

 

P.9 掲載の参考文献

1) Williams EA, Brastianos PK, Wakimoto H et al:A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4. Acta Neuropathol 146:515-525, 2023

 

2) Auffret L, Ajlil Y, Tauziede-Espariat A et al:A new subtype of diffuse midline glioma, H3 K27 and BRAF/FGFR1 co-altered:a clinico-radiological and histomolecular characterisation. Acta Neuropathol 147:2, 2023

 

3) Roberts HJ, Ji S, Picca A et al:Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations. Acta Neuropathol 146:849-852, 2023

 

P.10 掲載の参考文献

4) Jessa S, Mohammadnia A, Harutyunyan AS et al:K27M in canonical and noncanonical H3 variants occurs in distinct oligodendroglial cell lineages in brain midline gliomas. Nat Genet 54:1865-1880, 2022

 

5) Liu I, Jiang L, Samuelsson ER et al:The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location. Nat Genet 54:1881-1894, 2022

 

6) Mo Y, Duan S, Zhang X et al:Epigenome programming by H3.3K27M mutation creates a dependence of pediatric glioma on SMARCA4. Cancer Discov 12:2906-2929, 2022

 

7) Panditharatna E, Marques JG, Wang T et al:BAF complex maintains glioma stem cells in pediatric H3K27M glioma. Cancer Discov 12:2880-2905, 2022

 

8) Harpaz N, Mittelman T, Beresh O et al:Single-cell epigenetic analysis reveals principles of chromatin states in H3.3-K27M gliomas. Mol Cell 82:2696-2713. e9, 2022

 

9) Siddaway R, Canty L, Pajovic S et al:Oncohistone interactome profiling uncovers contrasting oncogenic mechanisms and identifies potential therapeutic targets in high grade glioma. Acta Neuropathol 144:1027-1048, 2022

 

10) Vuong HG, Le HT, Jea A et al:Risk stratification of H3 K27M-mutant diffuse midline gliomas based on anatomical locations:an integrated systematic review of individual participant data. J Neurosurg Pediatr 30:99-106, 2022

 

11) Chai RC, Yan H, An SY et al:Genomic profiling and prognostic factors of H3 K27M-mutant spinal cord diffuse glioma. Brain Pathol 33:e13153, 2023

 

P.11 掲載の参考文献

12) Wang Y, Pan C, Xie M et al:Adult diffuse intrinsic pontine glioma:clinical, radiological, pathological, molecular features, and treatments of 96 patients. J Neurosurg 137:1628-1638, 2022

 

13) Hirano Y, Shinya Y, Aono T et al:The role of stereotactic frame-based biopsy for brainstem tumors in the era of molecular-based diagnosis and treatment decisions. Curr Oncol 29:4558-4565, 2022

 

14) Dalmage M, LoPresti MA, Sarkar P et al:Survival and neurological outcomes after stereotactic biopsy of diffuse intrinsic pontine glioma:a systematic review. J Neurosurg Pediatr 32:665-672, 2023

 

15) Patel J, Aittaleb R, Doherty R et al:Liquid biopsy in H3K27M diffuse midline glioma. Neuro Oncol 26 (Supplement_2):S101-S109, 2024

 

16) Kline C, Jain P, Kilburn L et al:Upfront biology-guided therapy in diffuse intrinsic pontine glioma:therapeutic, molecular, and biomarker outcomes from PNOC003. Clin Cancer Res 28:3965-3978, 2022

 

P.12 掲載の参考文献

17) Grassl N, Poschke I, Lindner K et al:A H3K27M-targeted vaccine in adults with diffuse midline glioma. Nat Med 29:2586-2592, 2023

 

18) Majzner RG, Ramakrishna S, Yeom KW et al:GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas. Nature 603:934-941, 2022

 

19) Ausejo-Mauleon I, Labiano S, de la Nava D et al:TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory. Cancer Cell 41:1911-1926. e8, 2023

 

20) Venneti S, Kawakibi AR, Ji S et al:Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways. Cancer Discov 13:2370-2393, 2023

 

21) Arrillaga-Romany I, Gardner SL, Odia Y et al:ONC201 (dordaviprone) in recurrent H3 K27M-mutant diffuse midline glioma. J Clin Oncol 42:1542-1552, 2024

 

22) Arrillaga-Romany I, Lassman A, McGovern SL et al:ACTION:a randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse glioma. Neuro Oncol 26 (Supplement_2):S173-S181, 2024

 

P.13 掲載の参考文献

23) Jackson ER, Duchatel RJ, Staudt DE et al:ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma. Cancer Res 83:2421-2437, 2023

 

24) Izquierdo E, Carvalho DM, Mackay A et al:DIPG harbors alterations targetable by MEK inhibitors, with acquired resistance mechanisms overcome by combinatorial inhibition. Cancer Discov 12:712-729, 2022

 

25) Duchatel RJ, Jackson ER, Parackal SG et al:PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma. J Clin Invest 134:e170329, 2024

 

26) Mota M, Sweha SR, Pun M et al:Targeting SWI/SNF ATPases in H3.3K27M diffuse intrinsic pontine gliomas. Proc Natl Acad Sci U S A 120:e2221175120, 2023

 

27) McNicholas M, De Cola A, Bashardanesh Z et al:A compendium of syngeneic, transplantable pediatric high-grade glioma models reveals subtype-specific therapeutic vulnerabilities. Cancer Discov 13:1592-1615, 2023

 

28) van den Bent M, Saratsis AM, Geurts M et al:H3 K27M-altered glioma and diffuse intrinsic pontine glioma:semi-systematic review of treatment landscape and future directions. Neuro Oncol 26 (Supplement_2):S110-S124, 2024

 

29) Gallego Perez-Larraya J, Garcia-Moure M, Labiano S et al:Oncolytic DNX-2401 virus for pediatric diffuse intrinsic pontine glioma. N Engl J Med 386:2471-2481, 2022

 

30) Sasaki T, Watanabe J, He X et al:Intranasal delivery of nanoliposomal SN-38 for treatment of diffuse midline glioma. J Neurosurg 138:1570-1579, 2023

 

P.14 掲載の参考文献

1) Sturm D, Capper D, Andreiuolo F et al:Multiomic neuropathology improves diagnostic accuracy in pediatric neurooncology. Nat Med 29:917-926, 2023

 

P.15 掲載の参考文献

2) White CL, Kinross KM, Moore MK et al:Implementation of DNA methylation array profiling in pediatric central nervous system tumors:the AIM BRAIN Project:an Australian and New Zealand children's haematology/oncology group study. J Mol Diagn 25:709-728, 2023

 

3) Pickles JC, Fairchild AR, Stone TJ et al:DNA methylation-based profiling for paediatric CNS tumour diagnosis and treatment:a population-based study. Lancet Child Adolesc Health 4:121-130, 2020

 

P.16 掲載の参考文献

4) Benhamida JK, Harmsen HJ, Ma D et al:Recurrent TRAK1::RAF1 fusions in pediatric low-grade gliomas. Brain Pathol 33:e13185, 2023

 

5) Lucas CG, Sloan EA, Gupta R et al:Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1. Acta Neuropathol 144:747-765, 2022

 

P.17 掲載の参考文献

6) Auffret L, Ajlil Y, Tauziede-Espariat A et al:A new subtype of diffuse midline glioma, H3 K27 and BRAF/FGFR1 coaltered:a clinico-radiological and histomolecular characterisation. Acta Neuropathol 147:2, 2023

 

7) Neyazi S, Yamazawa E, Hack K et al:Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutation. Acta Neuropathol 147:22, 2024

 

P.18 掲載の参考文献

8) Sharma T, Schwalbe EC, Williamson D et al:Second-generation molecular subgrouping of medulloblastoma:an international meta-analysis of Group 3 and Group 4 subtypes. Acta Neuropathol 138:309-326, 2019

 

9) Goddard J, Castle J, Southworth E et al:Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification. Acta Neuropathol 145:651-666, 2023

 

P.19 掲載の参考文献

10) Li B, Zhao S, Li S et al:Novel molecular subtypes of intracranial germ cell tumors expand therapeutic opportunities. Neuro Oncol 26:1335-1351, 2024

 

P.20 掲載の参考文献

1) Wang J, Cazzato E, Ladewig E et al:Clonal evolution of glioblastoma under therapy. Nat Genet 48:768-776, 2016

 

2) Korber V, Yang J, Barah P et al:Evolutionary trajectories of IDHWT glioblastomas reveal a common path of early tumorigenesis instigated years ahead of initial diagnosis. Cancer Cell 35:692-704. e12, 2019

 

3) Barthel FP, Johnson KC, Varn FS et al;GLASS Consortium:Longitudinal molecular trajectories of diffuse glioma in adults. Nature 576:112-120, 2019

 

4) Varn FS, Johnson KC, Martinek J et al:Glioma progression is shaped by genetic evolution and microenvironment interactions. Cell 185:2184-2199. e16, 2022

 

5) Newman AM, Steen CB, Liu CL et al:Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol 37:773-782, 2019

 

6) Neftel C, Laffy J, Filbin MG et al:An integrative model of cellular states, plasticity, and genetics for glioblastoma. Cell 178:835-849. e21, 2019

 

P.21 掲載の参考文献

7) Hara T, Chanoch-Myers R, Mathewson ND et al:Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma. Cancer Cell 39:779-792. e11, 2021

 

P.22 掲載の参考文献

8) Malta TM, Sabedot TS, Morosini NS et al:The epigenetic evolution of glioma is determined by the IDH1 mutation status and treatment regimen. Cancer Res 84:741-756, 2024

 

9) Ceccarelli M, Barthel FP, Malta TM et al:Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma. Cell 164:550-563, 2016

 

10) Mellinghoff IK, van den Bent MJ, Blumenthal DT et al:Vorasidenib in IDH1-or IDH2-mutant low-grade glioma. N Engl J Med 389:589-601, 2023

 

P.23 掲載の参考文献

11) Shirahata M, Ono T, Stichel D et al:Novel, improved grading system (s) for IDH-mutant astrocytic gliomas. Acta Neuropathol 136:153-166, 2018

 

12) Kocakavuk E, Johnson KC, Sabedot TS et al:Hemizygous CDKN2A deletion confers worse survival outcomes in IDHmutnoncodel gliomas. Neuro Oncol 25:1721-1723, 2023

 

13) Sottoriva A, Spiteri I, Piccirillo SG et al:Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc Natl Acad Sci U S A 110:4009-4014, 2013

 

14) Suzuki H, Aoki K, Chiba K et al:Mutational landscape and clonal architecture in grade II and III gliomas. Nat Genet 47:458-468, 2015

 

15) Mathur R, Wang Q, Schupp PG et al:Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective. Cell 187:446-463. e16, 2024

 

16) Karschnia P, Young JS, Dono A et al:Prognostic validation of a new classification system for extent of resection in glioblastoma:a report of the RANO resect group. Neuro Oncol 25:940-954, 2023

 

P.24 掲載の参考文献

17) Appin CL, Hong C, Suwala AK et al:Whole tumor analysis reveals early origin of the TERT promoter mutation and intercellular heterogeneity in TERT expression. Neuro Oncol 26:640-652, 2024

 

18) Higa N, Akahane T, Yokoyama S et al:A tailored next-generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas. Cancer Sci 111:3902-3911, 2020

 

19) Nakashima T, Yamamoto R, Ohno M et al:Development of a rapid and comprehensive genomic profiling test supporting diagnosis and research for gliomas. Brain Tumor Pathol 41:50-60, 2024

 

20) Miller AM, Shah RH, Pentsova EI et al:Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid. Nature 565:654-658, 2019

 

21) Hayashi T, Tateishi K, Matsuyama S et al:Intraoperative integrated diagnostic system for malignant central nervous system tumors. Clin Cancer Res 30:116-126, 2024

 

22) Vermeulen C, Pages-Gallego M, Kester L et al:Ultra-fast deep-learned CNS tumour classification during surgery. Nature 622:842-849, 2023

 

P.25 掲載の参考文献

23) Satomi K, Ichimura K, Shibahara J:Decoding the DNA methylome of central nervous system tumors:an emerging modality for integrated diagnosis. Pathol Int 74:51-67, 2024

 

24) Otani Y, Satomi K, Suruga Y et al:Utility of genome-wide DNA methylation profiling for pediatric-type diffuse gliomas. Brain Tumor Pathol 40:56-65, 2023

 

25) Hadad S, Gupta R, Oberheim Bush NA et al:"De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade. Acta Neuropathol 147:3, 2024

 

P.26 掲載の参考文献

1) Ito S, Nakashima H, Segi N et al:Automated detection and diagnosis of spinal schwannomas and meningiomas using deep learning and magnetic resonance imaging. J Clin Med 12:5057, 2023

 

2) Zhuo Z, Zhang J, Duan Y et al:Automated classification of intramedullary spinal cord tumors and inflammatory demyelinating lesions using deep learning. Radiol Artif Intell 4:e210292, 2022

 

P.27 掲載の参考文献

3) Song C, Kim HS, Lee JH et al:Development of a novel prediction model for differential diagnosis between spinal myxopapillary ependymoma and schwannoma. Sci Rep 14:149, 2024

 

4) Endo T, Inoue T, Mizuno M et al;Investigators of intramedullary spinal cord tumors in the Neurospinal Society of Japan:Current trends in the surgical management of intramedullary tumors:a multicenter study of 1,033 patients by Neurospinal Society of Japan. Neurospine 19:441-452, 2022

 

P.28 掲載の参考文献

5) Watanabe G, Wong JM, Estes B et al:Diffuse midline H3K27-altered gliomas in the spinal cord:a systematic review. J Neurooncol 166:379-394, 2024

 

6) Zhang F, Cheng L, Ding Z et al:Dose H3K27M mutation impact survival outcome of high-grade spinal cord astrocytoma? Neurospine 20:1480-1489, 2023

 

P.29 掲載の参考文献

7) Naito K, Umebayashi D, Kurokawa R et al;study group of intramedullary spinal cord tumors in the Neurospinal Society of Japan:Predictors of progression-free survival in patients with spinal intramedullary ependymoma:a multicenter retorospective study by the Neurospinal Society of Japan. Neurosurgery 93:1046-1056, 2023

 

8) Alhalabi OT, Heene S, Landre V et al:Association of early surgery and absence of ataxia with full recovery after spinal intramedullary ependymoma resection. J Neurosurg Spine 40:185-195, 2023

 

9) Chaskis E, Bouchaala M, David P et al:Long-term outcomes after incomplete resection of intramedullary grade II ependymomas:is adjuvant radiotherapy justified? Cancers (Basel) 15:3674, 2023

 

P.30 掲載の参考文献

10) Kanematsu R, Mizuno M, Inoue T et al;Investigators of Intramedullary Spinal Cord Tumors in the Neurospinal Society of Japan:The impact of adjuvant radiotherapy on clinical performance status in patients with grade II spinal cord astrocytoma - a nationwide analysis by the Neurospinal Society of Japan. Neurospine 20:766-773, 2023

 

11) Muto J, Murata H, Shigekawa S et al;Investigators of Intramedullary Spinal Cord Tumors in the Neurospinal Society of Japan:Clinical characteristics and long-term outcomes of spinal pilocytic astrocytomas:a multicenter retrospective study by the Neurospinal Society of Japan. Neurospine 20:774-782, 2023

 

12) Inoue T, Endo T, Muto J et al;Investigators of Intramedullary Spinal Cord Tumors in the Neurospinal Society of Japan:Shorter survival time of adolescents and young adult patients than older adults with spinal cord glioblastoma:a multicenter study. J Neurosurg Spine 40:196-205, 2023

 

P.31 掲載の参考文献

13) Amelot A, Terrier LM, Mathon B et al;Medullary Glioblastoma study group:Natural course and prognosis of primary spinal glioblastoma:a nationwide study. Neurology 100:e1497-e1509, 2023

 

14) Takeshima Y, Takami H, Endo T et al;Investigators of Intramedullary Spinal Cord Tumors in the Neurospinal Society of Japan:Comparison of recurrence and surgical outcome of spinal hemangioblastoma in sporadic and von Hippel-Lindau diseases:a subanalysis of a nationwide study by the Neurospinal Society of Japan. Neurospine 20:756-765, 2023

 

15) Schwake M, Ricchizzi S, Krahwinkel S et al:Resection of intramedullary hemangioblastoma:timing of surgery and its impact on neurological outcome and quality of life. Medicina (Kaunas) 59:1611, 2023

 

16) Butenschoen VM, Schwendner M, Hubertus V et al:Preoerative angiographic considerations and neurological outcome after surgical treatment of intradural spinal hemangioblastoma:a multicenter retrospective case series. J Neurooncol 161:107-115, 2023

 

P.32 掲載の参考文献

17) Kurokawa R, Endo T, Takami T;Investigators of Intramedullary Spinal Cord Tumors in the Neurospinal Society of Japan:Acceptance of early surgery for treatment of spinal cord cavernous malformation in contemporary Japan. Neurospine 20:587-594, 2023

 

18) Srinivasan VM, Karahalios K, Shlobin N et al:Residual and recurrent spinal cord cavernous malformations:outcomes and techniques to optimize resection and a systematic review of the literature. Oper Neurosurg (Hagerstown) 24:44-54, 2023

 

P.33 掲載の参考文献

19) Jankovic D, Kalasauskas D, Othman A et al:Predictors of neurological worsening after resection of spinal meningiomas. Cancers (Basel) 15:5408, 2023

 

20) Sarikaya C, Ramazanoglu AF, Yaltirik CK et al:Short-term results of Simpson grade 2 resection in spinal meningiomas. World Neurosurg 171:e792-e795, 2023

 

21) Takahashi T, Hirai T, Yoshii T et al:Risk factors for recurrence and regrowth of spinal schwannoma. J Orthop Sci 28:554-559, 2023

 

P.34 掲載の参考文献

22) Singh A, Fletcher-Sandersjoo A, El-Hajj VG et al:Long-term functional outcomes following surgical treatment of spinal schwannomas:a population-based cohort study. Cancers (Basel) 16:519, 2024

 

23) Liu Z, Xu Z, Shen J et al:Scoring model to predict postoperative neurological deterioration in spinal schwannoma. Front Oncol 13:1086299, 2023

 

P.36 掲載の参考文献

1) Ehret F, Perez E, Teichmann D et al:Clinical implications of DNA methylationbased integrated classification of histologically defined grade 2 meningiomas. Acta Neuropathol Commun 12:74, 2024

 

2) Driver J, Hoffman SE, Tavakol S et al:A molecularly integrated grade for meningioma. Neuro Oncol 24:796-808, 2021

 

3) Maas SLN, Sievers P, Weber DC et al:Independent prognostic impact of DNA methylation class and chromosome 1p loss in WHO grade 2 and 3 meningioma undergoing adjuvant high-dose radiotherapy:comprehensive molecular analysis of EORTC 22042-26042. Acta Neuropathol 146:837-840, 2023

 

4) Chen WC, Choudhury A, Youngblood MW et al:Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. Nat Med 29:3067-3076, 2023

 

P.37 掲載の参考文献

5) Sasaki S, Takeda M, Hirose T et al:Correlation of MTAP immunohistochemistry with CDKN2A status assessed by fluorescence in situ hybridization and clinicopathological features in CNS WHO grade 2 and 3 meningiomas:a single center cohort study. J Neuropathol Exp Neurol 81:117-126, 2022

 

6) Ren L, Cheng H, Chen J et al:Progesterone receptor expression and prediction of benefits of adjuvant radiotherapy in de novo atypical meningiomas after gross-total resection. J Neurosurg 139:49-58, 2022

 

7) Nassiri F, Liu J, Patil V et al:A clinically applicable integrative molecular classification of meningiomas. Nature 597:119-125, 2021

 

8) Deng MY, Maas SLN, Hinz F et al:Efficacy and toxicity of bimodal radiotherapy in WHO grade 2 meningiomas following subtotal resection with carbon ion boost:prospective phase 2 MARCIE trial. Neuro Oncol 26:701-712, 2024

 

9) Teranishi Y, Miyawaki S, Nakatochi M et al:Meningiomas in patients with neurofibromatosis type 2 predominantly comprise 'immunogenic subtype' tumours characterised by macrophage infiltration. Acta Neuropathol Commun 11:156, 2023

 

P.38 掲載の参考文献

10) Choudhury A, Magill ST, Eaton CD et al:Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities. Nat Genet 54:649-659, 2022

 

11) Juratli TA, Jones PS, Wang N et al:Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations. Cancer 125:2910-2914, 2019

 

12) Brastianos PK, Twohy E, Geyer S et al:BRAF-MEK inhibition in newly diagnosed papillary craniopharyngiomas. N Engl J Med 389:118-126, 2023

 

P.39 掲載の参考文献

13) Fujio S, Juratli TA, Arita K et al:A clinical rule for preoperative prediction of BRAF mutation status in craniopharyngiomas. Neurosurgery 85:204-210, 2019

 

14) Huang Z, Xiao X, Li X et al:Machine learning-based multiparametric magnetic resonance imaging radiomic model for discrimination of pathological subtypes of craniopharyngioma. J Magn Reson Imaging 54:1541-1550, 2021

 

15) Plotkin SR, Messiaen L, Legius E et al:Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis:an international consensus recommendation. Genet Med 24:1967-1977, 2022

 

16) Hannan CJ, Lewis D, O'Leary C et al:The inflammatory microenvironment in vestibular schwannoma. Neurooncol Adv 2:vdaa023, 2020

 

17) Liu SJ, Casey-Clyde T, Cho NW et al:Epigenetic reprogramming shapes the cellular landscape of schwannoma. Nat Commun 15:476, 2024

 

P.41 掲載の参考文献

1) Villa C, Baussart B, Assie G et al:The World Health Organization classifications of pituitary neuroendocrine tumours:a clinico-pathological appraisal. Endocr Relat Cancer 30:e230021, 2023

 

2) Ho KKY, Kaiser UB, Chanson P et al:Pituitary adenoma or neuroendocrine tumour:the need for an integrated prognostic classification. Nat Rev Endocrinol 19:671-678, 2023

 

P.42 掲載の参考文献

3) Inoshita N, Yoshimoto T, Takazawa Y et al:Immunohistochemical and ultrastructural review of six cases previously diagnosed as null cell PitNETs. Brain Tumor Pathol 40:158-162, 2023

 

4) Sahakian N, Appay R, Resseguier N et al:Real-life clinical impact of a five-tiered classification of pituitary tumors. Eur J Endocrinol 187:893-904, 2022

 

5) Ho KKY, Fleseriu M, Wass J et al:A proposed clinical classification for pituitary neoplasms to guide therapy and prognosis. Lancet Diabetes Endocrinol 12:209-214, 2024

 

6) Saeger W, Mawrin C, Meinhardt M et al:Two pituitary neuroendocrine tumors (PitNETs) with very high proliferation and TP53 mutation - high-grade PitNET or PitNEC? Endocr Pathol 33:257-262, 2022

 

7) Nishioka H:Aggressive pituitary tumors (PitNET). Endocrine J 70:241-248, 2023

 

8) Raymond P, Raverot G, Ilie MD:Outcome and prognostic factors for pituitary carcinomas:lessons from a systematic review. Endocr Relat Cancer 30:e220338, 2023

 

P.43 掲載の参考文献

9) Ilie MD, De Alcubierre D, Carretti AL et al:Therapeutic targeting of the pituitary tumor microenvironment. Pharmacol Ther 250:108506, 2023

 

10) Jimenez AE, Azad TD, Mukherjee D:Decreasing reimbursement of pituitary tumor surgery:an analysis of Medicare data from 2010 to 2020. Neurosurgery 94:140-146, 2024

 

11) Candy NG, Ovenden C, Jukes AK et al:The learning curve for endoscopic endonasal pituitary surgery:a systematic review. Neurosurg Rev 46:241, 2023

 

12) cerny M, Sedlak V, Lesakova V et al:Methods of preoperative prediction of pituitary adenoma consistency:a systematic review. Neurosurg Rev 46:11, 2023

 

13) Muto J, Mine Y, Nishiyama Y et al:Intraoperative real-time near-infrared image-guided endoscopic endonasal surgery for pituitary tumors. World Neurosurg 175:e218-e229, 2023

 

14) Castle-Kirszbaum M, Wang YY, King J et al:Quality of life and surgical outcomes in incidental pituitary adenomas undergoing endoscopic endonasal resection. J Neurosurg 138:567-573, 2022

 

P.44 掲載の参考文献

15) Pontes JPM, Udoma-Udofa OC, de Oliveira JS et al:Efficacy and safety of cavernous sinus medial wall resection in pituitary adenoma surgery:a systematic review and a single-arm meta-analysis. Pituitary 26:340-351, 2023

 

16) Xiao L, Ouyang T, Wu B et al:Subclassification of Knosp grade 4 pituitary adenoma:bringing insights into the significance of tumor growth pathways. Neurosurgery 92:213-222, 2023

 

17) Zhang S, Yao S, Chen J et al:Correlation between tumor invasion and somatostatin receptor subtypes in acromegaly. J Neurosurg 6:1019-1028, 2023

 

18) Ironside N, Chen CJ, Xu Z et al:Effects of neuroanatomic structural distances on pituitary function after stereotactic radiosurgery:a multicenter study. Neurosurgery 92:1035-1042, 2023

 

19) Sathe AV, Siu A, Kang KC et al:Early versus delayed fractionated stereotactic radiotherapy for nonfunctioning pituitary adenoma. World Neurosurg 180:e317-e323, 2023

 

P.45 掲載の参考文献

20) Mamelak AN, Little AS, Gardner PA et al:A prospective, multicenter, observational study of surgical vs nonsurgical management for pituitary apoplexy. J Clin Endocrinol Metab 109:e711-e725, 2024

 

21) Oda Y, Amano K, Masui K et al:Clinical features of pituitary or parasellar tumor onset with cranial nerve palsy:surgical intervention considerations. World Neurosurg 175:e832-e840, 2023

 

22) Giustina A, Biermasz N, Casanueva FF et al:Consensus on criteria for acromegaly diagnosis and remission. Pituitary 27:7-22, 2024

 

23) Fleseriu M, Barkan A, Schneider MdP et al:Prevalence of comorbidities and concomitant medication use in acromegaly:analysis of real-world data from the United States. Pituitary 25:296-307, 2022

 

24) Petersenn S, Fleseriu M, Casanueva FF et al:Diagnosis and management of prolactin-secreting pituitary adenomas:a Pituitary society international Consensus Statement. Nat Rev Endocrinol 19:722-740, 2023

 

P.46 掲載の参考文献

25) Fleseriu M, Varlamov EV, Hinojosa-Amaya JM et al:An individualized approach to the management of Cushing disease. Nat Rev Endocrinol 19:581-599, 2023

 

26) Graffeo CS, Yagnik KJ, Carlstrom LP et al:Pituitary adenoma incidence, management trends, and long-term outcomes:a 30-year population-based analysis. Mayo Clin Proc 97:1861-1871, 2022

 

27) Botelho MS, Franzini IA, Nunes-Nogueira VDS et al:Treatment of non-functioning pituitary adenoma with cabergoline:a systematic review and meta-analysis. Pituitary 25:810-818, 2022

 

28) Coopmans EC, Korbonits M:Molecular genetic testing in the management of pituitary disease. Clin Endocrinol (Oxf) 97:424-435, 2022

 

II章 脳血管障害

P.49 掲載の参考文献

1) Jeon JP, Hong EP, Ha EJ et al:Genome-wide association study identifies novel susceptibilities to adult moyamoya disease. J Hum Genet 68:713-720, 2023

 

2) Nomura S, Akagawa H, Yamaguchi K et al:Difference in clinical phenotype, mutation position, and structural change of RNF213 rare variants between pediatric and adult Japanese patients with moyamoya disease. Transl Stroke Res, 2023. doi:10.1007/s12975-023-01194-w.

 

3) Wang Y, Zou Z, Yang Z et al:Whole exome sequencing and functional validation identify CAPN1 variants as a cause of Chinese moyamoya disease. Genes Dis 11:101090, 2024

 

4) Ikeuchi Y, Kitayama J, Sahara N et al:Filamin A variant as a possible secondhit gene promoting moyamoya diseaselike vascular formation associated with RNF213 p. R4810K variant. Neurol Genet 8:e200017, 2022

 

5) Pinard A, Ye W, Fraser SM et al:Rare variants in ANO1, encoding a calcium-activated chloride channel, predispose to moyamoya disease. Brain 146:3616-3623, 2023

 

6) He S, Hao X, Liu Z et al:Association between DIAPH1 variant and posterior circulation involvement with Moyamoya disease. Sci Rep 13:10732, 2023

 

P.50 掲載の参考文献

7) Guey S, Herve D, Kossorotoff M et al:Biallelic variants in NOS3 and GUCY1A3, the two major genes of the nitric oxide pathway, cause moyamoya cerebral angiopathy. Hum Genomics 17:24, 2023

 

8) Chen J, Zheng H, Wu X et al:Neuregulin 1 as a potential biomarker for disease progression in moyamoya disease:a casecontrol study in Chinese population. J Stroke Cerebrovasc Dis 33:107581, 2024

 

9) Ito M, Kawabori M, Sugiyama T et al:Impact of RNF213 founder polymorphism (p. R4810K) on the postoperative development of indirect pial synangiosis after direct/indirect combined revascularization surgery for adult Moyamoya disease. Neurosurg Rev 45:2305-2313, 2022

 

10) Kawabori M, Ito M, Kazumata K et al:Impact of RNF213 c. 14576G>A variant on the development of direct and indirect revascularization in pediatric moyamoya disease. Cerebrovasc Dis 52:171-176, 2023

 

11) Torazawa S, Miyawaki S, Imai H et al:Association of genetic variants with postoperative donor artery development in moyamoya disease:RNF213 and other moyamoya angiopathy-related gene analysis. Transl Stroke Res, 2024. doi:10.1007/s12975-024-01248-7

 

12) Uchino H, Ito M, Tokairin K et al:Association of RNF213 polymorphism and cortical hyperintensity sign on fluid-attenuated inversion recovery images after revascularization surgery for moyamoya disease:possible involvement of intrinsic vascular vulnerability. Neurosurg Rev 46:119, 2023

 

13) Gao G, Bao XY, Wang QN et al:Association between polymorphism in the MTHFR gene and encephaloduroarteriosynangiosis-induced collateral circulation formation. J Neurosurg, 2024. doi:10.3171/2024.1.JNS232121

 

14) Mineharu Y, Takagi Y, Koizumi A et al:Posterior cerebral artery involvement in unilateral moyamoya disease is exclusively ipsilateral and influenced by RNF213 mutation gene dose:the SUPRA Japan study:PCA involvement in unilateral moyamoya. J Stroke Cerebrovasc Dis 33:107513, 2024

 

P.51 掲載の参考文献

15) Xue Y, Zeng C, Ge P et al:Association of RNF213 variants with periventricular anastomosis in moyamoya disease. Stroke 53:2906-2916, 2022

 

16) Torazawa S, Miyawaki S, Imai H et al:RNF213 p. Arg4810Lys wild type is associated with de novo hemorrhage in asymptomatic hemispheres with moyamoya disease. Transl Stroke Res, 2023. doi:10.1007/s12975-023-01159-z

 

17) Ozaki D, Endo H, Tashiro R et al:Association between RNF213 c. 14576G>A variant (rs112735431) and peripheral pulmonary artery stenosis in moyamoya disease. Cerebrovasc Dis 51:282-287, 2022

 

18) Yajima H, Miyawaki S, Sayama S et al:Hypertensive disorders of pregnancy in moyamoya disease:a single institution experience. J Stroke Cerebrovasc Dis 32:107377, 2023

 

19) Hiruma M, Watanabe N, Mitsumatsu T et al:Clinical features of moyamoya disease with Graves' disease:a retrospective study of 394,422 patients with thyroid disease. Endocr J 70:141-148, 2023

 

20) Kuroda S, Fujimura M, Takahashi J et al:Diagnostic criteria for moyamoya disease - 2021 revised version. Neurol Med Chir (Tokyo) 62:307-312, 2022

 

21) Thamamongood T, Hara S, Akagawa H et al:Synergistic interaction of thyroid autoantibodies and ring finger protein 213 variant in moyamoya disease. Neurol Med Chir (Tokyo) 64:43-49, 2024

 

P.52 掲載の参考文献

22) Yoshimoto T, Ishiyama H, Hattori Y et al:Association of thyroid peroxidase antibody with the RNF213 p. R4810K variant in ischemic stroke/transient ischemic attack. Atherosclerosis 382:117281, 2023

 

23) Hong T, Xiao X, Ren J et al:Somatic MAP3K3 and PIK3CA mutations in sporadic cerebral and spinal cord cavernous malformations. Brain 144:2648-2658, 2021

 

P.53 掲載の参考文献

24) Wang J, Tang J, Yang Y et al:Genotypephenotype correlations in multiple lesions of familial cerebral cavernous malformations concerning phosphatidylinositol 3-kinase catalytic subunit alpha mutations. Clin Transl Med 14:e1610, 2024

 

25) Li L, Ren AA, Gao S et al:mTORC1 inhibitor rapamycin inhibits growth of cerebral cavernous malformation in adult mice. Stroke 54:2906-2917, 2023

 

26) Snellings DA, Girard R, Lightle R et al:Developmental venous anomalies are a genetic primer for cerebral cavernous malformations. Nat Cardiovasc Res 1:246-252, 2022

 

P.54 掲載の参考文献

1) Kim T, Lee H, Ahn S et al:Incidence and risk factors of intracranial aneurysm:a national cohort study in Korea. Int J Stroke 11:917-927, 2016

 

P.55 掲載の参考文献

2) Heo J, Park SJ, Kang SH et al:Prediction of intracranial aneurysm risk using machine learning. Sci Rep 10:6921, 2020

 

3) Kim T, Choi J, Park WJ et al:Validation of prediction algorithm for risk estimation of intracranial aneurysm development using real-world data. Sci Rep 13:14651, 2023

 

4) Xiong Y, Zheng Y, Yan Y et al:Circulating proteomic panels for risk stratification of intracranial aneurysm and its rupture. EMBO Mol Med 14:e14713, 2022

 

P.56 掲載の参考文献

5) Poppenberg KE, Chien A, Santo BA et al:Profiling of circulating gene expression reveals molecular signatures associated with intracranial aneurysm rupture risk. Mol Diagn Ther 27:115-127, 2023

 

6) Din M, Agarwal S, Grzeda M et al:Detection of cerebral aneurysms using artificial intelligence:a systematic review and meta-analysis. J Neurointerv Surg 15:262-271, 2023

 

7) Kuwabara M, Ikawa F, Sakamoto S et al:Effectiveness of tuning an artificial intelligence algorithm for cerebral aneurysm diagnosis:a study of 10,000 consecutive cases. Sci Rep 13:16202, 2023

 

P.57 掲載の参考文献

8) Tan J, Song R, Su J et al:Establishment and multicenter external validation of a risk prediction model for de novo intracranial aneurysms based on a systematic review and meta-analysis of 19 cohorts. J Neurosurg 140:783-791, 2024

 

9) Matano F, Mizunari T, Murai Y et al:White matter lesions as brain frailty and age are risk factors for surgical clipping of unruptured intracranial aneurysms in the elderly. J Stroke Cerebrovasc Dis 29:105121, 2020

 

P.58 掲載の参考文献

10) Rodrigues RS, Rabelo NN, Telles JPM et al:Sarcopenia as a predictor of the functional outcome in patients with intracranial aneurysms. Gerontology 69:65-72, 2023

 

11) Kuwabara M, Ikawa F, Michihata N et al:The 5-factor modified frailty index as a more useful associated factor than chronological age after unruptured cerebral aneurysm surgery:a nationwide registry study. Neurosurgery 92:329-337, 2023

 

12) Stroh N, Stefanits H, Maletzky A et al:Machine learning based outcome prediction of microsurgically treated unruptured intracranial aneurysms. Sci Rep 13:22641, 2023

 

P.59 掲載の参考文献

13) Liu Q, Li J, Zhang Y et al:Association of calcium channel blockers with lower incidence of intracranial aneurysm rupture and growth in hypertensive patients. J Neurosurg 139:651-660, 2023

 

14) Jabbarli R, Darkwah Oppong M, Chihi M et al:Regular medication as a risk factor for intracranial aneurysms:a comparative case-control study. Eur Stroke J 8:251-258, 2023

 

P.60 掲載の参考文献

1) Mohr JP, Parides MK, Stapf C et al;international ARUBA investigators:Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA):a multicentre, non-blinded, randomised trial. Lancet 383:614-621, 2014

 

P.61 掲載の参考文献

2) Mohr JP, Overbey JR, Hartmann A et al;ARUBA co-investigators:Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA):final follow-up of a multicentre, non-blinded, randomised controlled trial. Lancet Neurol 19:573-581, 2020

 

3) Al-Shahi Salman R, White PM, Counsell CE et al;Scottish Audit of Intracranial Vascular Malformations Collaborators:Outcome after conservative management or intervention for unruptured brain arteriovenous malformations. JAMA 311:1661-1669, 2014

 

4) Derdeyn CP, Zipfel GJ, Albuquerque FC et al;American Heart Association Stroke Council:Management of brain arteriovenous malformations:a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 48:e200-e224, 2017

 

P.62 掲載の参考文献

5) Pezeshkpour P, Dmytriw AA, Phan K et al:Treatment strategies and related outcomes for brain arteriovenous malformations in children:a systematic review and meta-analysis. AJR Am J Roentgenol 215:472-487, 2020

 

6) Lu VM, Wahood W, Rinaldo L et al:Longterm functional outcome after intervention for pediatric intracranial arteriovenous malformations:a systematic review and meta-analysis. Clin Neurol Neurosurg 191:105707, 2020

 

7) Borcek Ao, Celtikci E, Aksogan Y et al:Clinical outcomes of stereotactic radiosurgery for cerebral arteriovenous malformations in pediatric patients:systematic review and meta-analysis. Neurosurgery 85:E629-E640, 2019

 

8) Wu EM, El Ahmadieh TY, McDougall CM et al:Embolization of brain arteriovenous malformations with intent to cure:a systematic review. J Neurosurg 132:388-399, 2019

 

9) Dabhi N, Sokolowski J, Zanaty M et al:Primary embolization of cerebral arteriovenous malformations with intention to cure:a systematic review of literature and meta-analysis. Neurosurgery, 2024. doi:10.1227/neu.0000000000003001

 

10) Maroufi SF, Fallahi MS, Khorasanizadeh M et al:radiosurgery with prior embolization versus radiosurgery alone for intracranial arteriovenous malformations:a systematic review and meta-analysis. Neurosurgery 94:478-496, 2024

 

11) Jiang Z, Zhang X, Wan X et al:Efficacy and safety of combined endovascular embolization and stereotactic radiosurgery for patients with intracranial arteriovenous malformations:a systematic review and meta-analysis. Biomed Res Int 2021:6686167, 2021

 

12) Chang H, Silva MA, Weng J et al:The impact of embolization on radiosurgery obliteration rates for brain arteriovenous malformations:a systematic review and meta-analysis. Neurosurg Rev 46:28, 2022

 

P.63 掲載の参考文献

13) Ilyas A, Chen CJ, Abecassis IJ et al:stereotactic radiosurgery for a randomized trial of unruptured brain arteriovenous malformations-eligible patients:a meta-analysis. Neurosurgery 91:684-692, 2022

 

14) Jiang X, Zhao Z, Zhang Y et al:Preradiosurgery embolization in reducing the postoperative hemorrhage rate for patients with cerebral arteriovenous malformations:a systematic review and meta-analysis. Neurosurg Rev 44:3197-3207, 2021

 

15) Mamaril-Davis JC, Aguilar-Salinas P, Avila MJ et al:Complete seizure-free rates following interventional treatment of intracranial arteriovenous malformations:a systematic review and meta-analysis. Neurosurg Rev 45:1313-1326, 2022

 

16) Koester SW, Batista S, Bertani R et al:Angiographic factors leading to hemorrhage in AVMs:a systematic review and meta-analysis. Neurosurg Rev 46:72, 2023

 

17) de Liyis BG, Arini AAIK, Karuniamaya CP et al:Risk of intracranial hemorrhage in brain arteriovenous malformations:a systematic review and meta-analysis. J Neurol 271:2274-2284, 2024

 

18) Orscelik A, Musmar B, Matsukawa H et al:Optimal timing of microsurgical treatment for ruptured arteriovenous malformations:a systematic review and meta-analysis. Neurosurgery, 2024. doi:10.1227/neu.0000000000003043

 

19) Chye CL, Wang KW, Chen HJ et al:Haemorrhage rates of ruptured and unruptured brain arteriovenous malformation after radiosurgery:a nationwide population-based cohort study. BMJ Open 10:e036606, 2020

 

20) Davidoff CL, Lo Presti A, Rogers JM et al:Risk of first hemorrhage of brain arteriovenous malformations during pregnancy:a systematic review of the literature. Neurosurgery 85:E806-E814, 2019

 

21) Nikolaev SI, Vetiska S, Bonilla X et al:Somatic activating KRAS mutations in arteriovenous malformations of the brain. N Engl J Med 378:250-261, 2018

 

22) Al-Olabi L, Polubothu S, Dowsett K et al:Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapy. J Clin Invest 128:5185, 2018

 

P.64 掲載の参考文献

23) Hong T, Yan Y, Li J et al:High prevalence of KRAS/BRAF somatic mutations in brain and spinal cord arteriovenous malformations. Brain 142:23-34, 2019

 

24) Goss JA, Huang AY, Smith E et al:Somatic mutations in intracranial arteriovenous malformations. PLoS One 14:e0226852, 2019

 

25) Priemer DS, Vortmeyer AO, Zhang S et al:Activating KRAS mutations in arteriovenous malformations of the brain:frequency and clinicopathologic correlation. Hum Pathol 89:33-39, 2019

 

26) Oka M, Kushamae M, Aoki T et al:KRAS G12D or G12V mutation in human brain arteriovenous malformations. World Neurosurg 126:e1365-e1373, 2019

 

27) Couto JA, Huang AY, Konczyk DJ et al:Somatic MAP2K1 mutations are associated with extracranial arteriovenous malformation. Am J Hum Genet 100:546-554, 2017

 

28) Goss JA, Konczyk DJ, Smits PJ et al:Intramuscular fast-flow vascular anomaly contains somatic MAP2K1 and KRAS mutations. Angiogenesis 22:547-552, 2019

 

29) Raymond J, Gentric JC, Magro E et al;TOBAS Collaborative Group;Collaborators in the TOBAS Collaborative Group:Endovascular treatment of brain arteriovenous malformations:clinical outcomes of patients included in the registry of a pragmatic randomized trial. J Neurosurg 138:1393-1402, 2022

 

30) Darsaut TE, Magro E, Bojanowski MW et al;TOBAS Collaborative Group;List of participating TOBAS centers and physicians:Surgical treatment of brain arteriovenous malformations:clinical outcomes of patients included in the registry of a pragmatic randomized trial. J Neurosurg 138:891-899, 2022

 

31) Fish JE, Flores-Suarez CP, Boudreau E et al:Somatic gain of KRAS function in the endothelium is sufficient to cause vascular malformations that require MEK but not PI3K signaling. Circ Res 127:727-743, 2020

 

32) Bameri O, Salarzaei M, Parooie F:KRAS/BRAF mutations in brain arteriovenous malformations:a systematic review and meta-analysis. Interv Neuroradiol 27:539-546, 2021

 

33) Patel BG, Ahmed KA, Johnstone PA et al:Initial experience with combined BRAF and MEK inhibition with stereotactic radiosurgery for BRAF mutant melanoma brain metastases. Melanoma Res 26:382-386, 2016

 

P.65 掲載の参考文献

34) Lekwuttikarn R, Lim YH, Admani S et al:Genotype-guided medical treatment of an arteriovenous malformation in a child. JAMA Dermatol 155:256-257, 2019

 

35) Maynard K, LoPresti M, Iacobas I et al:Antiangiogenic agent as a novel treatment for pediatric intracranial arteriovenous malformations:case report. J Neurosurg Pediatr 24:673-679, 2019

 

36) Akers A, Al-Shahi Salman R, A Awad I et al:Synopsis of guidelines for the clinical management of cerebral cavernous malformations:consensus recommendations based on systematic literature review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel. Neurosurgery 80:665-680, 2017

 

37) Gao X, Yue K, Sun J et al:Treatment of cerebral cavernous malformations presenting with seizures:a systematic review and meta-analysis. Front Neurol 11:590589, 2020

 

38) Lanfranconi S, Scola E, Meessen JMTA et al;Treat_CCM Investigators:Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM):a randomised, openlabel, blinded-endpoint, phase 2 pilot trial. Lancet Neurol 22:35-44, 2023

 

39) CARE pilot trial collaboration:Medical management and surgery versus medical management alone for symptomatic cerebral cavernous malformation (CARE):a feasibility study and randomised, open, pragmatic, pilot phase trial. Lancet Neurol 23:565-576, 2024

 

P.66 掲載の参考文献

40) 日本脳卒中学会脳卒中ガイドライン委員会編:脳卒中治療ガイドライン2021〔改訂2023〕. 協和企画, 2023

 

P.67 掲載の参考文献

1) Kuroda S, Yamamoto S, Funaki T et al;AMORE Study Group:Five-year stroke risk and its predictors in asymptomatic moyamoya disease:Asymptomatic Moyamoya Registry (AMORE). Stroke 54:1494-1504, 2023

 

P.68 掲載の参考文献

2) Funaki T, Takahashi JC, Houkin K et al:High rebleeding risk associated with choroidal collateral vessels in hemorrhagic moyamoya disease:analysis of a nonsurgical cohort in the Japan Adult Moyamoya Trial. J Neurosurg 130:525-530, 2019

 

3) Funaki T, Takahashi JC, Houkin K et al:Effect of choroidal collateral vessels on de novo hemorrhage in moyamoya disease:analysis of nonhemorrhagic hemispheres in the Japan Adult Moyamoya Trial. J Neurosurg 132:408-414, 2019

 

4) Miyakoshi A, Funaki T, Fushimi Y et al:Cortical distribution of fragile periventricular anastomotic collateral vessels in moyamoya disease:an exploratory crosssectional study of Japanese patients with moyamoya disease. AJNR Am J Neuroradiol 41:2243-2249, 2020

 

5) Funaki T, Miyakoshi A, Kataoka H et al:Larger posterior revascularization associated with reduction of choroidal anastomosis in moyamoya disease:a quantitative angiographic analysis. AJNR Am J Neuroradiol 43:1279-1285, 2022

 

6) 日本脳卒中学会脳卒中ガイドライン委員会編:脳卒中治療ガイドライン2021〔改訂2023〕. pp219-220, 協和企画, 2023

 

7) Yanagihara W, Chida K, Kobayashi M et al:Impact of cerebral blood flow changes due to arterial bypass surgery on cognitive function in adult patients with symptomatic ischemic moyamoya disease. J Neurosurg 131:1716-1724, 2018

 

8) Uchida S, Kubo Y, Oomori D et al:Longterm cognitive changes after revascularization surgery in adult patients with ischemic moyamoya disease. Cerebrovasc Dis Extra 11:145-154, 2021

 

P.69 掲載の参考文献

9) Katakura Y, Kubo Y, Dobashi K et al:Delayed development of cerebral atrophy after cerebral hyperperfusion following arterial bypass for adult patients with ischemic moyamoya disease:supplementary analysis of a 5-year prospective cohort. Acta Neurochir (Wien) 164:1037-1045, 2022

 

10) Kimura K, Kubo Y, Dobashi K et al:Angiographic, cerebral hemodynamic, and cognitive outcomes of indirect revascularization surgery alone for adult patients with misery perfusion due to ischemic moyamoya disease. Neurosurgery 90:676-683, 2022

 

11) Mineharu Y, Takagi Y, Koizumi A et al:Genetic and nongenetic factors for contralateral progression of unilateral moyamoya disease:the first report from the SUPRA Japan Study Group. J Neurosurg 136:1005-1014, 2021

 

P.70 掲載の参考文献

12) Kaku Y, Ohmori Y, Kameno K et al:Inhalational anesthesia reduced transient neurological events after revascularization surgery for moyamoya disease. Neurosurgery, 2023. doi:10.1227/neu.0000000000002804

 

13) Hamano E, Kataoka H, Morita N et al:Clinical implications of the cortical hyperintensity belt sign in fluid-attenuated inversion recovery images after bypass surgery for moyamoya disease. J Neurosurg 126:1-7, 2017

 

14) Takemoto Y, Kawano T, Ohmori Y et al:Hemodynamic study about cortical hyperintensity belt sign after direct bypass surgery for moyamoya disease. J Clin Neurosci 74:124-129, 2020

 

P.71 掲載の参考文献

1) Kim J, Kim BM, Park KY et al:Angioarchitectural analysis of arteriovenous shunts in dural arteriovenous fistulas and its clinical implications. Neurosurgery 91:782-789, 2022

 

P.72 掲載の参考文献

2) Ubbink SWJ, van Dijk JMC, Hofman R et al:Performance of ear canal sound measurements in detecting dural arteriovenous fistulas. J Neurosurg, 2023. doi:10.3171/2023.10.JNS231255

 

3) Li X, Xu N, Meng X et al:Dual-phase contrast-enhanced CT evaluation of dural arteriovenous fistula in patients with pulsatile tinnitus as an initial symptom. Eur J Radiol 148:110137, 2022

 

4) Liang AS, Bounajem MT, Shoskes A et al:Dural arteriovenous fistula in the setting of cerebral venous sinus thrombosis and COVID-19 infection. Neurosurg Focus 56:E17, 2024

 

P.73 掲載の参考文献

5) Garcia-Garcia S, Cepeda S, Arrese I et al:Brain dural arteriovenous fistulas in the COVID-19 era:a warning and rationale for association. Clin Neurol Neurosurg 220:107367, 2022

 

6) Gerasimenko A, Mignot C, Naggara O et al:Cerebral dural arteriovenous fistulas in patients with PTEN-related hamartoma tumor syndrome. Clin Genet, 2024. doi:10.1111/cge.14515

 

7) Wang Y, Ma Y, Yang C et al:Potential biomarkers of spinal dural arteriovenous fistula:C4BPA and C1QA. J Neuroinflammation 19:165, 2022

 

P.74 掲載の参考文献

8) Sanchez S, Raghuram A, Wendt L et al:Natural history, angiographic presentation and outcomes of anterior cranial fossa dural arteriovenous fistulas. J Neurointerv Surg 15:903-908, 2023

 

9) Trivelato FP, Smajda S, Saleme S et al:Endovascular treatment of anterior cranial base dural arteriovenous fistulas as a first-line approach:a multicenter study. J Neurosurg 137:1758-1765, 2022

 

10) Berke CN, Naik A, Majmundar N et al:Microsurgical versus endovascular treatment of ethmoidal dural arteriovenous fistulas:systematic review and meta-analysis with a single-center case series. Neurosurg Focus 56:E15, 2024

 

P.75 掲載の参考文献

11) Xiao Z, Gao W, Zhou H et al:Clinical features, angio-architectural phenotypes, and treatment strategy of foramen magnum dural arteriovenous fistulas:a retrospective case series study. Front Neurol 14:1121075, 2023

 

12) Howard BM, Manupipatpong S, Dion JE et al:Classification and management considerations for intraosseous dural arteriovenous fistulae. Neurosurgery 93:387-398, 2023

 

P.76 掲載の参考文献

13) Schartz D, Rahmani R, Gunthri A et al:Observation versus intervention for Borden type I intracranial dural arteriovenous fistula:a pooled analysis of 469 patients. Interv Neuroradiol 30:175-182, 2024

 

14) Walker E, Srienc A, Lew D et al:Dural arteriovenous fistulas are not observed to convert to a higher grade after partial embolization. Neurosurg Focus 56:E8, 2024

 

15) Cheng HC, Bodani VP, Chung E et al:Transvenous retrograde pressure cooker technique for embolization of an ethmoidal dural arteriovenous fistula. J Neurointerv Surg, 2023. doi:10.1136/jnis-2023-020393

 

16) Devarajan A, Rossitto CP, Al-Kawaz M et al:Transvenous balloon-assisted approach to anterior fossa dural arteriovenous fistula using retrograde pressure cooker technique. J Neurointerv Surg, 2023. doi:10.1136/jnis-2023-020530

 

P.77 掲載の参考文献

17) Sun Z, Wang R, Dong H et al:Prophylactic intra-arterial injection of lidocaine:a novel strategy to prevent endovascular embolization-induced trigeminocardiac reflex. J Neurointerv Surg 15:473-477, 2023

 

18) Guedon A, Elhorany M, Labeyrie MA et al:Transarterial embolization of dural arteriovenous fistulas of the lateral sinuses with stent-assisted sinus protection. J Neurointerv Surg 14:962-967, 2022

 

P.78 掲載の参考文献

19) Muhammad N, Sioutas GS, Gajjar A et al:Intraoperative angiography via popliteal artery access for spinal neurovascular lesions:an institutional experience and systematic review. J Neurointerv Surg 15:787-792, 2023

 

20) Lee YL, Ko CC, Chen CM et al:How I do it:angiography-assisted full endoscopic treatment of spinal dural arteriovenous fistula. Acta Neurochir (Wien) 166:111, 2024

 

21) Singh R, Chen CJ, Didwania P et al:Stereotactic radiosurgery for dural arteriovenous fistulas:a systematic review and meta-analysis and international stereotactic radiosurgery society practice guidelines. Neurosurgery 91:43-58, 2022

 

P.79 掲載の参考文献

22) Kim MJ, Hong SW, Kim DJ et al:Efficacy and safety of stereotactic radiosurgery versus endovascular treatment for symptomatic cavernous sinus dural arteriovenous fistula without ophthalmological emergency:a single-center 10-year experience. J Neurosurg 139:139-149, 2023

 

23) Kim J, Hong SW, Jung HH et al:Stereotactic radiosurgery for noncavernous sinus dural arteriovenous fistulas:treatment outcomes and their predictors. J Neurosurg 140:1389-1398, 2023

 

24) Hasegawa H, Shin M, Kawagishi J et al:A practical grading scale for predicting outcomes of radiosurgery for dural arteriovenous fistulas:JLGK 1802 study. J Stroke 24:278-287, 2022

 

P.80 掲載の参考文献

25) Shinya Y, Hasegawa H, Kawashima M et al:Prognosis of rotational angiography-based stereotactic radiosurgery for dural arteriovenous fistulas:a retrospective analysis. Neurosurgery 92:167-178, 2023

 

P.82 掲載の参考文献

1) RESCUE BT Trial Investigators;Shuai J, Gong Z, Sang H et al:Effect of intravenous tirofiban vs placebo before endovascular thrombectomy on functional outcomes in large vessel occlusion stroke:the RESCUE BT randomized clinical trial. JAMA 328:543-553, 2022

 

2) Alexander H, Claus CF, Tong D et al:Safety and functional outcomes of early antiplatelet therapy within 24 hours following mechanical thrombectomy for secondary prevention in emergent largevessel occlusion strokes:a registry study. Neurosurg Focus 55:E19, 2023

 

3) Chen HS, Cui Y, Zhou ZH et al:Dual antiplatelet therapy vs alteplase for patients with minor nondisabling acute ischemic stroke:the ARAMIS randomized clinical trial. JAMA 329:2135-2144, 2023

 

P.83 掲載の参考文献

4) 日本脳卒中学会脳卒中ガイドライン委員会編:脳卒中治療ガイドライン2021〔改訂2023〕. 協和企画, 2023

 

5) Gao Y, Chen W, Pan Y et al:Dual antiplatelet treatment up to 72 hours after ischemic stroke. N Engl J Med 389:2413-2424, 2023

 

6) Yan Y, Hao R, Zhao X et al:Relationship between CYP2C19*2, *3 gene polymorphism and the recurrence in ischemic stroke patients treated with clopidogrel in China:a meta-analysis. J Stroke Cerebrovasc Dis 31:106798, 2022

 

7) Qiu X, Zhang Y, Gu H et al:Association between CYP2B6 polymorphisms and efficacy of clopidogrel in minor stroke or transient ischemic attack. Stroke 54:1770-1776, 2023

 

P.84 掲載の参考文献

8) Meng X, Wang A, Tian X et al:One-year outcomes of early therapy with ticagrelor vs clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA trial. Neurology 102:e207809, 2024

 

9) Wang A, Meng X, Tian X et al:Bleeding risk of dual antiplatelet therapy after minor stroke or transient ischemic attack. Ann Neurol 91:380-388, 2022

 

10) Xie X, Johnston SC, Wang A et al:Association of CYP2C19 loss-of-function metabolizer status with stroke risk among Chinese patients treated with ticagreloraspirin vs clopidogrel-aspirin:a prespecified secondary analysis of a randomized clinical trial. JAMA Netw Open 6:e2317037, 2023

 

11) Wang A, Xie X, Tian X et al:Ticagrelor-aspirin versus clopidogrel-aspirin among CYP2C19 loss-of-function carriers with minor stroke or transient ischemic attack in relation to renal function:a post hoc analysis of the CHANCE-2 trial. Ann Intern Med 175:1534-1542, 2022

 

12) Zhang J, Wang A, Tian X et al:Impact of body mass index on efficacy and safety of ticagrelor versus clopidogrel in patients with minor stroke or transient ischemic attack. CMAJ 195:E897-E904, 2023

 

13) Xie X, Jing J, Meng X et al:Dual antiplatelet therapies and causes in minor stroke or transient ischemic attack:a prespecified analysis in the CHANCE-2 trial. Stroke 54:2241-2250, 2023

 

14) Liu H, Jing J, Wang A et al:Stroke recurrence and antiplatelets in posterior versus anterior circulation minor stroke or transient ischemic attack. Stroke 54:964-972, 2023

 

15) Liu H, Jing J, Wang A et al:Genotypeguided dual antiplatelet therapy in minor stroke or transient ischemic attack with a single small subcortical infarction. Neurology 100:e1643-e1654, 2023

 

16) Lun R, Dhaliwal S, Zitikyte G et al:Comparison of ticagrelor vs clopidogrel in addition to aspirin in patients with minor ischemic stroke and transient ischemic attack. JAMA Neurol 79:141-148, 2022

 

17) Ma X, Li D, Liu S et al:Efficacy and safety of ticagrelor versus aspirin and clopidogrel for stroke prevention in patients with vascular disease:a systematic review and meta-analysis. Eur Neurol 86:229-241, 2023

 

P.85 掲載の参考文献

18) Aref HM, El-Khawas H, Elbassiouny A et al:A randomized pilot study of the efficacy and safety of loading ticagrelor in acute ischemic stroke. Neurol Sci 44:765-771, 2023

 

19) Zi W, Song J, Kong W et al:Tirofiban for stroke without large or medium-sized vessel occlusion. N Engl J Med 388:2025-2036, 2023

 

20) Pan Y, Meng X, Yuan B et al:Indobufen versus aspirin in patients with acute ischaemic stroke in China (INSURE):a randomised, double-blind, double-dummy, active control, non-inferiority trial. Lancet Neurol 22:485-493, 2023

 

P.86 掲載の参考文献

21) Liu X, Lv X, Peng Y et al:Clopidogrel with indobufen or aspirin in minor ischemic stroke or high-risk transient ischemic attack:a randomized controlled clinical study. BMC Neurol 24:81, 2024

 

22) Nishiyama Y, Kimura K, Otsuka T et al:Dual antiplatelet therapy with cilostazol for secondary prevention in lacunar stroke:subanalysis of the CSPS.com trial. Stroke 54:697-705, 2023

 

23) Toyoda K, Omae K, Hoshino H et al:Association of timing for starting dual antiplatelet treatment with cilostazol and recurrent stroke. Neurology 98:e983-e992, 2022

 

24) Uchiyama S, Toyoda K, Okamura S et al:Dual antiplatelet therapy with cilostazol in stroke patients with extracranial arterial stenosis or without arterial stenosis:a subgroup analysis of the CSPS.com trial. Int J Stroke 18:426-432, 2022

 

P.87 掲載の参考文献

25) Hoshino H, Toyoda K, Omae K et al:Sex difference in the impact of dual antiplatelet therapy using cilostazol for secondary stroke prevention:a sub-analysis of CSPS.com. J Atheroscler Thromb 30:675-683, 2023

 

26) Tornyos D, Komocsi A, Balint A et al:Antithrombotic therapy for secondary prevention in patients with stroke or transient ischemic attack:a multiple treatment network meta-analysis of randomized controlled trials. PLoS ONE 17:e0273103, 2022

 

27) Hou X, Cen K, Cui Y et al:Antiplatelet therapy for secondary prevention of lacunar stroke:a systematic review and network meta-analysis. Eur J Clin Pharmacol 79:63-70, 2023

 

28) Kitazono T, Kamouchi M, Matsumaru Y et al:Efficacy and safety of prasugrel vs clopidogrel in thrombotic stroke patients with risk factors for ischemic stroke recurrence:a double-blind, phaseIII study (PRASTRO-III). J Atheroscler Thromb 30:222-236, 2023

 

29) Kitazono T, Kamouchi M, Matsumaru Y et al:Comparison of prasugrel and clopidogrel in thrombotic stroke patients with risk factors for ischemic stroke recurrence:an integrated analysis of PRASTRO-I, PRASTRO-II, and PRASTRO-III. Cerebrovasc Dis 52:720-729, 2023

 

P.88 掲載の参考文献

30) Cloud GC, Williamson JD, Thao LTP et al:Low-dose aspirin and the risk of stroke and intracerebral bleeding in healthy older people:secondary analysis of a randomized clinical trial. JAMA Netw Open 6:e2325803, 2023

 

P.89 掲載の参考文献

1) Lip GYH, Proietti M, Potpara T et al:Atrial fibrillation and stroke prevention:25 years of research at EP Europace journal. Europace 25:euad226, 2023

 

2) Linz D, Gawalko M, Betz K et al:Atrial fibrillation:epidemiology, screening and digital health. Lancet Reg Health Eur 37:1007786, 2024

 

P.90 掲載の参考文献

3) Akao M, Ogawa H, Masunaga N et al;Fushimi AF Registry Investigators:10-year trends of antithrombotic therapy status and outcomes in Japanese atrial fibrillation patients - the Fushimi AF Registry. Circ J 86:726-736, 2022

 

4) Fischer U, Koga M, Strbian D et al;ELAN Investigators:Early versus later anticoagulation for stroke with atrial fibrillation. N Engl J Med 388:2411-2421, 2023

 

5) Ma H, Che R, Zhang Q et al:The optimum anticoagulation time after endovascular thrombectomy for atrial fibrillation-related large vessel occlusion stroke:a real-world study. J Neurol 270:2084-2095, 2023

 

P.91 掲載の参考文献

6) Ip YMB, Lau KK, Ko H et al:Association of alternative anticoagulation strategies and outcomes in patients with ischemic stroke while taking a direct oral anticoagulant. Neurology 101:e358-e369, 2023

 

7) RAF and RENO-EXTEND Investigators:Risk of recurrent stroke in patients with atrial fibrillation treated with oral anticoagulants alone or in combination with antiplatelet therapy. Eur Stroke J 8:722-730, 2023

 

8) Chao TF, Potpara TS, Lip GYH:Atrial fibrillation:stroke prevention. Lancet Reg Health Eur 37:100797, 2024

 

9) Chao TF, Tse HF, Teo WS et al;Asia Pacific Heart Rhythm Society Atrial Fibrillation Registry Investigators:Clinical utility and prognostic implications of the 4S-AF scheme:report from Asia Pacific Heart Rhythm Society Atrial Fibrillation Registry. Eur J Clin Invest 52:e13825, 2022

 

P.92 掲載の参考文献

10) Jensen M, Suling A, Metzner A et al:Early rhythm-control therapy for atrial fibrillation in patients with a history of stroke:a subgroup analysis of the EAST-AFNET 4 trial. Lancet Neurol 22:45-54, 2023

 

11) Chao TF, Unverdorben M, Kirchhof P et al:Prescribing patterns and outcomes of edoxaban in atrial fibrillation:one-year data from the Global ETNA-AF program. J Clin Med 12:1870, 2023

 

12) Caso V, de Groot JR, Sanmartin Fernandez M et al:Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation:a systematic review and meta-analysis. Heart 109:178-185, 2023

 

13) Sakai K, Suda S, Iguchi Y et al:High prestroke CHADS2 score predicts unfavorable functional outcome in acute cardioembolic stroke patients prescribed oral anticoagulant therapy:a sub-analysis of the PASTA registry study. J Stroke Cerebrovasc Dis 33:107519, 2024

 

14) Yoshimoto T, Toyoda K, Ihara M et al:Impact of previous stroke on clinical outcome in elderly patients with nonvalvular atrial fibrillation:ANAFIE registry. Stroke 53:2549-2558, 2022

 

P.93 掲載の参考文献

15) Kumar V, Ilkhanoff L:Anticoagulants for atrial fibrillation:from warfarin and DOACs to the promise of factor XI inhibitors. Front Cardiovasc Med 11:1352734, 2024

 

16) Savage P, Cox B, Shahmohammadi M et al:Advances in clinical cardiology 2023:a summary of key clinical Trials. AdvTher, 2024. doi:10.1007/s12325-024-02877-y

 

17) Osmancik P, Herman D, Neuzil P et al;PRAGUE-17 Trial Investigators:4-year outcomes after left atrial appendage closure versus nonwarfarin oral anticoagulation for atrial fibrillation. J Am Coll Cardiol 79:1-14, 2022

 

P.94 掲載の参考文献

18) Dai WL, Zhao ZX, Jiang C et al:Catheter ablation versus medical therapy for atrial fibrillation with prior stroke history:a prospective propensity score-matched cohort study. J Geriatr Cardiol 20:707-715, 2023

 

19) Kanaoka K, Nishida T, Iwanaga Y et al:Oral anticoagulation after atrial fibrillation catheter ablation:benefits and risks. Eur Heart J 45:522-534, 2024

 

20) Nogami A, Soejima K, Morishima I et al;RYOUMA Investigators:Real-world investigation on anticoagulation management before and after catheter ablation for atrial fibrillation in Japan - periprocedural and long-term outcomes. Circ J 87:50-62, 2022

 

21) Milling TJ Jr, Middeldorp S, Xu L et al;ANNEXA-4 Investigators:Final study report of andexanet alfa for major bleeding with factor Xa inhibitors. Circulation 147:1026-1038, 2023

 

P.95 掲載の参考文献

22) Rahman AA, Platt RW, Beradid S et al:Concomitant use of selective serotonin reuptake inhibitors with oral anticoagulants and risk of major bleeding. JAMA Netw Open 7:e243208, 2024

 

23) Wagner B, Hert L, Polymeris AA et al:Impact of type of oral anticoagulants in patients with cerebral microbleeds after atrial fibrillation-related ischemic stroke or TIA:results of the NOACISP-LONG-TERM registry. Front Neurol 13:964723, 2022

 

P.96 掲載の参考文献

24) Masunaga N, Ogawa H, Minami K et al;Fushimi AF Registry Investigators:Association of concomitant coronary artery disease with cardiovascular events in patients with atrial fibrillation - the Fushimi AF Registry. Circ J 86:1252-1262, 2022

 

25) Pardo-Galiana B, Medina-Rodriguez M, Millan-Vazquez M et al:Antithrombotic treatment after carotid stenting in patients with concomitant atrial fibrillation. AJNR Am J Neuroradiol 43:727-730, 2022

 

P.97 掲載の参考文献

26) Al-Shahi Salman R, Stephen J, Tierney JF et al;Collaboration of Controlled Randomised Trials of Long-Term Oral Antithrombotic Agents After Spontaneous Intracranial Haemorrhage (COCROACH):Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH):prospective, individual participant data meta-analysis of randomised trials. Lancet Neurol 22:1140-1149, 2023

 

P.98 掲載の参考文献

1) Dusenbury W, Mathiesen C, Whaley M et al:Ideal foundational requirements for stroke program development and growth:a scientific statement from the American Heart Association. Stroke 54:e175-e187, 2023

 

P.99 掲載の参考文献

2) Raychev R, Sun JL, Schwamm L et al:Performance of thrombectomy-capable, comprehensive, and primary stroke centers in reperfusion therapies for acute ischemic stroke:report from the Get With The Guidelines-Stroke registry. Circulation 148:2019-2028, 2023

 

3) Ren N, Ogata S, Kiyoshige E et al:Associations between adherence to evidence-based, stroke quality indicators and outcomes of acute reperfusion therapy. Stroke 53:3359-3368, 2022

 

P.100 掲載の参考文献

4) Zheng S, Zhang T, Gu HQ et al:Adherence to stroke care performance measures in different regions in China, 2015-2019:evidence from the Chinese Stroke Center Alliance. Neurology 99:e1767-e1778, 2022

 

5) Asif KS, Otite FO, Desai SM et al:Mechanical Thrombectomy Global Access For Stroke (MT-GLASS):a mission thrombectomy (MT-2020 Plus) study. Circulation 147:1208-1220, 2023

 

6) Feldmeier M, Kim AS, Zachrison KS et al:Heterogeneity of state stroke center certification and designation processes. Stroke 55:1051-1058, 2024

 

P.101 掲載の参考文献

7) van Stigt MN, Groenendijk EA, van Meenen LCC et al:Prehospital detection of large vessel occlusion stroke with EEG. Neurology 101:e2522-e2532, 2023

 

8) Perez de la Ossa N, Abilleira S, Jovin TG et al:Effect of direct transportation to thrombectomy-capable center vs local stroke center on neurological outcomes in patients with suspected large-vessel occlusion stroke in nonurban areas:the RACECAT randomized clinical trial. JAMA 327:1782-1794, 2022

 

9) Ramos-Pachon A, Rodriguez-Luna D, Marti-Fabregas J et al:Effect of bypassing the closest stroke center in patients with intracerebral hemorrhage:a secondary analysis of the RACECAT randomized clinical trial. JAMA Neurol 80:1028-1036, 2023

 

P.102 掲載の参考文献

10) Katsanos AH, Sarraj A, Froehler M et al:IV thrombolysis initiated before transfer for endovascular stroke thrombectomy:a systematic review and meta-analysis. Neurology 100:e1436-e1443, 2023

 

11) Hubert GJ, Hubert ND, Maegerlein C et al:Association between use of a flying intervention team vs patient interhospital transfer and time to endovascular thrombectomy among patients with acute ischemic stroke in nonurban Germany. JAMA 327:1795-1805, 2022

 

P.103 掲載の参考文献

12) Garcia-Esperon C, Wu TY, Carraro do Nascimento V et al:Ultra-long transfers for endovascular thrombectomy-mission impossible?:the Australia-New Zealand experience. Stroke 54:151-158, 2023

 

13) Sarraj A, Hill MD, Hussain MS et al:Endovascular thrombectomy treatment effect in direct vs transferred patients with large ischemic strokes:a prespecified analysis of the SELECT2 trial. JAMA Neurol 81:327-335, 2024

 

14) Liu Z, Yang K, Gu H et al:Impact of offhour admission on in-hospital outcomes for patients with stroke receiving reperfusion therapy in China. Stroke 55:1359-1369, 2024

 

15) Seker F, Fifi JT, Morey JR et al:Transferring neurointerventionalists saves time compared with interhospital transfer of stroke patients for endovascular thrombectomy:a collaborative pooled analysis of 1001 patients (EVEREST). J Neurointerv Surg 15:517-520, 2023

 

P.104 掲載の参考文献

16) Elijovich L, Dornbos Iii D, Nickele C et al:Automated emergent large vessel occlusion detection by artificial intelligence improves stroke workflow in a hub and spoke stroke system of care. J Neurointerv Surg 14:704-708, 2022

 

17) Al-Kawaz M, Primiani C, Urrutia V et al:Impact of RapidAI mobile application on treatment times in patients with large vessel occlusion. J Neurointerv Surg 14:233-236, 2022

 

18) Ho W, Fawcett AP:Outcomes in patients with acute stroke treated at a comprehensive stroke center using telemedicine versus in-person assessments. J Telemed Telecare, 2023. doi:10.1177/1357633X231169115

 

19) Lyerly MJ, Daggy J, LaPradd M et al:Impact of telestroke implementation on emergency department transfer rate. Neurology 98:e1617-e1625, 2022

 

20) Sanmartin MX, Katz JM, Eusemann C et al:Cost-effectiveness of remote robotic mechanical thrombectomy in acute ischemic stroke. J Neurosurg 139:721-731, 2023

 

P.105 掲載の参考文献

1) Nguyen TN, Castonguay AC, Siegler JE et al:Mechanical thrombectomy in the late presentation of anterior circulation large vessel occlusion stroke:a guideline from the Society of Vascular and Interventional Neurology Guidelines and Practice Standards Committee. Stroke Vasc Interv Neurol 3:e000512, 2023

 

2) Olthuis SGH, Pirson FAV, Pinckaers FME et al:Endovascular treatment versus no endovascular treatment after 6-24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEANLATE) in the Netherlands:a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial. Lancet 401:1371-1380, 2023

 

P.106 掲載の参考文献

3) Huo X, Ma G, Tong X et al:Trial of endovascular therapy for acute ischemic stroke with large infarct. N Engl J Med 388:1272-1283, 2023

 

4) Sarraj A, Hassan AE, Abraham MG et al:Trial of endovascular thrombectomy for large ischemic strokes. N Engl J Med 388:1259-1271, 2023

 

5) Bendszus M, Fiehler J, Subtil F et al:Endovascular thrombectomy for acute ischaemic stroke with established large infarct:multicentre, open-label, randomised trial. Lancet 402:1753-1763, 2023

 

6) Sarraj A, Abraham MG, Hassan AE et al:Endovascular thrombectomy plus medical care versus medical care alone for large ischaemic stroke:1-year outcomes of the SELECT2 trial. Lancet 403:731-740, 2024

 

7) 日本脳卒中学会脳卒中ガイドライン委員会編:脳卒中治療ガイドライン2021〔改訂2023〕. 協和企画, 2023

 

8) 日本脳卒中学会, 日本脳神経外科学会, 日本脳神経血管内治療学会:経皮経管的脳血栓回収用機器適正使用指針第5版2023年8月. 脳卒中 46:181-216, 2024

 

9) Tao C, Nogueira RG, Zhu Y et al:Trial of endovascular treatment of acute basilarartery occlusion. N Engl J Med 387:1361-1372, 2022

 

10) Jovin TG, Li C, Wu L et al:Trial of thrombectomy 6 to 24 hours after stroke due to basilar-artery occlusion. N Engl J Med 387:1373-1384, 2022

 

11) Fischer U, Kaesmacher J, Strbian D et al;SWIFT DIRECT Collaborators:Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke:an open-label, blinded-outcome, randomised non-inferiority trial. Lancet 400:104-115, 2022

 

12) Mitchell PJ, Yan B, Churilov L et al:Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4.5 h of stroke onset:an open-label, blinded-endpoint, randomised non-inferiority trial. Lancet 400:116-125, 2022

 

13) Majoie CB, Cavalcante F, Gralla J et al;IRIS collaborators:Value of intravenous thrombolysis in endovascular treatment for large-vessel anterior circulation stroke:individual participant data meta-analysis of six randomised trials. Lancet 402:965-974, 2023

 

P.107 掲載の参考文献

14) Turc G, Tsivgoulis G, Audebert HJ et al:European Stroke Organisation (ESO) -European Society for Minimally Invasive Neurological Therapy (ESMINT) expedited recommendation on indication for intravenous thrombolysis before mechanical thrombectomy in patients with acute ischemic stroke and anterior circulation large vessel occlusion. J Neurointervent Surg 14:209-227, 2022

 

15) Kaesmacher J, Cavalcante F, Kappelhof M et al:Time to treatment with intravenous thrombolysis before thrombectomy and functional outcomes in acute ischemic stroke:a meta-analysis. JAMA 331:764-777, 2024

 

16) Albers GW, Jumaa M, Purdon B et al:Tenecteplase for stroke at 4.5 to 24 hours with perfusion-imaging selection. N Engl J Med 390:701-711, 2024

 

17) RESCUE BT Trial Investigators;Qiu Z, Li F, Sang H et al:Effect of intravenous tirofiban vs placebo before endovascular thrombectomy on functional outcomes in large vessel occlusion stroke:the RESCUE BT randomized clinical trial. JAMA 328:543-553, 2022

 

18) Hong JM, Lee JS, Lee YB et al:Nelonemdaz for patients with acute ischemic stroke undergoing endovascular reperfusion therapy:a randomized phase II trial. Stroke 53:3250-3259, 2022

 

19) Hernandez-Jimenez M, Abad-Santos F, Cotgreave I et al:Safety and efficacy of ApTOLL in patients with ischemic stroke undergoing endovascular treatment:a phase 1/2 randomized clinical trial. JAMA Neurol 80:779-788, 2023

 

P.108 掲載の参考文献

20) MARVEL Trial Authors for the MARVEL Investigators;Yang Q, Guo C, Yue C et al:Methylprednisolone as adjunct to endovascular thrombectomy for large-vessel occlusion stroke:the MARVEL randomized clinical trial. JAMA 331:840-849, 2024

 

21) Maurice A, Eugene F, Ronziere T et al;GASS (General Anesthesia versus Sedation for Acute Stroke Treatment) Study Group and the French Society of Anesthesiologists (SFAR) Research Network:General anesthesia versus sedation, both with hemodynamic control, during intraarterial treatment for stroke:the GASS randomized trial. Anesthesiology 136:567-576, 2022

 

22) Chabanne R, Geeraerts T, Begard M et al:Outcomes after endovascular therapy with procedural sedation vs general anesthesia in patients with acute ischemic stroke:the AMETIS randomized clinical trial. JAMA Neurol 80:474-483, 2023

 

23) Liang F, Wu Y, Wang X et al;CANVAS II Group:General anesthesia vs conscious sedation for endovascular treatment in patients with posterior circulation acute ischemic stroke:an exploratory randomized clinical trial. JAMA Neurol 80:64-72, 2023

 

24) Yang P, Song L, Zhang Y et al;ENCHANTED2/MT Investigators:Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT):a multicentre, open-label, blinded-endpoint, randomised controlled trial. Lancet 400:1585-1596, 2022

 

25) Mistry EA, Hart KW, Davis LT et al:Blood pressure management after endovascular therapy for acute ischemic stroke:the BEST-II randomized clinical trial. JAMA 330:821-831, 2023

 

P.109 掲載の参考文献

26) Nam HS, Kim YD, Heo J et al;OPTIMAL-BP Trial Investigators:Intensive vs conventional blood pressure lowering after endovascular thrombectomy in acute ischemic stroke:the OPTIMAL-BP randomized clinical trial. JAMA 330:832-842, 2023

 

27) Gharaibeh K, Aladamat N, Mierzwa AT et al:Blood pressure after successful endovascular therapy:a systematic review and meta-analysis of randomized control trials. Ann Neurol 95:858-865, 2024

 

28) Perez de la Ossa N, Abilleira S, Jovin TGet al;RACECAT Trial Investigators:Effect of direct transportation to thrombectomy-capable center vs local stroke center on neurological outcomes in patients with suspected large-vessel occlusion stroke in nonurban areas:the RACECAT randomized clinical trial. JAMA 327:1782-1794, 2022

 

29) Behrndtz A, Blauenfeldt RA, Johnsen SP et al:Transport strategy in patients with suspected acute large vessel occlusion stroke:TRIAGE-STROKE, a randomized clinical trial. Stroke 54:2714-2723, 2023

 

30) Nogueira RG, Lobsien D, Klisch J et al:Thrombectomy with the pRESET vs Solitaire stent retrievers as first-line large vessel occlusion stroke treatment:a randomized clinical trial. JAMA Neurol 81:170-178, 2024

 

P.112 掲載の参考文献

1) Dmytriw AA, Dibas M, Ghozy S et al:The Woven EndoBridge (WEB) device for the treatment of intracranial aneurysms:ten years of lessons learned and adjustments in practice from the World-WideWEB consortium. Transl Stroke Res 14:455-464, 2023

 

2) Semeraro V, Palmisano V, Limbucci N et al:Woven EndoBridge device for unruptured wide-neck bifurcation aneurysm:a multicenter 5-year follow-up. Neurosurgery 94:1044-1050, 2024

 

3) Fiorella D, Molyneux A, Coon A et al:Safety and effectiveness of the Woven EndoBridge (WEB) system for the treatment of wide necked bifurcation aneurysms:final 5 year results of the pivotal WEB Intra-saccular Therapy study (WEBIT). J NeuroInterv Surg 15:1175-1180, 2023

 

P.113 掲載の参考文献

4) Rodriguez-Calienes A, Vivanco-Suarez J, Lu Y et al:Woven EndoBridge versus stentassisted coil embolization for the treatment of ruptured wide-necked aneurysms:a multicentric experience. Interv Neuroradiol, 2024. doi:10.1177/15910199231223538

 

5) Salem MM, Jankowitz BT, Burkhardt JK et al:Comparative analysis of long term effectiveness of Neuroform Atlas stent versus low profile visualized intraluminal stent/Woven EndoBridge devices in treatment of wide necked intracranial aneurysms. J Neurointerv Surg, 2023. doi:10.1136/jnis-2023-020716

 

6) Signorovitch JE, Sikirica V, Erder MH et al:Matching-adjusted indirect comparisons:a new tool for timely comparative effectiveness research. Value Health 15:940-947, 2012

 

P.114 掲載の参考文献

7) Gallo-Pineda F, Fernandez-Gomez M, Dominguez-Rodriguez C et al:Evaluating efficacy and complications of contour intrasaccular device in cerebral aneurysm management:a multicenter analysis. World Neurosurg 183:e738-e746, 2024

 

8) Mostafa K, Neves FB, Gartner F et al:Contour device implantation versus coil embolization for treatment of narrow neck intracranial aneurysms. Sci Rep 13:4904, 2023

 

9) Liebig T, Gal G, O'Kelly C et al:Neqstent coil-assisted flow diverter (NQS) for the treatment of bifurcation aneurysms:the coil-assisted flow diversion safety and performance study (CAFI). J Neurointerv Surg, 2023. doi:10.1136/jnis-2022-020056

 

10) Morales-Caba L, Lylyk I, Vazquez-Anon V et al:The pCONUS2 and pCONUS2 HPC neck bridging devices:results from an international multicenter retrospective study. Clin Neuroradiol 33:129-136, 2023

 

P.115 掲載の参考文献

11) Lim J, Monteiro A, Jacoby WT et al:Coiling variations for treatment of ruptured intracranial aneurysms:a meta-analytical comparison of comaneci-, stent-, and balloon-coiling assistance techniques. World Neurosurg 175:e1324-e1340, 2023

 

P.116 掲載の参考文献

1) Shehata MA, Ibrahim MK, Ghozy S et al:Long-term outcomes of flow diversion for unruptured intracranial aneurysms:a systematic review and meta-analysis. J Neurointerv Surg 15:898-902, 2023

 

2) Salem MM, Sweid A, Kuhn AL et al:Repeat flow diversion for cerebral aneurysms failing prior flow diversion:safety and feasibility from multicenter experience. Stroke 53:1178-1189, 2022

 

P.117 掲載の参考文献

3) Gui S, Chen X, Wei D et al:Long-term outcomes and dynamic changes of in-stent stenosis after Pipeline embolization device treatment of intracranial aneurysms. J Neurointerv Surg 15:1187-1193, 2023

 

4) Li S, Zeng C, Tao W et al:The safety and efficacy of flow diversion versus conventional endovascular treatment for intracranial aneurysms:a meta-analysis of real-world cohort studies from the past 10 years. AJNR Am J Neuroradiol 43:1004-1011, 2022

 

5) Cler SJ, Lauzier DC, Chatterjee AR et al:Comparative study of on-label versus off-label treatment of intracranial aneurysms with the Pipeline embolization device. J Neurosurg 137:685-690, 2022

 

6) Wang J, Deng X, Li D et al:Pipeline embolization of complex, wide-necked middle cerebral artery bifurcation aneurysms:a single-center experience. Interv Neuroradiol 30:227-233, 2024

 

7) Lee J, Kim DH, Lee SH et al:Stent-assisted coiling vs. flow diverter for treating blood blister-like aneurysms:a proportion meta-analysis. Clin Neuroradiol 32:889-902, 2022

 

8) Srinivasan VM, Jubran JH, Stonnington HO et al:Flow diversion for basilar quadrifurcation aneurysms. J Neurointerv Surg 16:372-378, 2024

 

P.118 掲載の参考文献

9) Chia GS, de Villiers L, Carraro do Nascimento V et al:Safety and clinical effectiveness of Pipeline Shield Device for intracranial aneurysms in an Australian cohort (SCOPE-AUS). Stroke Vasc Neurol 2:e000292, 2022

 

10) Cortez GM, Benalia VHC, Sauvageau E et al:Diffusion-weighted imaging lesions after intracranial aneurysm treatment with Pipeline Flex and Pipeline Flex with Shield technology:a retrospective cohort analysis. J Neurointerv Surg 16:385-391, 2024

 

11) Vollherbst DF, Lucking H, DuPlessis J et al:The FRESH study:treatment of intracranial aneurysms with the New FRED X flow diverter with antithrombotic surface treatment technology-first multicenter experience in 161 patients. AJNR Am J Neuroradiol 44:474-480, 2023

 

12) Sciacca S, Bassiouny A, Mansoor N et al:Early outcomes of the Pipeline Vantage flow diverter:a multicentre study. Clin Neuroradiol 33:887-896, 2023

 

13) de Villiers L, Carraro do Nascimento V, Domitrovic L et al:Vanguard Study:initial experience with the new fourth generation Pipeline Vantage Flow Diverter (PVFD):6-month results, technical and clinical considerations. J Neurointerv Surg, 2024. doi:10.1136/jnis-2023-021182

 

P.119 掲載の参考文献

14) Bonafe A, Perez MA, Henkes H et al:Diversion-p64:results from an international, prospective, multicenter, single-arm post-market study to assess the safety and effectiveness of the p64 flow modulation device. J Neurointerv Surg 14:898-903, 2022

 

15) Oliver AA, Bilgin C, Vercnocke AJ et al:Benchtop proof of concept and comparison of iron- and magnesium-based bioresorbable flow diverters. J Neurosurg 139:150-156, 2023

 

16) Sasaki N, Ishii A, Yagi S et al:Bioresorbable poly (L-lactic acid) flow diverter versus cobalt-chromium flow diverter:in vitro and in vivo analysis. Stroke 54:1627-1635, 2023

 

17) Akiyama R, Ishii A, Kikuchi T et al:Onset-to-treatment time and aneurysmal regression predict improvement of cranial neuropathy after flow diversion treatment in patients with symptomatic internal carotid artery aneurysms. J Neurointerv Surg 15:886-891, 2023

 

P.120 掲載の参考文献

18) Kiyofuji S, Graffeo CS, Perry A et al:Meta-analysis of treatment outcomes of posterior circulation non-saccular aneurysms by flow diverters. J Neurointerv Surg 10:493-499, 2018

 

19) Baker CM, Hunsaker JC, Folzenlogen ZA et al:Technical nuances and outcomes of Telescoping pipeline flow diverters:a multicenter study. Oper Neurosurg (Hagerstown) 24:e255-e263, 2023

 

20) Hohenstatt S, Ulfert C, Herweh C et al:Acute intraprocedural thrombosis after flow diverter stent implantation:risk factors and relevance of standard observation time for early detection and management. Clin Neuroradiol 33:343-351, 2023

 

21) El Naamani K, Saad H, Chen CJ et al:Comparison of flow-redirection endoluminal device and pipeline embolization device in the treatment of intracerebral aneurysms. Neurosurgery 92:118-124, 2023

 

22) Matsukawa H, Uchida K, Rajbhandari S et al:Difference in the cumulative incidence of aneurysmal occlusion by Flow Redirection Endoluminal Device and Pipeline Embolization Device in the treatment of unruptured internal carotid artery aneurysms:a propensity score-matched cohort study. Neurosurg Rev 46:125, 2023

 

P.122 掲載の参考文献

1) Li W, Wu C, Deng R et al:Comparison of perioperative safety of carotid artery stenting and endarterectomy in the treatment of carotid artery stenosis:a meta-analysis of randomized controlled trials. World Neurosurg 181:e356-e375, 2024

 

2) Reiff T, Eckstein HH, Mansmann U et al:Carotid endarterectomy or stenting orbest medical treatment alone for moderate-to-severe asymptomatic carotid artery stenosis:5-year results of a multicentre, randomised controlled trial. Lancet Neurol 21:877-888, 2022

 

3) Poorthuis MHF, Solomon Y, Herings RAR et al:Temporal trends and determinants of stroke risk in patients with medically treated asymptomatic carotid stenosis. Stroke 54:1735-1749, 2023

 

4) Kremer C, Lorenzano S, Bejot Y et al:Sex differences in outcome after carotid revascularization in symptomatic and asymptomatic carotid artery stenosis. J VascSurg 78:817-827. e10, 2023

 

5) Larson A, Nardi V, Brinjikji W et al:Endarterectomy for symptomatic non-stenotic carotids:a systematic review and descriptive analysis. Stroke Vasc Neurol 7:6-12, 2022

 

6) Kurosaki Y, Kinosada M, Ikeda H et al:Clinical features and long-term outcomes of symptomatic low-grade carotid stenosis. J Stroke Cerebrovasc Dis 31:106779, 2022

 

P.123 掲載の参考文献

7) Leung YYR, Bera K, Urriza Rodriguez D et al:Safety of carotid endarterectomy for symptomatic stenosis by age:meta-analysis with individual patient data. Stroke 54:457-467, 2023

 

8) Sugiyama T, Ito M, Sugimori H et al:Tissue acceleration as a novel metric for surgical performance during carotid endarterectomy. Oper Neurosurg (Hagerstown) 25:343-352, 2023

 

9) Rychen J, Madarasz A, Murek M et al:Management of postoperative internal carotid artery intimal flap after carotid endarterectomy:a cohort study and systematic review. J Neurosurg 136:647-654, 2022

 

P.124 掲載の参考文献

10) Squizzato F, Piazza M, Forcella E et al:Impact of carotid stent design on embolic filter debris load during carotid artery stenting. Stroke 54:2534-2541, 2023

 

11) Batista S, Oliveira L de B, Sousa MP et al:Transradial artery access for carotid artery stenting:a pooled analysis. Neuroradiol J, 2024. doi:10.1177/19714009231224410

 

12) Zhou C, Cao YZ, Jia ZY et al:Endovascular recanalization of symptomatic chronic ICA occlusion:procedural outcomes and radiologic predictors. AJNR Am J Neuroradiol 44:303-310, 2023

 

13) de Borst GJ:Transcarotid artery revascularization. Br J Surg 110:127-128, 2023

 

14) Stonko DP, Goldsborough E 3rd, Kibrik P et al:Use of transcarotid artery revascularization, transfemoral carotid artery stenting, and carotid endarterectomy in the US from 2015 to 2019. JAMA Netw Open 5:E2231944, 2022

 

P.125 掲載の参考文献

15) Zarrintan S, Elsayed N, Patel RJ et al:Propensity-score matched analysis of three years survival of trans carotid artery revascularization versus carotid endarterectomy in the Vascular Quality Initiative Medicare-Linked database. Ann Surg 278:559-567, 2023

 

16) Naazie IN, Dodo-Williams T, Janssen C et al:Impact of flow reversal duration on neurological outcomes of transcarotid artery revascularization (TCAR). Ann Vasc Surg 89:11-19, 2023

 

17) Mayorga-Carlin M, Shaw P, Ozsvath K et al:Transcarotid revascularization outcomes do not differ by patient age or sex. J Vasc Surg 76:209-219. e2, 2022

 

18) Mehta V, Tharp P, Caruthers C et al:Transcarotid artery revascularization can safely be performed with regional anesthesia and no intensive care unit stay. J VascSurg 77:555-558, 2023

 

19) Farooqui M, Zaidat OO, Hassan AE et al:Functional and safety outcomes of carotid artery stenting and mechanical thrombectomy for large vessel occlusion ischemic stroke with tandem lesions. JAMA Netw Open 6:E230736, 2023

 

20) Diana F, Romoli M, Toccaceli G et al:Emergent carotid stenting versus no stenting for acute ischemic stroke due to tandem occlusion:a meta-analysis. J Neurointerv Surg 15:428-432, 2023

 

21) van Elk T, Maes L, van der Meij A et al:Immediate carotid artery stenting or deferred treatment in patients with tandem carotid lesions treated endovascularly for acute ischaemic stroke. EJVES Vasc Forum 61:31-35, 2024

 

P.126 掲載の参考文献

22) van Dam-Nolen DHK, Truijman MTB, van der Kolk AG et al:Carotid plaque characteristics predict recurrent ischemic stroke and TIA:the PARISK (Plaque At RISK) Study. JACC Cardiovasc Imaging 15:1715-1726, 2022

 

23) Camps-Renom P, McCabe J, Marti-Fabregas J et al:Association of plaque inflammation with stroke recurrence in patients with unproven benefit from carotid revascularization. Neurology 99:e109-e118, 2022

 

24) Zhang R, Zhang Q, Ji A et al:Prediction of new cerebral ischemic lesion after carotid artery stenting:a high-resolution vessel wall MRI-based radiomics analysis. Eur Radiol 33:4115-4126, 2023

 

25) Homssi M, Saha A, Delgado D et al:Extracranial carotid plaque calcification and cerebrovascular ischemia:a systematic review and meta-analysis. Stroke 54:2621-2628, 2023

 

P.127 掲載の参考文献

26) Mota L, Wang SX, Cronenwett JL et al:Association of stroke or death with severity of carotid lesion calcification in patients undergoing carotid artery stenting. J Vasc Surg 79:305-315. e3, 2024

 

27) Marfella R, Prattichizzo F, Sardu C et al:Microplastics and nanoplastics in atheromas and cardiovascular events. N Engl J Med 390:900-910, 2024

 

28) Griffin KJ, Harmsen WS, Mandrekar J et al:Epidemiology of spontaneous cervical artery dissection:population-based study. Stroke 55:670-677, 2024

 

29) Bontinis V, Antonopoulos CN, Bontinis A et al:A systematic review and meta-analysis of carotid artery stenting for the treatment of cervical carotid artery dissection. Eur J Vasc Endovasc Surg 64:299-308, 2022

 

30) Yaghi S, Engelter S, Del Brutto VJ et al:Treatment and outcomes of cervical artery dissection in adults:a scientific statement from the American Heart Association. Stroke 55:e91-e106, 2024

 

P.128 掲載の参考文献

1) Zhai Y, Shi M, Liu Y et al:Magnitude of systolic blood pressure reduction and early achieved blood pressure and clinical outcomes after acute ischemic stroke. J Am Heart Assoc 12:e030692, 2023

 

P.129 掲載の参考文献

2) Liu L, Xie X, Pan Y et al:Early versus delayed antihypertensive treatment in patients with acute ischaemic stroke:multicentre, open label, randomised, controlled trial. BMJ 383:e076448, 2023

 

3) Wang X, Minhas JS, Moullaali TJ et al:Associations of early systolic blood pressure control and outcome after thrombolysis-eligible acute ischemic stroke:results from the ENCHANTED Study. Stroke 53:779-787, 2022

 

P.130 掲載の参考文献

4) Mistry EA, Hart KW, Davis LT et al:Blood pressure management after endovascular therapy for acute ischemic stroke:the BEST-II randomized clinical trial. JAMA 330:821-831, 2023

 

5) Hsu CY, Saver JL, Ovbiagele B et al:Association between magnitude of differential blood pressure reduction and secondary stroke prevention:a meta-analysis and meta-regression. JAMA Neurol 80:506-515, 2023

 

P.131 掲載の参考文献

6) Zhan R, Zhang J, Chen X et al:Targeting the efficacy of intensive blood pressure treatment in hypertensive patients - an exploratory analysis of SPRINT. Circ J 87:1212-1218, 2023

 

7) Ho VS, Cenzer IS, Nguyen BT et al:Time to benefit for stroke reduction after blood pressure treatment in older adults:a meta-analysis. J Am Geriatr Soc 70:1558-1568, 2022

 

8) Gaba P, O'Donoghue ML, Park JG et al:Association between achieved lowdensity lipoprotein cholesterol levels and long-term cardiovascular and safety outcomes:an analysis of FOURIER-OLE. Circulation 147:1192-1203, 2023

 

9) San X, Lv Z, Xu P et al:The prevention of stroke by statins:a meta-analysis. Medicine (Baltimore) 101:e30606, 2022

 

P.132 掲載の参考文献

10) Khan SU, Yedlapati SH, Lone AN et al:PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction:a systematic review and network meta-analysis. BMJ 377:e069116, 2022

 

11) Lee B, Hong SJ, Rha SW et al:Moderate-intensity statin plus ezetimibe vs high-intensity statin according to baseline LDL-C in the treatment of atherosclerotic cardiovascular disease:a post-hoc analysis of the RACING randomized trial. Atherosclerosis 386:117373, 2023

 

12) Lee YJ, Cho JY, You SC et al:Moderate-intensity statin with ezetimibe vs. high-intensity statin in patients with diabetes and atherosclerotic cardiovascular disease in the RACING trial. Eur Heart J 44:972-983, 2023

 

13) Betrisey S, Haller ML, Efthimiou O et al:Lipid-lowering therapy and risk of hemorrhagic stroke:a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc 13:e030714, 2024

 

14) Das Pradhan A, Glynn RJ, Fruchart JC et al:Triglyceride lowering with pemafibrate to reduce cardiovascular risk. N Engl J Med 387:1923-1934, 2022

 

15) Olshansky B, Bhatt DL, Miller M et al:Cardiovascular benefits of icosapent ethyl in patients with and without atrial fibrillation in REDUCE-IT. J Am Heart Assoc 12:e026756, 2023

 

16) Xu Q, Du L, Gu H et al:The effect of omega-3 polyunsaturated fatty acids on stroke treatment and prevention:a systematic review and meta-analysis. Nutr Hosp 39:924-935, 2022

 

17) Lv X, Liu X, Peng Y et al:Medium-intensity statin with ezetimibe versus high-intensity statin in acute ischemic cerebrovascular disease (MESIA):a randomized clinical trial. J Stroke Cerebrovasc Dis 33:107647, 2024

 

P.133 掲載の参考文献

18) Yin Y, Zhang L, Marshall I et al:Statin therapy for preventing recurrent stroke in patients with ischemic stroke:a systematic review and meta-analysis of randomized controlled trials and observational cohort studies. Neuroepidemiology 56:240-249, 2022

 

19) Lee M, Cheng CY, Wu YL et al:Association between intensity of low-density lipoprotein cholesterol reduction with statin-based therapies and secondary stroke prevention:a meta-analysis of randomized clinical trials. JAMA Neurol 79:349-358, 2022

 

20) Zheng H, Li H, Wang Y et al:Rosuvastatin slows progression of carotid intima-media thickness:the METEOR-China randomized controlled study. Stroke 53:3004-3013, 2022

 

21) Zhang T, Liang Z, Lin T et al:Cost-effectiveness of folic acid therapy for primary prevention of stroke in patients with hypertension. BMC Med 20:407, 2022

 

22) Bao H, Huang X, Li P et al:Combined use of amlodipine and folic acid are significantly more efficacious than amlodipine alone in lowering plasma homocysteine and blood pressure among hypertensive patients with hyperhomocysteinemia and intolerance to ACEI:a multicenter, randomized, double-blind, parallel-controlled clinical trial. J Clin Hypertens (Greenwich) 25:689-699, 2023

 

23) Lee SE, Nam H, Choi HS et al:Comparative effects of sodium-glucose cotransporter 2 inhibitor and thiazolidinedione treatment on risk of stroke among patients with type 2 diabetes mellitus. Diabetes Metab J 46:567-577, 2022

 

24) Rahman H, Khan SU, Lone AN et al:Sodium-glucose cotransporter-2 inhibitors and primary prevention of atherosclerotic cardiovascular disease:a meta-analysis of randomized trials and systematic review. J Am Heart Assoc 12:e030578, 2023

 

P.134 掲載の参考文献

25) Wang ZM, Chen B, Zhou B et al:Green tea consumption and the risk of stroke:a systematic review and meta-analysis of cohort studies. Nutrition 107:111936, 2023

 

26) Wang ZM, Bu XX, Zhou B et al:Dietary calcium intake and the risk of stroke:meta-analysis of cohort studies. Nutr Metab Cardiovasc Dis 33:934-946, 2023

 

27) Anadani M, Turan TN, Yaghi S et al:Change in smoking behavior and outcome after ischemic stroke:post-hoc analysis of the SPS3 trial. Stroke 54:921-927, 2023

 

28) Ihl T, Ahmadi M, Laumeier I et al:Patient-centered outcomes in a randomized trial investigating a multimodal prevention program after transient ischemic attack or minor stroke:the INSPiRE-TMS trial. Stroke 53:2730-2738, 2022

 

III章 脳外傷

P.137 掲載の参考文献

1) Encarnacion Ramirez MJ, Barrientos Castillo RE, Vorobiev A et al:Basal cisternostomy for traumatic brain injury:a case report of unexpected good recovery. Chin J Traumatol 25:302-305, 2022

 

2) Giammattei L, Starnoni D, Messerer M et al:Basal cisternostomy for severe TBI:surgical technique and cadaveric dissection. Front Surg 9:915818, 2022

 

3) Chandra VVR, Mowliswara Prasad BC, Banavath HN et al:Cisternostomy versus decompressive craniectomy for the management of traumatic brain injury:a randomized controlled trial. World Neurosurg 162:e58-e64, 2022

 

4) Kumari S, Jaiswal M, Ojha BK:Is basal cisternostomy in traumatic brain injury a need of hour or white elephant - a randomized trial to answer. Surg Neurol Int 14:412, 2023

 

5) Liu J, Zhang S, Chen Y et al:Cisternostomy is not beneficial to reduce the occurrence of post-traumatic hydrocephalus in traumatic brain injury. Acta Neurochir (Wien) 166:200, 2024

 

P.138 掲載の参考文献

6) Hutchinson PJ, Adams H, Mohan M et al:Decompressive craniectomy versus craniotomy for acute subdural hematoma. N Engl J Med 388:2219-2229, 2023

 

7) van Essen TA, van Erp IAM, Lingsma HF et al:Comparative effectiveness of decompressive craniectomy versus craniotomy for traumatic acute subdural hematoma (CENTER-TBI):an observational cohort study. EClinicalMedicine 63:102161, 2023

 

8) Habibi MA, Kobets AJ, Boskabadi AR et al:A comprehensive systematic review and meta-analysis study in comparing decompressive craniectomy versus craniotomy in patients with acute subdural hematoma. Neurosurg Rev 47:77, 2024

 

9) Shafique MA, Mustafa MS, Luke-Wold B et al:Surgical strategies in acute subdural hematoma:a meta-analysis of decompressive craniectomy vs. craniotomy. Acta Neurochir (Wien) 166:121, 2024

 

10) Nadeem A, Siddiqui T, Rais T et al:Comparing surgical outcomes:craniotomy versus decompressive craniectomy in acute subdural hematoma - a systematic review and meta-analysis. World Neurosurg X 23:100368, 2024

 

11) Vreeburg RJG, Singh RD, van Erp IAM et al:Early versus delayed cranioplasty after decompressive craniectomy in traumatic brain injury:a multicenter observational study within CENTER-TBI and Net-QuRe. J Neurosurg, 2024. doi:10.3171/2024.1.JNS232172

 

P.139 掲載の参考文献

12) Shibahashi K, Ohbe H, Matsui H et al:Real-world benefit of intracranial pressure monitoring in the management of severe traumatic brain injury:a propensity score matching analysis using a nationwide inpatient database. J Neurosurg 139:1514-1522, 2023

 

13) Waack AL, Lucarelli V, Leverich M et al:Patterns and outcomes of intracranial pressure monitoring in traumatic brain injury:an analysis of the National Inpatient Sample. Clin Neurol Neurosurg 238:108168, 2024

 

14) Payen JF, Launey Y, Chabanne R et al:Intracranial pressure monitoring with and without brain tissue oxygen pressure monitoring for severe traumatic brain injury in France (OXY-TC):an open-label, randomized controlled superiority trial. Lancet Neurol 22:1005-1014, 2023

 

15) Santana LS, Diniz JBC, Solla DJF et al:Brain tissue oxygen combined with intracranial pressure monitoring versus isolated intracranial pressure monitoring in patients with traumatic brain injury:an updated systematic review and meta-analysis. Neurol Sci, 2024. doi:10.1007/s10072-024-07392-0

 

P.140 掲載の参考文献

16) Svedung Wettervik T, Beqiri E, Hanell A et al:Visualization of cerebral pressure autoregulatory insults in traumatic brain injury. Crit Care Med, 2024. doi:10.1097/CCM.0000000000006287

 

17) Laic RAG, Verhamme P, Vander Sloten J et al:Long-term outcomes after traumatic brain injury in elderly patients on antithrombotic therapy. Acta Neurochir (Wien) 165:1297-1307, 2023

 

18) Pan L, Hu J:Effect of prior anticoagulation therapy on outcomes of traumatic brain injury:a systematic review and metaanalysis. Exp Ther Med 27:160, 2024

 

19) O'Donohoe RB, Lee HQ, Tan T et al:The impact of preinjury antiplatelet and anticoagulant use on elderly patients with moderate or severe traumatic brain injury following traumatic acute subdural hematoma. World Neurosurg 166:e521-e527, 2022

 

P.141 掲載の参考文献

20) Yorkgitis BK, Tatum DM, Taghavi S et al:Eastern association for the surgery of trauma multicenter trial:comparison of pre-injury antithrombotic use and reversal strategies among severe traumatic brain injury patients. J Trauma Acute Care Surg 92:88-92, 2022

 

21) Vattipally VN, Ran KR, Giwa GA et al:Impact of antithrombotic medications and reversal strategies on the surgical management and outcomes of traumatic acute subdural hematoma. World Neurosurg 182:e431-e441, 2024

 

22) Sheth KN, Solomon N, Alhanti B et al:Time to anticoagulation reversal and outcomes after intracerebral hemorrhage. JAMA Neurology 81:363-372, 2024

 

23) Rychen J, Weiger VF, Halbeisen FS et al:Perioperative continuation or ultra-early resumption of antithrombotics in elective neurosurgical cranial procedures. Neurosurg Focus 55:E6, 2023

 

P.142 掲載の参考文献

1) Patricios JS, Schneider KJ, Dvorak J et al:Consensus statement on concussion in sport:the 6th International Conference on Concussion in Sport-Amsterdam, October 2022. Br J Sports Med 57:695-711, 2023

 

2) 荻野雅宏, 中山晴雄, 荒木尚 他:スポーツによる脳振盪に関する共同声明-第6回国際スポーツ脳振盪会議(アムステルダム, 2022)-日本語版. 神経外傷 (in submission)

 

P.143 掲載の参考文献

3) Echemendia RJ, Brett BL, Broglio S et al:Sport concussion assessment tool(TM)-6 (SCAT6). Br J Sports Med 57:622-631, 2023

 

4) Davis GA, Echemendia RJ, Ahmed OH et al:Child SCAT6. Br J Sports Med 57:636-647, 2023

 

5) Echemendia RJ, Ahmed OH, Bailey CM et al:The Concussion Recognition Tool 6 (CRT6). Br J Sports Med 57:692-694, 2023

 

6) Patricios J, Schneider GM, van Ierssel J et al:Sport Concussion Office Assessment Tool 6 (SCOAT6). Br J Sports Med 2023:651-667, 2023

 

7) Davis GA, Patricios JS, Purcell LK et al:Child SCOAT6. Br J Sports Med 57:672-688, 2023

 

8) 日本脳神経外傷学会スポーツ脳神経外傷検討委員会:脳振盪を疑ったときのツール. http://sports.hc.keio.ac.jp/ja/athlete-support/files/2020/5/8/26f5c581548b9dd3b074a24343ad8704.pdf

 

P.144 掲載の参考文献

9) Leddy JJ, Burma JS, Toomey CM et al:Rest and exercise early after sport-related concussion:a systematic review and meta-analysis. Br J Sports Med 57:762-770, 2023

 

10) Macnow T, Curran T, Tolliday C et al:Effect of screen time on recovery from concussion:a randomized clinical trial. JAMA Pediatr 175:1124-1131, 2021

 

11) Cairncross M, Yeates KO, Tang K et al:Early postinjury screen time and concussion recovery. Pediatrics 150:e2022056835, 2022

 

12) Leddy JJ, Master CL, Mannix R et al:Early targeted heart rate aerobic exercise versus placebo stretching for sport-related concussion in adolescents:a randomized controlled trial. Lancet Child Adolesc Health 5:792-799, 2021

 

13) Trbovich AM, Howie EK, Elbin RJ et al:The relationship between accelerometer measured sleep and next day ecological momentary assessment symptom report during sport-related concussion recovery. Sleep Health 7:519-525, 2021

 

P.145 掲載の参考文献

14) Schneider KJ, Critchley ML, Anderson V et al:Targeted interventions and their effect on recovery in children, adolescents and adults who have sustained a sportrelated concussion:a systematic review. Br J Sports Med 57:771-779, 2023

 

15) Eliason P, Galarneau JM, Kolstad AT et al:Prevention strategies and modifiable risk factors for sport-related concussions and head impacts:a systematic review and meta-analysis. Br J Sports Med 57:749-761, 2023

 

16) Katz DI, Bernick C, Dodick DW et al:National Institute of neurological disorders and stroke consensus diagnostic criteria for traumatic encephalopathy syndrome. Neurology 96:848-863, 2021

 

P.146 掲載の参考文献

17) Daneshvar DH, Mez J, Alosco ML et al:Incidence of and mortality from amyotrophic lateral sclerosis in National Football League athletes. JAMA Netw Open 4:e2138801, 2021

 

18) Pupillo E, Bianchi E, Vanacore N et al:Increased risk and early onset of ALS in professional players from Italian soccer teams. Amyotroph Lateral Scler Frontotemporal Degener 21:403-409, 2020

 

19) Tabor JB, Brett BL, Nelson L et al:Role of biomarkers and emerging technologies in defining and assessing neurobiological recovery after sport-related concussion:a systematic review. Br J Sports Med 57:789-797, 2023

 

20) Makdissi M, Critchley ML, Cantu RC et al:When should an athlete retire or discontinue participating in contact or collision sports following sport-related concussion? A systematic review. Br J Sports Med 57:822-830, 2023

 

21) Willick SE, Lexell J:Paralympic sports medicine and sports science - introduction. PM R 6 (8 Suppl):S1-S3, 2014

 

22) Derman W, Runciman P, Jordaan E:High incidence of injuries at the Pyeongchang 2018 Paralympic Winter Games:a prospective cohort study of 6804 athlete days. Br J Sports Med 54:38-43, 2020

 

P.148 掲載の参考文献

1) Christian CW, Block R;Committee on Child Abuse and Neglect;American Academy of Pediatrics:Abusive head trauma in infants and children. Pediatrics 123:1409-1411, 2009

 

2) こども家庭庁:こども虐待による死亡事例等の検証結果等について(第19次報告)(令和5年9月). 個別調査票による死亡事例の調査報告. https://www.cfa.go.jp/assets/contents/node/basic_page/field_ref_resources/c36a12d5-fb29-481d-861c-a7fea559909d/f31e8d7f/20230905_councils_shingikai_gyakutai_boushihogojirei_19-houkoku_07.pdf

 

3) こども家庭庁:令和4年度児童相談所における児童虐待相談対応件数とその推移. https://www.cfa.go.jp/assets/contents/node/basic_page/field_ref_resources/a176de99-390e-4065-a7fb-fe569ab2450c/12d7a89f/20230401_policies_jidougyakutai_19.pdf

 

4) 宮本信也:子ども虐待のいま. チャイルドヘルス 26:166-169, 2023

 

P.149 掲載の参考文献

5) 天笠俊介, 辻聡, 守谷俊:日本における虐待頭部外傷診療の問題点. 日救急医会誌 31:112-119, 2020

 

6) 山田不二子, 丸山朋子, 相田典子 他:AHT診断アルゴリズム(診断の手引き). 2022年9月1日第2版.

 

7) 田村正徳, 中村肇, 奥山眞紀子 他;厚生労働省・神経疾患研究委託費研究班:「虐待が疑われる乳幼児頭部外傷(Abusive head trauma in infants and young children, AHT)」の診断・治療・予防の手引き. 2009

 

8) Duhaime AC, Christian CW:Abusive head trauma:evidence, obfuscation, and informed management. J Neurosurg Pediatr 24:481-488, 2019

 

9) Narisawa A, Nonaka M, Akutsu N et al: Unexplained mechanism of subdural hematoma with convulsion suggests nonaccidental head trauma:a multicenter, retrospective study by the Japanese Head injury of Infants and Toddlers study (JHITs) group. PLoS One 17:e0277103, 2022

 

10) 宮坂実木子:虐待による乳幼児頭部外傷. 日小児放射線会誌 36:91-100, 2020

 

P.150 掲載の参考文献

11) Wright JN:CNS injuries in abusive head trauma. AJR Am J Roentgenol 208:991-1001, 2017

 

12) Choudhary AK, Ishak R, Zacharia TT et al:Imaging of spinal injury in abusive head trauma:a retrospective study. Pediatric Radiol 44:1130-1140, 2014

 

13) 吉野智美, 古家信介, 石川順一 他:Abusive Head Traumaの退院時神経学的転帰 不良例の臨床的特徴. 日救急医会誌 33:103-109, 2022

 

14) Takanashi J:Two newly proposed encephalitis/encephalopathy syndromes. Brain Dev 31:521-528, 2009

PubMed

15) Takanashi J, Mizuguchi M, Terai M et al:Disrupted glutamate-glutamine cycle in acute encephalopathy with bi-phasic seizures and late reduced diffusion. Neuroradiology 57:1163-1168. 2015

 

16) Takanashi J, Tada H, Terada H et al:Excitotoxicity in acute encephalopathy with biphasic seizures and late reduced diffusion. AJNR Am J Neuroraiol. 30:132-135, 2009

 

17) Takase N, Igarashi N, Taneichi H et al:Infantile traumatic brain injury with a biphasic clinical course and late reduced diffusion. J Neurol Sci 390:63-66, 2018

 

18) Wang HC, Tsai JC, Lee JE et al:Direct visualization of microcirculation impairment after acute subdural hemorrhage in a novel animal model. J Neurosurg 129:997-1007, 2018

 

P.151 掲載の参考文献

19) Suh DW, Song HH, Mozafari H et al:Determining the tractional forces on vitreoretinal interface using a computer simulation model in abusive head trauma. Am J Ophthalmol 223:396-404, 2021

 

20) Maguire SA, Watts PO, Shaw AD et al:Retinal haemorrhages and related findings in abusive and non-abusive head trauma:a systematic review. Eye (Lond) 27:28-36, 2013

 

21) Christian CW, Levin AV;Council on Child Abuse and Neglect et al:The eye examination in the evaluation of child abuse. Pediatrics 142:e20181411, 2018

 

22) Hymel KP, Carroll CL, Frazier TN et al:Validation of the PediBIRN-7 clinical prediction rule for pediatric abusive head trauma. Child Abuse Negl 152:106799, 2024

 

P.152 掲載の参考文献

23) Pfeiffer H, Cowley LE, Kemp AM et al:Validation of the PredAHT-2 prediction tool for abusive head trauma. Emerg Med J 37:119-126, 2020

 

24) Okuzono S, Fujiwara T, Kato T er al:Spanking and subsequent behavioral problems in toddlers:a propensity score-matched, prospective study in Japan. Child Abuse Negl 69:62-71, 2017

 

P.153 掲載の参考文献

25) Fujiwara T, Isumi A, Sampei M et al:Effectiveness of using an educational video simulating the anatomical mechanism of shaking and smothering in a home-visit program to prevent self-reported infant abuse:a population-based quasi-experimental study in Japan. Child Abuse Negl 101:104359, 2020

 

26) Scott LJ, Wilson R, Davies P et al:Educational interventions to prevent paediatric abusive head trauma in babies younger than one year old:a systematic review and meta-analyses. Child Abuse Negl 134:105935, 2022

 

27) 小橋孝介:医療機関向け虐待対応啓発プログラムBEAMS(ビームス)～わが国の子ども虐待対応の均霑化に向けて～. 外来小児科 23:60-64, 2020

 

P.154 掲載の参考文献

1) American Congress of Rehabilitation Medicine, Brain Injury Interdisciplinary Special Interest Group, Disorders of Consciousness Task Force:Definition of mild traumatic brain injury. J Head Trauma Rehabil 8:86-87, 1993

 

P.155 掲載の参考文献

2) Silverberg ND, Iverson GL;ACRM Mild TBI Definition Expert Consensus Group and the ACRM Brain Injury Special Interest Group Mild TBI Task Force:Expert panel survey to update the American Congress of Rehabilitation Medicine definition of mild traumatic brain injury. Arch Phys Med Rehabil 102:76-86, 2021

 

3) Silverberg ND, Iverson GL;ACRM Brain Injury Special Interest Group Mild TBI Task Force members:The American Congress of Rehabilitation Medicine diagnostic criteria for mild traumatic brain injury. Arch Phys Med Rehabil 104:1343-1355, 2023

 

4) Bryant AM, Rose NB, Temkin NR et al:Profiles of cognitive functioning at 6 months after traumatic brain injury among patients in level I trauma centers:a TRACK-TBI study. JAMA Netw Open 6:e2349118, 2023

 

P.156 掲載の参考文献

5) Shahim P, Zetterberg H:Neurochemical markers of traumatic brain injury:relevance to acute diagnostics, disease monitoring, and neuropsychiatric outcome prediction. Biol Psychiatry 91:405-412, 2022

 

6) Bernick C, Shan G, Ritter A et al:Blood biomarkers and neurodegeneration in individuals exposed to repetitive head impacts. Alzheimers Res Ther 15:173, 2023

 

P.157 掲載の参考文献

7) Schneider ALC, Huie JR, Boscardin WJ et al:Cognitive outcome 1 year after mild traumatic brain injury:results from the TRACK-TBI study. Neurology 98:e1248-e1261, 2022

 

8) Lennon MJ, Brooker H, Creese B et al:Lifetime traumatic brain injury and cognitive domain deficits in late life:the PROTECT-TBI cohort study. J Neurotrauma 40:1423-1435, 2023

 

P.158 掲載の参考文献

9) Chanti-Ketterl M, Pieper CF, Yaffe K et al:Associations between traumatic brain injury and cognitive decline among older male veterans:a twin study. Neurology 101:e1761-e1770, 2023

 

10) Haarbauer-Krupa J, Pugh MJ, Prager EM et al:Epidemiology of chronic effects of traumatic brain injury. J Neurotrauma 38:3235-3247, 2021

 

P.159 掲載の参考文献

11) Wright TJ, Elliott TR, Randolph KM et al:Prevalence of fatigue and cognitive impairment after traumatic brain injury. PLoS One 19:e0300910, 2024

 

12) Robertson-Benta CR, Pabbathi Reddy S, Stephenson DD et al:Cognition and post-concussive symptom status after pediatric mild traumatic brain injury. Child Neuropsychol 30:203-220, 2024

 

P.160 掲載の参考文献

13) Clark E, Faruque S, Mutebi C et al:Investigating the relationship between mild traumatic brain injury and Alzheimer's disease and related dementias:a systematic review. J Neurol 269:4635-4645, 2022

 

IV章 定位・機能

P.162 掲載の参考文献

1) Misra S, Kasner SE, Dawson J et al:Outcomes in patients with poststroke seizures:a systematic review and meta-analysis. JAMA Neurol 80:1155-1165, 2023

 

2) Yoshimura H, Tanaka T, Fukuma K et al;PROPOSE Study Investigators:Impact of seizure recurrence on 1-year functional outcome and mortality in patients with poststroke epilepsy. Neurology 99:e376-e384, 2022

 

3) Hou H, Sun G, Duan Z et al:Clinical characteristics of cognitive impairment and its related risk factors in post-stroke epilepsy. Epileptic Disord 24:677-686, 2022

 

4) Stefanidou M, Himali JJ, Devinsky O et al:Vascular risk factors as predictors of epilepsy in older age:the Framingham Heart Study. Epilepsia 63:237-243, 2022

 

P.163 掲載の参考文献

5) Liu F, Chen D, Fu Y et al:Incidence and association of seizures in stroke patients following endovascular treatment:a systematic review and meta-analysis. Eur J Neurol 30:134-143, 2023

 

6) Tanaka T, Fukuma K, Abe S et al:Association of cortical superficial siderosis with post-stroke epilepsy. Ann Neurol 93:357-370, 2023

 

7) Sinka L, Abraira L, Imbach LL et al:Association of mortality and risk of epilepsy with type of acute symptomatic seizure after ischemic stroke and an updated prognostic model. JAMA Neurol 80:605-613, 2023

 

8) Huang L, Fu C, Li J et al:Late-onset epilepsy and the risk of dementia:a systematic review and meta-analysis. Aging Clin Exp Res 34:1771-1779, 2022

 

9) Helmstaedter C, Lutz T, Wolf V et al:Prevalence of dementia in a level 4 university epilepsy center:how big is the problem? Front Neurol 14:1217594, 2023

 

10) Tai XY, Torzillo E, Lyall DM et al:Association of dementia risk with focal epilepsy and modifiable cardiovascular risk factors. JAMA Neurol 80:445-454, 2023

 

11) Zhang X, Ahmed R, Thayer Z et al:Late-onset epilepsy with cognitive symptoms:Comparison of cognitive and imaging profiles with probable Alzheimer's disease. Epilepsy Behav 146:109371, 2023

 

12) Hernandez G, Sala-Padro J, Adell V et al:Cognitive decline in adult-onset temporal lobe epilepsy:insights from aetiology. Clin Neurol Neurosurg 237:108159, 2024

 

13) Ha J, Son NH, Park YH et al:Association of cognitive enhancers and incident seizure risk in dementia:a population-based study. BMC Geriatr 22:480, 2022

 

14) Hodges JR, Warlow CP:Syndromes of transient amnesia:towards a classification. a study of 153 cases. J Neurol Neurosurg Psychiatry 53:834-843, 1990

 

15) Zeman AZ, Boniface SJ, Hodges JR:Transient epileptic amnesia:a description of the clinical and neuropsychological features in 10 cases and a review of the literature. J Neurol Neurosurg Psychiatry 64:435-443, 1998

 

P.164 掲載の参考文献

16) Sancetta BM, Ricci L, Assenza G et al:EPIAMNE:a new scoring system for differentiating transient EPIleptic AMNEsia from transient global amnesia. Brain Sci 12:1632, 2022

 

17) Cretin B, Philippi N, Bousiges O et al:Transient epileptic amnesia:a retrospective cohort study of 127 cases, including CSF amyloid and tau features. J Neurol 270:2256-2270, 2023

 

18) Lam AD, Deck G, Goldman A et al:Silent hippocampal seizures and spikes identified by foramen ovale electrodes in Alzheimer's disease. Nat Med 23:678-680, 2017

 

19) Vossel KA, Ranasinghe KG, Beagle AJ et al:Incidence and impact of subclinical epileptiform activity in Alzheimer's disease. Ann Neurol 80:858-870, 2016

PubMed

20) Devulder A, Macea J, Kalkanis A et al:Subclinical epileptiform activity and sleep disturbances in Alzheimer's disease. Brain Behav 13:e3306, 2023

 

21) Dun C, Zhang Y, Yin J et al:Bi-directional associations of epilepsy with dementia and Alzheimer's disease:a systematic review and meta-analysis of longitudinal studies. Age Ageing 51:afac010, 2022

 

22) Leo A, Tallarico M, Sciaccaluga M et al:Epilepsy and Alzheimer's disease:current concepts and treatment perspective on two closely related pathologies. Curr Neuropharmacol 20:2029-2033, 2022

 

23) Elo J, Tolppanen AM, Koponen M et al:Recent hospitalization and initiation of antiepileptics among persons with Alzheimer's disease. J Am Med Dir Assoc 24:213-219. e6, 2023

 

24) Gouilly D, Vrillon A, Bertrand E et al:Translocator protein (TSPO) genotype does not change cerebrospinal fluid levels of glial activation, axonal and synaptic damage markers in early Alzheimer's disease. Neuroimage Clin 43:103626, 2024

 

25) Negi D, Granak S, Shorter S et al:Molecular biomarkers of neuronal injury in epilepsy shared with neurodegenerative diseases. Neurotherapeutics 20:767-778, 2023

 

P.165 掲載の参考文献

26) Tong J, Ji T, Liu T et al:Efficacy and safety of six new antiseizure medications for adjunctive treatment of focal epilepsy and epileptic syndrome:a systematic review and network meta-analysis. Epilepsy Behav 152:109653, 2024

 

27) Talwar A, Estes E, Aparasu R et al:Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications:a systematic review and meta-analysis. Exp Neurol 359:114238, 2023

 

28) Tzadok M, Gur-Pollack R, Florh H et al:Real-life experience with purified cannabidiol treatment for refractory epilepsy:a multicenter retrospective study. Pediatr Neurol 150:91-96, 2024

 

29) Solmi M, De Toffol M, Kim JY et al:Balancing risks and benefits of cannabis use:umbrella review of meta-analyses of randomised controlled trials and observational studies. BMJ 382:e072348, 2023

 

30) Perriguey M, Succar ME, Clement A et al:High-purified cannabidiol efficacy and safety in a cohort of adult patients with various types of drug-resistant epilepsies. Rev Neurol (Paris) 180:147-153, 2024

 

31) Szaflarski JP, Devinsky O, Lopez M et al:Long-term efficacy and safety of cannabidiol in patients with treatment-resistant epilepsies:four-year results from the expanded access program. Epilepsia 64:619-629, 2023

 

32) Peltola J, Colon AJ, Pimentel J et al;MORE Study Group:Deep brain stimulation of the anterior nucleus of the thalamus in drug-resistant epilepsy in the MORE multicenter patient registry. Neurology 100:e1852-e1865, 2023

 

P.166 掲載の参考文献

33) Fisher R, Salanova V, Witt T et al;SANTE Study Group:Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia 51:899-908, 2010

 

P.167 掲載の参考文献

1) Touma L, Dansereau B, Chan AY et al:Neurostimulation in people with drugresistant epilepsy:systematic review and meta-analysis from the ILAE Surgical Therapies Commission. Epilepsia 63:1314-1329, 2022

 

P.168 掲載の参考文献

2) Kostov KH, Kostov H, Larsson PG et al:Norwegian population-based study of longterm effects, safety, and predictors of response of vagus nerve stimulation treatment in drug-resistant epilepsy:the NORPulse study. Epilepsia 63:414-425, 2022

 

3) Bagic AI, Verner R, Afra P et al;ASCEND Study Group:ASCEND:a randomized controlled trial of titration strategies for vagus nerve stimulation in drug-resistant epilepsy. Epilepsy Behav 145:109333, 2023

 

4) Peltola J, Colon AJ, Pimentel J et al;MORE Study Group:Deep brain stimulation of the anterior nucleus of the thalamus in drug-resistant epilepsy in the MORE multicenter patient registry. Neurology 100:e1852-e1865, 2023

 

5) Dalic LJ, Warren AEL, Bulluss KJ et al:DBS of thalamic centromedian nucleus for lennox-gastaut syndrome (ESTEL Trial). Ann Neurol 91:253-267, 2022

 

P.169 掲載の参考文献

6) Fields MC, Eka O, Schreckinger C et al:A multicenter retrospective study of patients treated in the thalamus with responsive neurostimulation. Front Neurol 14:1202631, 2023

 

7) Singh RK, Eschbach K, Samanta D et al:Responsive neurostimulation in drug-resistant pediatric epilepsy:findings from the epilepsy surgery subgroup of the Pediatric Epilepsy Research Consortium. Pediatr Neurol 143:106-112, 2023

 

P.170 掲載の参考文献

8) Zou X, Shi Y, Wu X et al:Efficacy of short pulse and conventional deep brain stimulation in Parkinson's disease:a systematic review and meta-analysis. Neurol Science 44:815-825, 2023

 

9) Schnitzler A, Mir P, Brodsky MA et al;PROGRESS Study Investigators:Directional deep brain stimulation for Parkinson's disease:results of an international crossover study with randomized, double-blind primary endpoint. Neuromodulation 25:817-828, 2022

 

10) Kapural L, Patterson DG, Li S et al:Multiphase spinal cord stimulation in participants with chronic back or leg pain:results of the BENEFIT-02 randomized clinical trial. Neuromodulation 26:1400-1411, 2023

 

11) Wang D, Lu Y, Han Y et al:The influence of etiology and stimulation target on the outcome of deep brain stimulation for chronic neuropathic pain:a systematic review and meta-analysis. Neuromodulation 27:83-94, 2024

 

12) Liu C, Li L, Li B et al:Efficacy and safety of theta burst vs repetitive transcranial magnetic stimulation for the treatment of depression:a meta-analysis of randomized controlled trials. Neuromodulation, 2023. doi:10.1016/j.neurom.2023.08.009

 

P.171 掲載の参考文献

13) Remore LG, Tolossa M, Wei W et al:Deep brain stimulation of the medial forebrain bundle for treatment-resistant depression:a systematic review focused on the long-term antidepressive effect. Neuromodulation, 2023. doi:10.1016/j.neurom.2023.03.011

 

14) Rubin DB, Ajiboye AB, Barefoot L et al:Interim safety profile from the feasibility study of the BrainGate Neural Interface system. Neurology 100:e1177-e1192, 2023

 

15) Lycke R, Kim R, Zolotavin P et al:Low-threshold, high-resolution, chronically stable intracortical microstimulation by ultraflexible electrodes. Cell Rep 42:112554, 2023

 

16) Angrick M, Luo S, Rabbani Q et al:Online speech synthesis using a chronically implanted brain-computer interface in an individual with ALS. Sci Rep 14:9617, 2024

 

17) Zhang Q, Hu S, Talay R et al:A prototype closed-loop brain-machine interface for the study and treatment of pain. Nat Biomed Eng 7:533-545, 2023

 

P.172 掲載の参考文献

18) Catalan JM, Trigili E, Nann M et al:Hybrid brain/neural interface and autonomous vision-guided whole-arm exoskeleton control to perform activities of daily living (ADLs). J Neuroeng Rehabil 20:61, 2023

 

19) Jia T, Li C, Mo L et al:Tailoring brain-machine interface rehabilitation training based on neural reorganization:towards personalized treatment for stroke patients. Cereb Cortex 33:3043-3052, 2023

 

20) Tang J, LeBel A, Jain S et al:Semantic reconstruction of continuous language from non-invasive brain recordings. Nat Neurosci 26:858-866, 2023

 

21) Kim S, Moon HS, Vo TT et al:Whole-brain mapping of effective connectivity by fMRI with cortex-wide patterned optogenetics. Neuron 111:1732-1747. e6, 2023

 

22) Griggs WS, Norman SL, Deffieux T et al:Decoding motor plans using a closed-loop ultrasonic brain-machine interface. Nat Neurosci 27:196-207, 2024

 

P.173 掲載の参考文献

23) Guo Y, Sun L, Zhong W et al:Artificial intelligence-assisted repair of peripheral nerve injury:a new research hotspot and associated challenges. Neural Regen Res 19:663-670, 2024

 

24) Sujatha Ravindran A, Contreras-Vidal J:An empirical comparison of deep learning explainability approaches for EEG using simulated ground truth. Sci Rep 13:17709, 2023

 

P.174 掲載の参考文献

1) Schmidt SL, Chowdhury AH, Mitchell KT et al:At home adaptive dual target deep brain stimulation in Parkinson's disease with proportional control. Brain 147:911-922, 2024

 

P.175 掲載の参考文献

2) Marceglia S, Conti C, Svanidze O et al:Double-blind cross-over pilot trial protocol to evaluate the safety and preliminary efficacy of long-term adaptive deep brain stimulation in patients with Parkinson's disease. BMJ open 12:e049955, 2022

 

3) Sarica C, Zemmar A, Yousefi O:Spinal cord stimulation for Parkinson's disease:a systematic review and meta-analysis of pain and motor outcomes. Stereotact Funct Neurosurg 101:244-253, 2023

 

P.176 掲載の参考文献

4) Milekovic T, Moraud EM, Macellari N et al:A spinal cord neuroprosthesis for locomotor deficits due to Parkinson's disease. Nat Med 29:2854-2865, 2023

 

P.177 掲載の参考文献

5) Blesa J, Pineda-Pardo JA, Inoue KI et al:BBB opening with focused ultrasound in nonhuman primates and Parkinson's disease patients:targeted AAV vector delivery and PET imaging. Sci Adv 9:eadf4888, 2023

 

6) Lin S, Shu Y, Zhang C et al:Globus pallidus internus versus subthalamic nucleus deep brain stimulation for isolated dystonia:a 3-year follow-up. Eur J Neurol 30:2629-2640, 2023

 

7) Hock AN, Jensen SR, Svaerke KW et al:A randomised double-blind controlled study of Deep Brain Stimulation for dystonia in STN or GPi - a long term follow-up after up to 15 years. Parkinsonism Relat Disord 96:74-79, 2022

 

P.178 掲載の参考文献

8) Krause P, Kroneberg D, Gruber D et al:Long-term effects of pallidal deep brain stimulation in tardive dystonia:a follow-up of 5-14 years. J Neurol 269:3563-3568, 2022

 

9) Horn A, Reich MM, Ewert S et al:Optimal deep brain stimulation sites and networks for cervical vs. generalized dystonia. Proc Natl Acad Sci U S A 119:e2114985119, 2022

 

P.179 掲載の参考文献

10) Kvernmo N, Konglund AE, Reich MM et al:Deep brain stimulation for arm tremor:a randomized trial comparing two targets. Ann Neurol 91:585-601, 2022

 

P.180 掲載の参考文献

11) Blomstedt Y, Stenmark Persson R, Awad A et al:10 years follow - up of deep brain stimulation in the caudal Zona incerta/posterior subthalamic area for essential tremor. Mov Disord Clin Pract 10:783-793, 2023

 

12) Neudorfer C, Kroneberg D, Al-Fatly B et al:Personalizing deep brain stimulation using advanced imaging sequences. Ann Neurol 91:613-628, 2022

 

13) Murakami M, Horisawa S, Kim K et al:Long-term follow-up of task-specific tremor after thalamotomy:a retrospective observational study. Ann Clin Transl Neurol 11:321-327, 2024

 

P.183 掲載の参考文献

1) Cosgrove GR, Lipsman N, Lozano AM et al:Magnetic resonance imaging-guided focused ultrasound thalamotomy for essential tremor:5-year follow-up results. J Neurosurg 138:1028-1033, 2022

 

2) Fukutome K, Hirabayashi H, Osakada Y et al:Bilateral magnetic resonance imaging-guided focused ultrasound thalamotomy for essential tremor. Stereotact Funct Neurosurg 100:44-52, 2022

 

P.184 掲載の参考文献

3) Yamamoto K, Sarica C, Elias GJB et al:Ipsilateral and axial tremor response to focused ultrasound thalamotomy for essential tremor:clinical outcomes and probabilistic mapping. J Neurol Neurosurg Psychiatry, 2022. doi:10.1136/jnnp-2021-328459

 

4) Arcadi A, Aviles-Olmos I, Gonzalez-Quarante LH et al:Magnetic resonanceguided focused ultrasound (MRgFUS) -thalamotomy for essential tremor:lesion location and clinical outcomes. Mov Disord, 2024. doi:10.1002/mds.29801

 

5) Feltrin FS, Chopra R, Pouratian N et al:Focused ultrasound using a novel targeting method four-tract tractography for magnetic resonance-guided high-intensity focused ultrasound targeting. Brain Commun 4:fcac273, 2022

 

6) Germann J, Santyr B, Boutet A et al:Comparative neural correlates of DBS and MRgFUS lesioning for tremor control in essential tremor. J Neurol Neurosurg Psychiatry 95:180-183, 2024

 

7) Buchele F, Mahendran S, Uhl M et al:Impact of target depth on safety and efficacy outcomes in MR-guided focused ultrasound thalamotomy for tremor patients. J Neurosurg 140:1451-1458, 2023

 

8) Golfre Andreasi N, Braccia A, Levi V et al:The optimal targeting for focused ultrasound thalamotomy differs between dystonic and essential tremor:a 12-month prospective pilot study. Mov Disord Clin Pract 11:69-75, 2024

 

9) Swytink-Binnema CA, Coreas A, Pichardo S et al:An intraoperative accelerometry and real-time analysis tool for magnetic resonance-guided focused ultrasound thalamotomy. J Neurosurg, 2024. doi:10.3171/2024.1.JNS231830

 

10) Hino S, Maki F, Yamaguchi T et al:Effectiveness and safety of MR-guided focused ultrasound thalamotomy in patients with essential tremor and low skull density ratio:a study of 101 cases. J Neurosurg, 2024. doi:10.3171/2023.11.JNS231799

 

P.185 掲載の参考文献

11) Iijima K, Yokota H, Yamaguchi T et al:Predictors of thermal increase in magnetic resonance-guided focused ultrasound treatment for essential tremor:histogram analysis of skull density ratio values for 1024 elements. J Neurosurg 136:1381-1386, 2021

 

12) Kyle K, Peters J, Jonker B et al:Magnetic resonance-guided focused ultrasound for treatment of essential tremor:ventral intermediate nucleus ablation alone or additional posterior subthalamic area lesioning? Mov Disord Clin Pract 11:504-514, 2024

 

13) Rohringer CR, Sewell IJ, Gandhi S et al:Cognitive effects of unilateral thalamotomy for tremor:a meta-analysis. Brain Commun 4:fcac287, 2022

 

14) Saporito G, Sucapane P, Ornello R et al:Cognitive outcomes after focused ultrasound thalamotomy for tremor:results from the COGNIFUS (COGNitive in Focused UltraSound) study. Parkinsonism Relat Disord 106:105230, 2023

 

15) Bagarinao E, Maesawa S, Kato S et al:Cerebellar and thalamic connector hubs facilitate the involvement of visual and cognitive networks in essential tremor. Parkinsonism Relat Disord 121:106034, 2024

 

16) Chua MMJ, Blitz SE, Ng PR et al:Focused ultrasound thalamotomy for tremor in Parkinson's disease:outcomes in a large, prospective cohort. Mov Disord 38:1962-1967, 2023

 

17) Krishna V, Fishman PS, Eisenberg HM et al:Trial of globus pallidus focused ultrasound ablation in Parkinson's disease. N Engl J Med 388:683-693, 2023

 

P.186 掲載の参考文献

18) Martinez-Fernandez R, Natera-Villalba E, Manez Miro JU et al:Prospective longterm follow-up of focused ultrasound unilateral subthalamotomy for Parkinson disease. Neurology 100:e1395-e1405, 2023

 

19) Martinez Fernandez R, Natera Villalba E, Rodriguez-Rojas R et al:Unilateral focused ultrasound subthalamotomy in early Parkinson's disease:a pilot study. J Neurol Neurosurg Psychiatry 95:206-213, 2024

 

20) Deuschl G, Antonini A, Costa J et al:European Academy of Neurology/Movement Disorder Society-European section guideline on the treatment of Parkinson's disease:I. Invasive therapies. Mov Disord 37:1360-1374, 2022

 

P.187 掲載の参考文献

21) Blesa J, Pineda-Pardo JA, Inoue KI et al:BBB opening with focused ultrasound in nonhuman primates and Parkinson's disease patients:targeted AAV vector delivery and PET imaging. Sci Adv 9:eadf4888, 2023

 

22) Meng Y, Pople CB, Huang Y et al:Putaminal recombinant glucocerebrosidase delivery with magnetic resonance-guided focused ultrasound in Parkinson's disease:a phase I study. Mov Disord 37:2134-2139, 2022

 

23) Meng Y, Goubran M, Rabin JS et al:Blood-brain barrier opening of the default mode network in Alzheimer's disease with magnetic resonance-guided focused ultrasound. Brain 146:865-872, 2023

 

24) Rezai AR, Ranjan M, Haut MW et al:Focused ultrasound-mediated blood-brain barrier opening in Alzheimer's disease:long-term safety, imaging, and cognitive outcomes. J Neurosurg 139:275-283, 2022

 

25) Rezai AR, D'Haese PF, Finomore V et al:Ultrasound blood-brain barrier opening and aducanumab in Alzheimer's disease. N Engl J Med 390:55-62, 2024

 

26) Xhima K, Markham-Coultes K, Hahn Kofoed R et al:Ultrasound delivery of a TrkA agonist confers neuroprotection to Alzheimer-associated pathologies. Brain 145:2806-2822, 2022

 

27) Zrinzo L:Severe refractory obsessive compulsive disorder and depression:should we consider stereotactic neurosurgery? Neuropsychiatr Dis Treat 20:469-478, 2024

 

P.188 掲載の参考文献

28) Krishna V, Mindel J, Sammartino F et al:A phase 1 open-label trial evaluating focused ultrasound unilateral anterior thalamotomy for focal onset epilepsy. Epilepsia 64:831-842, 2023

 

P.189 掲載の参考文献

1) Doquenia MLM:Developments in poststroke spasticity care with early use of botulinum toxin A:a review. Journal of Medicine, University of Santo Tomas 7:1244-1251, 2023

 

P.190 掲載の参考文献

2) Suputtitada A:Emerging theory of sensitization in post-stroke muscle spasticity. Front Rehabil Sci 4:1169087, 2023

 

3) Lindsay C, Humphreys I, Phillips C et al:Estimating the cost consequence of the early use of botulinum toxin in post-stroke spasticity:secondary analysis of a randomised controlled trial. Clin Rehabil 37:373-380, 2023

 

4) Baricich A, Bertoni M, Santamato A et al:Adjunctive treatment and BoNT-A for post-stroke spasticity:are we really focusing on the patient-centered goals? Front Neurol 14:1134691, 2023

 

5) Novarella F, Carotenuto A, Cipullo P et al:Persistence with botulinum toxin treatment for spasticity symptoms in multiple sclerosis. Toxins (Basel) 14:774. 2022

 

6) Masrour M, Zare A, Presedo A et al.:Intrathecal baclofen efficacy for managing motor function and spasticity severity in patients with cerebral palsy:a systematic review and meta-analysis. BMC Neurol 24:143, 2024

 

7) Abdelmageed S, Horak VJ, Mossner J et al:Safety and efficacy of intrathecal baclofen trials for the treatment of hypertonia:a retrospective cohort study. J Neurosurg Pediatr 33:179-184, 2023

 

P.191 掲載の参考文献

8) Cho SR:Intrathecal baclofen therapy:pros and cons. Ann Rehabil Med 47:1-3, 2023

 

9) Duan H, Lian Y, Jing Y et al:Research progress in extracorporeal shock wave therapy for upper limb spasticity after stroke. Front Neurol 14:1121026, 2023

 

10) Otero-Luis I, Cavero-Redondo I, Alvarez-Bueno C et al:Effectiveness of extracorporeal shock wave therapy in treatment of spasticity of different aetiologies:a systematic review and meta-analysis. J Clin Med 13:1323, 2024

 

11) Zhang X, Ma Y:Global trends in research on extracorporeal shock wave therapy (ESWT) from 2000 to 2021. BMC Musculoskelet Disord 24:312, 2023

 

12) Chen ZJ, Li YA, Xia N et al: Effects of repetitive peripheral magnetic stimulation for the upper limb after stroke:metaanalysis of randomized controlled trials. Heliyon 22:e15767, 2023

 

P.192 掲載の参考文献

13) Allen JR, Karri SR, Yang C et al:Spinal cord stimulation for poststroke hemiparesis:a scoping review. Am J Occup Ther 7:7802180220, 2024

 

14) Yee J, Low CY, Mohamad Hashim N et al:Clinical spasticity assessment assisted by machine learning methods and rule-based decision. Diagnostics 13:739, 2023

 

15) Ho JS, Ko KS, Law SW et al:The effectiveness of robotic-assisted upper limb rehabilitation to improve upper limb function in patients with cervical spinal cord injuries:a systematic literature review. Front Neurol 14:1126755, 2023

 

16) Murakami Y, Honaga K, Kono H et al:New artificial intelligence-integrated electromyography-driven robot hand for upper extremity rehabilitation of patients with stroke:a randomized, controlled trial. Neurorehabil Neural Repair 37:298-306, 2023

 

17) Syringas P, Economopoulos T, Kouris I et al:Rehabotics:a comprehensive rehabilitation platform for post-stroke spasticity, incorporating a soft glove, a robotic exoskeleton hand and augmented reality serious games. Eng Proc 50:2, 2023

 

18) Suputtitada A, Chatromyen S, Chen CPC et al: Best practice guidelines for the management of patients with post-stroke spasticity:a modified scoping review. Toxins (Basel) 16:98, 2024

 

P.194 掲載の参考文献

1) Guan Y, Li J, Gong X et al:Safety and efficacy of hypofractionated stereotactic radiotherapy with anlotinib targeted therapy for glioblastoma at the first recurrence:a preliminary report. Brain Sci 12:471, 2022

 

P.195 掲載の参考文献

2) Grzbiela H, Nowicka E, Gawkowska M et al:Robotic stereotactic radiotherapy for intracranial meningiomas - an opportunity for radiation dose de-escalation. Cancers (Basel) 15:5436, 2023

 

3) Fatima N, La Dine AK, Barnard ZR et al:Safety and efficacy of hypofractionated stereotactic radiosurgery in facial nerve Schwannoma. Otol Neurotol 43:e841-e845, 2022

 

4) Curry SD, Kocharyan A, Lekovic GP:Multi-disciplinary approach to skull base paragangliomas. Brain Sci 13:1533, 2023

 

5) Berber T, Numanoglu C, Uysal E et al:Results of salvage treatment with CyberKnife(R) fractioned radiosurgery in recurrent large chordoma. Eur Spine J 32:244-253, 2023

 

P.196 掲載の参考文献

6) Palmer JD, Klamer BG, Ballman KV et al:Association of long-term outcomes with stereotactic radiosurgery vs whole-brain radiotherapy for resected brain metastasis:a secondary analysis of the N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group) randomized clinical trial. JAMA Oncol 8:1809-1815, 2022

 

7) Grishchuk D, Dimitriadis A, Sahgal A et al:ISRS technical guidelines for stereotactic radiosurgery:treatment of small brain metastases (<- 1 cm in diameter). Pract Radiat Oncol 13:183-194, 2023

 

8) Lee J, Kim HJ, Kim WC:CyberKnifebased stereotactic radiosurgery of fractionated stereotactic radiotherapy in older patients with brain metastases from non-small cell lung cancer. Radiat Oncol J 41:258-266, 2023

 

P.197 掲載の参考文献

9) Li C, Li K, Zhong S et al:Which is the best treatment for melanoma brain metastases? A Bayesian network meta-analysis and systematic review. Crit Rev Oncol Hematol 194:104227, 2024

 

10) Franklin C, Mohr P, Bluhm L et al:Impact of radiotherapy and sequencing of systematic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis:a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG. J Immunother Cancer 10:e004509, 2022

 

P.198 掲載の参考文献

11) Wang HH, Tian SS, Yang JM et al:Risk-adapted stereotactic body radiotherapy for patients with cervical spinal metastases. Cancer Sci 113:4277-4288, 2022

 

12) Loebel F, Pontoriero A, Kluge A et al:Image-guided robotic radiosurgery for the treatment of arteriovenous malformations. PLos One 17:e0266744, 2022

 

13) Niwa R, Ichi S, Nomura R et al:Hypofractionated stereotactic radiosurgery with CyberKnife for large arteriovenous malformation and arteriovenous malformation located in eloquent area. Acta Neurol Med Chir (Tokyo) 62:445-450, 2022

 

P.199 掲載の参考文献

14) Luna AL, Gonzalez JA, Guardo LL et al:CyberKnife radiosurgery for refractory bilateral trigeminal neuralgia. Case report. Colom Med (Cali) 53:e5005283, 2022

 

15) Goc B, Roch-Zniszczol A, Larysz D et al:The effectiveness and toxicity of frameless CyberKnife based radiosurgery for Parkinson's disease:phaseII study. Biomedicines 11:288-297, 2023

 

16) Lovo EE, Moreira A, Cruz C et al:Radio-modulation in mixed, complex, cancer pain by triple target irradiation in the brain:a preliminary experience. Cureus 14:e25430, 2022

 

P.200 掲載の参考文献

17) Romanelli P, Beltramo G:Image-guided stereotactic radiosurgery for the treatment of spasticity and pain:a preliminary experience. Cureus 14:e24021, 2022

 

V章 小児

P.202 掲載の参考文献

1) 阪本博昭:脊髄髄膜瘤. "胎児水頭症診断と治療ガイドライン改訂第2版" 山崎麻美 編. pp104-119, 金芳堂, 2010

 

2) 近藤厚生, 多田克彦, 和田誠司 他:葉酸による神経管閉鎖障害の予防:発生率, リスク因子, 葉酸サプリメントの摂取, 行政への要望. 日周産期新生児会誌 57:8-18, 2021

 

P.203 掲載の参考文献

3) Adzick NS, Thom EA, Spong CY et al;MOMS Investigators:A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med 364:993-1004, 2011

 

P.204 掲載の参考文献

4) Elbabaa SK, Gildehaus AM, Pierson MJ et al:First 60 fetal in-utero myelomeningocele repairs at Saint Louis Fetal Care Institute in the post-MOMS trial era:hydrocephalus treatment outcomes (endoscopic third ventriculostomy versus ventriculoperitoneal shunt). Childs Nerv Syst 33:1157-1168, 2017

 

5) Omar AT, Espiritu AI, Spears J:Endoscopic third ventriculostomy with or without choroid plexus coagulation for myelomeningocele-associated hydrocephalus:systematic review and meta-analysis. J Neurosurg Pediatr 29:435-443, 2022

 

6) Albalkhi I, Garatli S, Helal B et al:Morbidity and etiology-based success rate of combined endoscopic ventriculostomy and choroid plexus cauterization:a systematic review and meta-analysis of 1918 infants. Neurosurg Rev 46:180, 2023

 

7) Warf BC, Weber DS, Day EL et al:Endoscopic third ventriculostomy with choroid plexus cauterization:predictors of long-term success and comparison with shunt placement for primary treatment of infant hydrocephalus. J Neurosurg Pediatr 32:201-213, 2023

 

8) Tulipan N, Wellons JC 3rd, Thom EA et al:Prenatal surgery for myelomeningocele and the need for cerebrospinal fluid shunt placement. J Neurosurg Pediatr 16:613-620, 2015

 

9) Agrawal S, Al-Refai A, Abbasi N et al:Correlation of fetal ventricular size and need for postnatal cerebrospinal fluid diversion surgery in open spina bifida. Ultrasound Obstet Gynecol 59:799-803, 2022

 

10) Donepudi R, Brock C, Schulte S et al:Trend in ventricle size during pregnancy and its use for prediction of ventriculoperitoneal shunt in fetal open neural tube defect. Ultrasound Obstet Gynecol 56:678-683, 2020

 

P.205 掲載の参考文献

11) Mitts MD, Whitehead W, Corroenne R et al:Prenatal surgery in fetal myelomeningocele with severe ventriculomegaly. Ultrasound Obstet Gynecol, 2024. doi:10.1002/uog.27585

 

12) Lapa DA, Chmait RH, Gielchinsky Y et al:Percutaneous fetoscopic spina bifida repair:effect on ambulation and need for postnatal cerebrospinal fluid diversion and bladder catheterization. Ultrasound Obstet Gynecol 58:582-589, 2021

 

13) Trigo L, Chmait RH, Llanes A et al:Revisiting MOMS criteria for prenatal repair of spina bifida:upper gestational-age limit should be raised and assessment of prenatal motor function rather than anatomical level improves prediction of postnatal function. Ultrasound Obstet Gynecol 63:53-59, 2024

 

14) Houtrow AJ, Thom EA, Fletcher JM et al:Prenatal repair of myelomeningocele and school-age functional outcomes. Pediatrics 145:e20191544, 2020

 

15) Sanz Cortes M, Corroenne R, Pyarali M et al:Ambulation after in-utero fetoscopic and open spina bifida repair:predictors for ambulation at 30 months. Ultrasound Obstet Gynecol, 2024. doi:10.1002/uog.27589

 

P.206 掲載の参考文献

16) Brock JW 3rd, Carr MC, Adzick NS et al:Bladder function after fetal surgery for myelomeningocele. Pediatrics 136:906-913, 2015

 

17) Brock JW 3rd, Thomas JC, Baskin LS et al:Effect of prenatal repair of myelomeningocele on urological outcomes at school age. J Urol 202:812, 2019

 

18) Clayton DB, Thomas JC, Brock JW 3rd:Fetal repair of myelomeningocele:current status and urologic implications. J Pediatr Urol 16:3-9, 2020

 

19) Feng S, Yang Y, Yu Z et al:Folic acid supplementation rescues bladder injury in fetal rats with myelomeningocele. Birth Defects Res 115:1685-1692, 2023

 

20) Sasaoka AKS, Moron AF, Araujo Junior E et al:Ultrasound evaluation of uterine scar thickness after open fetal surgery for myelomeningocele. Childs Nerv Syst 39:655-661, 2023

 

21) McLone DG, Knepper PA:The cause of Chiari II malformation:a unified theory. Pediatr Neurosci 15:1-12, 1989

 

22) Heffez DS, Aryanpur J, Hutchins GM et al:The paralysis associated with myelomeningocele:clinical and experimental data implicating a preventable spinal cord injury. Neurosurgery 26:987-992, 1990

 

P.207 掲載の参考文献

23) Espinoza J, Shamshirsaz AA, Sanz Cortes M et al:Two-port, exteriorized uterus, fetoscopic meningomyelocele closure has fewer adverse neonatal outcomes than open hysterotomy closure. Am J Obstet Gynecol 225:327. e1-327. e9, 2021

 

24) Joyeux L, van der Merwe J, Aertsen M et al:Neuroprotection is improved by watertightness of fetal spina bifida repair in the sheep model. Ultrasound Obstet Gynecol 61:81-92, 2023

 

25) Coelho G, Trigo L, Faig F et al:The potential applications of augmented reality in fetoscopic surgery for antenatal treatment of myelomeningocele. World Neurosurg 159:27-32, 2022

 

26) Joyeux L, De Bie F, Danzer E et al:Learning curves of open and endoscopic fetal spina bifida closure:systematic review and meta-analysis. Ultrasound Obstet Gynecol 55:730-739, 2020

 

P.208 掲載の参考文献

27) Nonaka M, Komori Y, Isozaki H et al:Current status and challenges of neurosurgical procedures for patients with myelomeningocele in real-world Japan. Childs Nerv Syst 39:3137-3145, 2023

 

28) 香川尚己, 渡邊美穂, 遠藤誠之:脊髄髄膜瘤胎児手術の治療. 小児外科 55:56-62, 2023

 

29) MRC Vitamin Study Research Group:Prevention of neural tube defects:results of the Medical Research Council Vitamin Study. Lancet 338:131-137, 1991

 

30) Caceres A, Jimenez-Chaverri AL, Alpizar-Quiros PA et al:Pre and postnatal care characteristics and management features of children born with myelomeningocele in the post-folate fortification era of staple foods in Costa Rica (2004-2022). Childs Nerv Syst 39:1755-1764, 2023

 

31) Mai CT, Evans J, Alverson CJ et al:Changes in spina bifida lesion level after folic acid fortification in the US. J Pediatr 249:59-66, 2022

 

P.209 掲載の参考文献

32) Zanon N, Dos Santos Silva RP, Varjao Vieira E et al:Spina bifida folate fortification in Brazil, update 2022:a cross-sectional study. Childs Nerv Syst 39:1765-1771, 2023

 

P.210 掲載の参考文献

1) Morota N, Sakamoto H:Surgery for spina bifida occulta:spinal lipoma and tethered spinal cord. Childs Nerv Syst 39:2847-2864, 2023

 

P.211 掲載の参考文献

2) Perera D, Craven CL, Thompson D:Lumbosacral lipoma in childhood, how strong is the evidence base? A systematic review. Childs Nerv Syst 40:715-728, 2024

 

3) Casado-Ruiz J, Ros B, Iglesias S et al:Spinal cord lipomas:lessons learned in the era of total resection. Childs Nerv Syst 40:1121-1128, 2024

 

P.212 掲載の参考文献

4) Saeed F, Tyagi A:Transition from partial to near-total/radical resection of spinal cord lipomas. Childs Nerv Syst 39:1595-1602, 2023

 

5) Lim JX, Fong E, Goh C et al:Complex lumbosacral spinal cord lipomas:a longitudinal study on outcomes from a Singapore children's hospital. J Clin Neurosci 121:119-128, 2024

 

P.213 掲載の参考文献

6) Idriceanu T, Beuriat PA, Di Rocco F et al:Recurrent tethering in conus lipomas:a late complication not to be ignored. World Neurosurg 168:e12-e18, 2022

 

7) Moreno Gomez LM, Garcia-Perez D, Gonzalez-Leon PJ et al:Pathogenesis of spinal intramedullary lipomas:two case reports. J Med Case Rep 17:317, 2023

 

P.214 掲載の参考文献

8) Sagenly M, Karnoub MA, Vinchon M:Non-dysraphic intramedullary spinal cord lipoma of the child:report of 3 cases. Neurochirurgie 69:101473, 2023

 

9) Roohollahi F, Sharifi V, Abousaeidi SR et al:Adult nondysraphic cervicomedullary intramedullary lipoma:a case report and literature review. Clin Case Rep 11:e7239, 2023

 

10) Oketani H, Harimaya K, Ono T et al:A presenile patient with filar lipoma who developed tethered spinal cord syndrome triggered by lumbar canal stenosis. NMC Case Rep J 10:109-113, 2023

 

P.215 掲載の参考文献

11) Pahari S, Thapa S, Bhattarai B et al:Lipomeningocele with tethered cord syndrome in an adult:a case report. J Nepal Med Assoc 61:620-622, 2023

 

12) Ishisaka E, Tahara S, Tsukiyama A et al:Endoscopic spinal cord untethering using a 1 cm skin incision technique in pediatrics:a technical case report. BMC Pediatr 23:604, 2023

 

13) Ogawa Y, Hayashi H, Sasaki R et al:Motor-evoked potential monitoring from urinary sphincter muscle during pediatric untethering surgery:a case series. Childs Nerv Syst 39:2147-2153, 2023

 

14) Morizawa Y, Satoh H, Arai M et al:Urodynamics findings pre- and postuntethering surgery in children with filum lipoma:a single-institution experience. Int J Urol 29:884-889, 2022

 

P.216 掲載の参考文献

15) Lim JX, Low SY, Ng LP et al:Prevention and treatment of CSF leaks in congenital complex spinal lipomas. Acta Neurochir (Wien) 164:1157-1160, 2022

 

16) Gao D, Bao N, Yang B et al:Preventive surgery for asymptomatic spinal lipomas in children. Turk Neurosurg 34:1-5, 2024

 

P.217 掲載の参考文献

1) Kim JW, Kim KH, Phi JH et al:Neurocognitive outcomes and associated clinical factors 5 years after surgery in children with craniosynostosis. J Neurosurg Pediatr 33:602-609, 2024

 

P.218 掲載の参考文献

2) Aksogan Y, Kuzucu P, Soysal Acar AS et al:Evaluation of neurocognitive and social developments after craniosynostosis surgery. Childs Nerv Syst 40:1489-1499, 2024

 

3) Junn AH, Long AS, Hauc SC et al:Long-term neurocognitive outcomes in 204 single-suture craniosynostosis patients. Childs Nerv Syst 39:1921-1928, 2023

 

4) Long AS, Hauc SC, Almeida MN et al:"Morphologic severity and age at surgery are associated with school age neurocognitive outcomes in metopic craniosynostosis". Plast Reconstr Surg, 2023. doi:10.1097/PRS.0000000000010999

 

5) Magge SN, Fotouhi AR, Allhusen V et al:Cognitive outcomes of children with sagittal craniosynostosis treated with either endoscopic or open calvarial vault surgery. JAMA Netw Open 7:e248762, 2024

 

P.219 掲載の参考文献

6) Kurniawan M, van de Beeten SDC, Raat H et al:Health-related quality of life in children and adolescents with sagittal synostosis. J Craniofac Surg 34:2284-2287, 2023

 

7) Hevia-Rodriguez P, Romero-Lopez C, Martin-Fernandez J et al:Endoscopy-assisted craniosynostosis surgery without postoperative helmet molding therapy. World Neurosurg 183:79-85, 2024

 

8) Lutz K, Rohrig A, Al-Hourani J et al:Long-term results of minimally invasive strip craniectomy without helmet therapy for scaphocephaly - a single-centre experience. Neurosurg Rev 47:164, 2024

 

9) Fotouhi AR, Patel KB, Skolnick GB et al:School-age anthropometric and patient-reported outcomes after open or endoscopic repair of sagittal craniosynostosis. J Neurosurg Pediatr 32:455-463, 2023

 

P.220 掲載の参考文献

10) Uno K, Sakamoto Y, Miwa T:Is postoperative helmet molding therapy necessary for craniectomy for sagittal suture synostosis? J Craniofac Surg 35:111-113, 2024

 

11) Cross C, Delye H, Khonsari RH et al:A preliminary analysis of replicating the biomechanics of helmet therapy for sagittal craniosynostosis. Childs Nerv Syst 39:989-996, 2023

 

12) Yousefi O, Taheri R, Sabahi M et al:Outcomes of the early endoscopic-assisted suturectomy for treatment of multisuture craniosynostosis. Neurosurg Rev 46:289, 2023

 

13) Labuschagne J, Mutyaba D, Ouma J et al:Flexible endoscope-assisted suture release and barrel stave osteotomy for the correction of sagittal synostosis. J Neurosurg Pediatr 31:71-77, 2023

 

P.221 掲載の参考文献

14) Berton Q, Arrighi M, Barthelemy I et al:Reossification of bone defects after surgical correction of nonsyndromic craniosynostosis:a review and an original study. Neurosurgery, 2024. doi:10.1227/neu.0000000000002854

 

15) Wagner CS, Pontell ME, Shakir S et al:Utilization of carbonated calcium phosphate cement for contouring cranioplasty in patients with syndromic craniosynostosis. Childs Nerv Syst 39:2155-2160, 2023

 

16) Chocron Y, Alabdulkarim A, Gilardino MS:Patient-specific implants and fat grafting for contour deformities post craniosynostosis reconstruction:a therapeutic approach. J Craniofac Surg 34:959-963, 2023

 

17) Gaillard L;ERN CRANIO-Craniosynostosis Workgroup:A photo score for aesthetic outcome in sagittal synostosis:an ERN CRANIO collaboration. J Craniofac Surg 34:2279-2283, 2023

 

18) Leclair NK, Chern J, Ahn ES et al:Clinical metrics and tools for provider assessment and tracking of trigonocephaly. J Neurosurg Pediatr 32:82-90, 2023

 

19) Messerer M, Cottier R, Vandenbulcke A et al:Aesthetic results in children with single suture craniosynostosis:proposal for a modified Whitaker classification. Childs Nerv Syst 39:221-228, 2023

 

P.222 掲載の参考文献

1) Dirik MA, Sanlidag B:Intracranial cysts:incidental or neurodevelopmental? Childs Nerv Syst 39:775-780, 2023

 

P.223 掲載の参考文献

2) Ramachandran T, Valayatham V, Ganesan D:Postnatal posterior fossa arachnoid cyst:a developmental etiology to be considered. Asian J Neurosurg 17:676-679, 2022

 

P.224 掲載の参考文献

3) Zhao H, Cao L, Zhao Y et al:Clinical value of classification in the treatment of children with suprasellar arachnoid cysts. Childs Nerv Syst 39:767-773, 2023

 

P.226 掲載の参考文献

4) Massimi L, Bianchi F, Benato A et al:Ruptured Sylvian arachnoid cysts:an update on a real problem. Childs Nerv Syst 39:93-119, 2023

 

P.231 掲載の参考文献

5) AlMousa SS:A 3-year-old girl with brain imaging findings suggesting arachnoid cyst, and biopsy diagnosis of extra-axial multi-cystic pilocytic astrocytoma. Am J Case Rep 25:e941990, 2024

 

6) Watson I, Patrick J, McDonald PJ et al:Acetazolamide to treat symptomatic ruptured arachnoid cysts:illustrative cases. J Neurosurg Case Lessons 3:CASE21462, 2022

 

7) Beltagy MAE, Enayet AER:Surgical indications in pediatric arachnoid cysts. Childs Nerv Syst 39:87-92, 2023

 

8) Sahap SK, Unal S, Fitoz S:The unique features of middle cranial fossa and Sylvian fissure arachnoid cysts in children:MRI evaluation. Childs Nerv Syst 39:79-85, 2023

 

9) Guler TM, Sahinoglu M, Sen HE et al:Effectiveness of multiple endoscopic fenestrations for the treatment of Sylvian fissure arachnoid cysts:a multicenter study. Childs Nerv Syst 39:121-125, 2023

 

10) Tomita T, Kwasnicki AM, McGuire LS et al:Temporal sylvian fissure arachnoid cyst in children:treatment outcome following microsurgical cyst fenestration with special emphasis on cyst reduction and subdural collection. Childs Nerv Syst 39:127-139, 2023

 

11) Drozdz A, Wojciechowski T, Ciszek B et al:Large intradiploic arachnoid cyst of the skull in child - a case report and new terminology proposition. Childs Nerv Syst 40:1271-1276, 2024

 

12) Chanclud J, Valence S, Perre SV et al:Prenatal diagnosis of vermian cyst:a new type of posterior fossa cyst. Pediatr Radiol 53:461-469, 2023

 

13) Kadri H, Dughly M, Agha MS et al:Giant supra and retrosellar glioependymal cyst presenting with only precocious puberty. Clinical study and review of the literature. Int J Surg Case Rep 116:109360, 2024

 

14) Yamila BM, Pablo NJ, Romina A et al:Surgical treatment of a patient with a giant choroidal fissure cyst:a case report. Childs Nerv Syst 39:1097-1100, 2023

 

15) He Y, Zhang S:An unexpected case report of epidermoid cyst at the oculomotor nerve:mimicking a common cyst on MRI. Front Endocrinol (Lausanne) 14:1153263, 2023

 

16) Gotecha S, Chugh A, Punia P et al:Epidermoid cyst of the brainstem in 3-year-old child:a rare case report. Indian J Otolaryngol Head Neck Surg 76:1224-1228, 2024

 

17) Laverde-Reyes MF, Marquez JC, Nasner D et al:Intracranial progression of the epidermoid cyst to a white epidermoid cyst in a pediatric patient:a case report. J Med Case Rep 17:495, 2023

 

18) Stavarache I, Parazzini C, Doneda C et al:Spontaneous regression of an epidermoid cyst in a pediatric patient - case report and review of the literature. Childs Nerv Syst 40:1961-1964, 2024

 

VI章 脊髄・脊椎・末梢神経

P.235 掲載の参考文献

1) Chiba K, Matsuyama Y, Seo T et al:Condoliase for the treatment of lumbar disc herniation:a randomized controlled trial. Spine (Phila Pa 1976) 43:E869-E876, 2018

 

2) Matsuyama Y, Seo T, Chiba K:Condoliase chemonucleolysis for lumbar disc herniation:a post-hoc follow-up study of patients in previous clinical trials. J Orthop Sci 28:724-732, 2023

 

3) Banno T, Hasegawa T, Yamato Y et al:Condoliase therapy for lumbar disc herniation -2 year clinical outcome. J Orthop Sci 29:64-70, 2024

 

P.236 掲載の参考文献

4) Ohtonari T, Torii R, Noguchi S et al:Short-term clinical and radiographic outcomes of chemonucleolysis with condoliase for painful lumbar disc herniation and analysis regarding intradiscal injection area. Neurosurg Rev 46:59, 2023

 

5) Huang Z, Xu B, Liu Y et al:The efficacy and safety of condoliase for lumbar disc herniation:a systematic review and meta-analysis. Front Pharmacol 14:1151998, 2023

 

6) Banno T, Hasegawa T, Yamato Y et al:Psychological factors can affect the clinical outcome of chemonucleolysis with condoliase in patients with lumbar disk herniation. Spine Surg Relat Res 8:195-202, 2024

 

P.237 掲載の参考文献

7) Banno T, Hasegawa T, Yamato Y et al:Efficacy of chemonucleolysis with condoliase in patients aged under 20 years. Spine Surg Relat Res, 2024. doi:10.22603/ssrr.2023-0289

 

8) Kagami Y, Nakashima H, Segi N et al:Clinical outcomes of condoliase injection therapy for lateral lumbar disc herniation. Spine Surg Relat Res 7:363-370, 2023

 

P.238 掲載の参考文献

9) Fukui H, Kamei N, Fujiwara Y et al:Intradiscal condoliase injection therapy for recurrent lumbar disc herniation:case series and literature review. Medicina (Kaunas) 59:1561, 2023

 

10) Inoue M, Sainoh T, Kojima A et al:Efficacy and safety of condoliase disc administration as a new treatment for lumbar disc herniation. Spine Surg Relat Res 6:31-37, 2022

 

P.239 掲載の参考文献

11) Takaki S, Miyama H, Iwasaki M:Cost-effectiveness analysis of intradiscal condoliase injection vs. surgical or conservative treatment for lumbar disc herniation. J Med Econ 26:233-242, 2023

 

12) Kobayashi K, Sato K, Ando T et al:MRI characteristics of disc degeneration after condoliase injection in young patients:a consecutive case series. J Orthop Sci 29:494-501, 2024

 

P.240 掲載の参考文献

13) Ju DG, Kanim LE, Bae HW:Intervertebral disc repair:current concepts. Global Spine J 10 (2 Suppl):130S-136S, 2020

 

14) 木下英幸, 鴨田博人, 折田純久他:脊椎領域におけるPRPを用いた組織再生. 臨床整形外科 54:92-99, 2019

 

15) Kawabata S, Nagai S, Ito K et al:Intradiscal administration of autologous platelet-rich plasma in patients with Modic type 1 associated low back pain:a prospective pilot study. JOR Spine 7:e1320, 2024

 

16) Zhang L, Zhang C, Song D et al:Combination of percutaneous endoscopic lumbar discectomy and platelet-rich plasma hydrogel injection for the treatment of lumbar disc herniation. J Orthop Surg Res 18:609, 2023

 

P.241 掲載の参考文献

17) Hasegawa T, Akeda K, Yamada J et al:Regenerative effects of platelet-rich plasma releasate injection in rabbit discs degenerated by intradiscal injection of condoliase. Arthritis Res Ther 25:216, 2023

 

P.243 掲載の参考文献

1) Abel F, Avrumova F, Goldman SN et al:Robotic-navigated assistance in spine surgery. Bone Joint J 105-B:543-550, 2023

 

2) Li C, Wang Z, Li D et al:Safety and accuracy of cannulated pedicle screw placement in scoliosis surgery:a comparison of robotic-navigation, O-arm-based navigation, and freehand techniques. Eur Spine J 32:3094-3104, 2023

 

3) Tovar M, Dowlati E, Zhao DY et al:Robot-assisted and augmented reality-assisted spinal instrumentation:a systematic review and meta-analysis of screw accuracy and outcomes over the last decade. J Neurosurg Spine 37:299-314, 2022

 

4) Toossi N, Vardiman AB, Benech CA et al:Factors affecting the accuracy of pedicle screw placement in robot-assisted surgery:a multicenter study. Spine (Phila Pa 1976) 47:1613-1619, 2022

 

5) 川口善治, 牧野絋士, 安田剛敏他:ロボット支援脊椎手術:開発の歴史, 現状, 導入初期の使用経験, 将来展望. J Spine Res 14:59-64, 2023

 

6) Akazawa T, Torii Y, Ueno J et al:Accuracy of computer-assisted pedicle screw placement for adolescent idiopathic scoliosis:a comparison between robotics and navigation. Eur Spine J 32:651-658, 2023

 

P.244 掲載の参考文献

7) Lee NJ, Zuckerman SL, Buchanan IA et al:Is there a difference in screw accuracy, robot time per screw, robot abandonment, and radiation exposure between the Mazor X and the Renaissance? A propensity-matched analysis of 1179 robot-assisted screws. Global Spine J 13:1286-1293, 2023

 

8) Wei FL, Gao QY, Heng W et al:Association of robot-assisted techniques with the accuracy rates of pedicle screw placement:a network pooling analysis. eClinicalMedicine 48:101421, 2022

 

9) Patel NA, Kuo CC, Pennington Z et al:Robot-assisted percutaneous pedicle screw placement accuracy compared with alternative guidance in lateral single-position surgery:a systematic review and metaanalysis. J Neurosurg Spine 39:443-451, 2023

 

10) Brown NJ, Pennington Z, Kuo CC et al:Retrospective single-surgeon study of prone versus lateral robotic pedicle screw placement:a CT-based assessment of accuracy. J Neurosurg Spine 39:490-497, 2023

 

11) Fayed I, Tai A, Triano MJ et al:Lateral versus prone robot-assisted percutaneous pedicle screw placement:a CT-based comparative assessment of accuracy. J Neurosurg Spine 37:112-120, 2022

 

P.245 掲載の参考文献

12) Shahi P, Subramanian T, Araghi K et al:Comparison of robotics and navigation for clinical outcomes after minimally invasive lumbar fusion. Spine (Phila Pa 1976) 48:1342-1347, 2023

 

13) Liounakos JI, Khan A, Eliahu K et al:Ninety-day complication, revision, and readmission rates for current-generation robot-assisted thoracolumbar spinal fusion surgery:results of a multicenter case series. J Neurosurg Spine 36:841-848, 2022

 

14) Shahi P, Subramanian T, Maayan O et al:Surgeon experience influences robotics learning curve for minimally invasive lumbar fusion:a cumulative sum analysis. Spine (Phila Pa 1976) 48:1517-1525, 2023

 

15) Feng F, Chen X, Liu Z et al:Learning curve of junior surgeons in robot-assisted pedicle screw placement:a comparative cohort study. Eur Spine J 33:314-323, 2024

 

16) 谷陽一, 田中貴大, 川島康輝他:脊椎ロボット支援下のPPS刺入精度-脊椎手術経験の多寡は影響するか?-. J Spine Res 14:1109-1116, 2023

 

P.246 掲載の参考文献

17) Beyer RS, Nguyen A, Brown NJ et al:Spinal robotics in cervical spine surgery:a systematic review with key concepts and technical considerations. J Neurosurg Spine 38:66-74, 2023

 

18) Zhou LP, Zhang ZG, Li D et al:Robotics in cervical spine surgery:feasibility and safety of posterior screw placement. Neurospine 20:329-339, 2023

 

19) Lang Z, Han X, Fan M et al:Posterior atlantoaxial internal fixation using Harms technique assisted by 3D-based navigation robot for treatment of atlantoaxial instability. BMC Surg 22:378, 2022

 

20) Li S, Du J, Huang Y et al:Comparison of the efficacies of TINAVI robot-assisted surgery and conventional open surgery for Levine-Edward type IIA (postreduction) hangman fractures. Sci Rep 13:15934, 2023

 

21) Wang Z, Tan Y, Fu K et al:Minimally invasive trans-superior articular process percutaneous endoscopic lumbar discectomy with robot assistance. BMC Musculoskelet Disord 23:1144, 2022

 

22) Tan L, Wen B, Guo Z et al:Robot-assisted percutaneous vertebroplasty for osteoporotic vertebral compression fractures:a retrospective matched-cohort study. Int Orthop 47:595-604, 2023

 

P.247 掲載の参考文献

23) Bettag C, Jann T, Rohde V et al:Robot-assisted spinal augmentation procedures:is it worth the increased effort? Eur Spine J 32:3927-3932, 2023

 

24) Chen H, Li J, Wang X et al:Effects of robot-assisted minimally invasive surgery on osteoporotic vertebral compression fracture:a systematic review, meta-analysis, and meta-regression of retrospective study. Arch Osteoporos 18:46, 2023

 

P.249 掲載の参考文献

1) Salzmann SN, Okano I, Hughes AP et al:Preoperative MRI-based vertebral bone quality (VBQ) score assessment in patients undergoing lumbar spinal fusion. Spine J 22:1301-1308, 2022

 

P.250 掲載の参考文献

2) Shen L, Gao C, Hu S et al:Using artificial intelligence to diagnose osteoporotic vertebral fractures on plain radiographs. J Bone Miner Res 38:1278-1287, 2023

 

3) Cho ST, Shin DE, Kim JW et al:Prediction of progressive collapse in osteoporotic vertebral fractures using conventional statistics and machine learning. Spine (Phila Pa 1976) 48:1535-1543, 2023

 

P.251 掲載の参考文献

4) Funayama T, Tatsumura M, Ikumi A et al;the Tsukuba Spine Group:Therapeutic effects of conservative treatment with 2-week bed rest for osteoporotic vertebral fractures:a prospective cohort study. J Bone Joint Surg Am 104:1785-1795, 2022

 

5) Pieroh P, Spiegl UJA, Volker A et al:Spinal orthoses in the treatment of osteoporotic thoracolumbar vertebral fractures in the elderly:a systematic review with quantitative quality assessment. Global Spine J13 (Suppl 1):59S-72S, 2023

 

6) Ullrich BW, Schnake KJ, Schenk P et al;Working Group Osteoporotic Fractures of the Spine Section of the German Society of Orthopaedics and Trauma:Clinical evaluation of the osteoporotic fracture treatment score (OF-Score):results of the Evaluation of the Osteoporotic Fracture Classification, Treatment Score and Therapy Recommendations (EOFTT) study. Global Spine J 13 (Suppl 1):29S-35S, 2023

 

P.252 掲載の参考文献

7) Ullrich BW, Schenk P, Scheyere MJ;Working Group Osteoporotic Fractures of the Spine Section of the German Society of Orthopaedics and Trauma:Georg Schmorl prize of the German spine society (DWG) 2022:current treatment for inpatients with osteoporotic thoracolumbar fractures-results of the EOFTT study. Eur Spine J 32:1525-1535, 2023

 

8) Carli D, Venmans A, Lodder P et al:Vertebroplasty versus active control intervention for chronic osteoporotic vertebral compression fractures:the VERTOS V randomized controlled trial. Radiology 308:e222535, 2023

 

9) Tan CW, Sahota O:A 3-year retrospective analysis of patients admitted with clinical vertebral fragility fractures across hospitals in England, UK. Osteoporos Int 34:607-611, 2023

 

P.253 掲載の参考文献

10) Mills ES, Hah RJ, Fresquez Z et al:Secondary fracture rate after vertebral osteoporotic compression fracture is decreased by anti-osteoporotic medication but not increased by cement augmentation. J Bone Joint Surg Am 104:2178-2185, 2022

 

11) Yu W, Jiang X, Zhang H et al:Establishment of a novel risk prediction model for recompression of augmented vertebrae at the thoracolumbar junction and modified puncture technique for prevention:a multicenter retrospective study. J Neurosurg Spine 39:238-246, 2023

 

12) Inose H, Kato T, Ichimura S et al:Factors affecting the quality of life in the chronic phase of thoracolumbar osteoporotic vertebral fracture managed conservatively with a brace. Spine J 23:425-432, 2023

 

P.254 掲載の参考文献

13) Wakao N, Sakai Y, Watanabe T et al:Spinal pseudoarthrosis following osteoporotic vertebral fracture:prevalence, risk factors, and influence on patients' activities of daily living 1 year after injury. Arch Osteoporos 18:45, 2023

 

14) Schwendner M, Motov S, Ryang YM:Dorsal instrumentation with and without vertebral body replacement in patients with thoracolumbar osteoporotic fractures shows comparable outcome measures. Eur Spine J 31:1138-1146, 2022

 

15) Tani Y, Tanaka T, Kawashima K et al:A triple minimally invasive surgery combination for subacute osteoporotic lower lumbar vertebral collapse with neurological compromise:a potential alternative to the vertebral corpectomy/expandable cage strategy. Neurosurg Focus 54:E10, 2023

 

P.255 掲載の参考文献

16) Hagino H, Yoshinaga Y, Hamaya E et al:A real-world study of treatment patterns among patients with osteoporotic fracture:analysis of a Japanese hospital database. Arch Osteoporos 18:23, 2023

 

17) Gregson CL, Compston JE:New national osteoporosis guidance-implications for geriatricians. Age Ageing 51:afac044, 2022

 

18) Paccou J, Philippoteaux C, Cortet B et al:Effectiveness of fracture liaison services in osteoporosis. Joint Bone Spine 90:105574, 2023

 

P.256 掲載の参考文献

1) Chang H, Xu J, Yang D et al:Comparison of full-endoscopic foraminoplasty and lumbar discectomy (FEFLD), unilateral biportal endoscopic (UBE) discectomy, and microdiscectomy (MD) for symptomatic lumbar disc herniation. Eur Spine J 32:542-554, 2023

 

P.257 掲載の参考文献

2) Chen CH, Chen CM, Jaw FS et al:Ultrasound guidance for full endoscopic spinal surgery:a technical note. World Neurosurg 162:19-26, 2022

 

3) Okada R, Sakai T, Nishisho T et al:Preoperative planning using three-dimensional printing for full-endoscopic spine surgery:a technical note. NMC Case Rep J 9:249-253, 2022

 

4) Xu DR, Luan LR, Ma XX et al:Comparison of electromagnetic and optical navigation assisted Endo-TLIF in the treatment of lumbar spondylolisthesis. BMC Musculoskelet Disord 23:522, 2022

 

5) Kim JH, Jitpakdee K, Kotheeranurak V et al:Is navigation beneficial for transforaminal endoscopic lumbar foraminotomy? A preliminary comparison study with fluoroscopic guidance. Eur Spine J 32:2808-2818, 2023

 

6) Yang Y, Dong J, Liu Z et al:Clinical study on real-time three-dimensional CT navigation-guided full-endoscopic lumbar interbody fusion. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 36:665-671, 2022

 

7) Hara T, Ohara Y:Perioperative management for full-endoscopic lumbar discectomy:consideration from the perspective of preventing complication. Neurospine 20:28-32, 2023

 

8) Kotheeranurak V, Liawrungrueang W, Quillo-Olvera J et al:Full-endoscopic lumbar discectomy approach selection:a systematic review and proposed algorithm. Spine (Phila Pa 1976) 48:534-544, 2023

 

9) Yagi K, Kishima K, Tezuka F et al:Advantages of revision transforaminal full-endoscopic spine surgery in patients who have previously undergone posterior spine surgery. J Neurol Surg A Cent Eur Neurosurg 84:528-535, 2023

 

10) Saravi B, Ulkumen S, Lang G et al:Casematched radiological and clinical outcome evaluation of interlaminar versus microsurgical decompression of lumbar spinal stenosis. Eur Spine J 32:2863-2874, 2023

 

P.258 掲載の参考文献

11) Kaen A, Park MK, Son SK:Clinical outcomes of uniportal compared with biportal endoscopic decompression for the treatment of lumbar spinal stenosis:a systematic review and meta-analysis. Eur Spine J 32:2717-2725, 2023

 

12) Han S, Zeng X, Zhu K et al:Clinical application of large channel endoscopic systems with full endoscopic visualization technique in lumbar central spinal stenosis:a retrospective cohort study. Pain Ther 11:1309-1326, 2022

 

P.259 掲載の参考文献

13) Kaneko T, Takano Y, Iwai H:Unilateral biportal endoscopic laminectomy-bilateral decompression using a monoportal scope and bipolar coagulator for lumbar spinal stenosis:a technical report. Cureus 15:e46944, 2023

 

14) Kim JY, Heo DH, Lee DC et al:Comparative analysis with modified inclined technique for posterior endoscopic cervical foraminotomy in treating cervical osseous foraminal stenosis:radiological and midterm clinical outcomes. Neurospine 19:603-615, 2022

 

P.260 掲載の参考文献

15) Paik S, Choi Y, Chung CK et al:Cervical kinematic change after posterior full-endoscopic cervical foraminotomy for disc herniation or foraminal stenosis. PLoS One 18:e0281926, 2023

 

16) Guo L, Wang J, Zhao Z et al:Microscopic anterior cervical discectomy and fusion versus posterior percutaneous endoscopic cervical keyhole foraminotomy for single-level unilateral cervical radiculopathy:a systematic review and meta-analysis. Clin Spine Surg 36:59-69, 2023

 

17) Ishihama Y, Morimoto M, Tezuka F et al:Full-endoscopic trans-Kambin triangle lumbar interbody fusion:surgical technique and nomenclature. J Neurol Surg A Cent Eur Neurosurg 83:308-313, 2022

 

18) Kim HS, Wu PH, An JW et al:Evaluation of two methods (inside-out/outside-in) inferior articular process resection for uniportal full endoscopic posterolateral transforaminal lumbar interbody fusion:technical note. Brain Sci 11:1169, 2021

 

P.261 掲載の参考文献

19) Kim HS, Wu PH, Sairyo K et al:A narrative review of uniportal endoscopic lumbar interbody fusion:comparison of uniportal facet-preserving trans-Kambin endoscopic fusion and uniportal facet-sacrificing posterolateral transforaminal lumbar interbody fusion. Int J Spine Surg 15 (suppl 3):S72-S83, 2021

 

20) Bae J, Lee SH, Wagner R et al:Full endoscopic surgery for thoracic pathology:next step after mastering lumbar and cervical endoscopic spine surgery? Biomed Res Int 2022:8345736, 2022

 

P.262 掲載の参考文献

21) Gibson RDS, Wagner R, Gibson JNA et al:Full endoscopic surgery for thoracic pathology:an assessment of supportive evidence. EFORT Open Rev 6:50-60, 2021

 

22) Choi G, Pophale CS, Patel B et al:Endoscopic spine surgery. J Korean Neurosurg Soc 60:485-497, 2017

 

P.264 掲載の参考文献

1) Yao YW, Yao ZP, Jiang M et al:Three-dimensional high-definition exoscope in minimally invasive transforaminal lumbar interbody fusion:a retrospective cohort study. Orthop Surg 15:187-196, 2023

 

2) Giorgi PD, Pallotta ML, Legrenzi S et al:Spinal cord compression in thoracolumbar burst fractures:application of high-definition three-dimensional exoscope in minimally invasive lateral surgery. Eur J Orthop Surg Traumatol 33:2173-2177, 2023

 

3) Ferreira T, Roy S, Tan JK et al:Exoscope-assisted spine surgery:current applications and future directions. World Neurosurg X 23:100335, 2024

 

4) Schupper AJ, Hrabarchuk EI, McCarthy L et al:Improving surgeon well-being:ergonomics in neurosurgery. World Neurosurg 175:e1220-e1225, 2023

 

5) Begagic E, Pugonja R, Beculic H et al:The new era of spinal surgery:exploring the use of exoscopes as a viable alternative to operative microscopes - a systematic review and meta-analysis. World Neurosurg 182:144-158. e1, 2024

 

6) Vattipally VN, Jiang K, Weber-Levine C et al:Exoscope use in spine surgery:a systematic review of applications, benefits, and limitations. World Neurosurg 184:283-292. e3, 2024

 

7) Nawabi NLA, Saway BF, Cunningham C et al:Intraoperative performance with the exoscope in spine surgery:an institutional experience. World Neurosurg 182:208-213, 2024

 

8) Lin H, Chen F, Mo J et al:Cervical spine microsurgery with the high-definition 3D exoscope:advantages and disadvantages. World Neurosurg 161:e1-e7, 2022

 

9) Rosler J, Georgiev S, Roethe AL et al:Clinical implementation of a 3D4K-exoscope (Orbeye) in microneurosurgery. Neurosurg Rev 45:627-635, 2022

 

10) Kusyk DM, Jeong S, Fitzgerald E et al:Surgical posture with microscopic versus exoscopic visualization in anterior cervical procedures. World Neurosurg 181:e562-e566, 2024

 

P.265 掲載の参考文献

11) Encarnacion Ramirez M, Peralta Baez I, Nurmukhametov R et al:Comparative survey study of the use of a low cost exoscope vs. microscope for anterior cervical discectomy and fusion (ACDF). Front Med Technol 4:1055189, 2022

 

12) Battistelli M, Polli FM, D'Alessandris QG et al:An overview of recent advances in anterior cervical decompression and fusion surgery. Surg Technol Int 43:sti43/1732, 2023

 

13) Lei F, Xie Y, Fu J et al:Advantages of 3-dimensional exoscope-assisted anterior cervical spine surgery:a meta-analysis. Acta Neurochir (Wien) 165:3077-3087, 2023

 

14) Peron S, Rusconi A, Minotti M et al:High definition 4K-three-dimensional exoscope for removal of a C1-C2 meningioma:technical case report. Neurocirugia (Astur:Engl Ed) 34:48-52, 2023

 

15) Sarikonda A, Leibold A, Ali DM et al:What is the marginal intraoperative cost of using an exoscope or operative microscope for anterior cervical discectomy and fusion? A time-driven activity-based cost analysis. World Neurosurg 181:e3-e10, 2024

 

16) Rechav Ben-Natan A, Agarwal N, Shabani S et al:Use of an exoscope for enhanced visualization of a Schwab grade 5 osteotomy to correct kyphotic deformity. Neurosurg Focus Video 6:V19, 2022

 

P.266 掲載の参考文献

17) Giorgi PD, Legrenzi S, Sacchi L et al:Implementation of robotic exoscope in minimally invasive corpectomy at thoracolumbar junction for the treatment of traumatic spinal cord compression. World Neurosurg 184:23-28, 2024

 

18) Auricchio AM, Calvanese F, Vasankari V et al:Digital exoscope versus surgical microscope in spinal dural arteriovenous fistula surgery:a comparative series. Neurosurg Focus 56:E13, 2024

 

19) Rodriguez-Unda NA, Wu DS:Exoscope for upper extremity peripheral nerve surgery:revision carpal tunnel release with epineurolysis and hypothenar fat flap. Cureus 14:e22539, 2022

 

20) Calvanese F, Auricchio AM, Vasankari V et al:Digital 3D exoscope is safe and effective in surgery for intradural extramedullary tumors:a comparative series. World Neurosurg 184:e1-e8, 2024

 

21) Cunningham CM, Nawabi N, Saway BF et al:Exoscope efficacy and feasibility in pediatric spinal neurosurgery:a single-institution cohort case series. World Neurosurg 183:e314-e320, 2024

 

22) Gabrovsky N, Petrov M, Ilkov P et al:Subjective workload measurement of the transition from a conventional operative microscope to a Robotic Digital Microscope. A pilot study. Brain Spine 2:100928, 2022

 

23) Motov S, Bonk MN, Krauss P et al:Implementation of a three-dimensional (3D) robotic digital microscope (AEOS) in spinal procedures. Sci Rep 12:22553, 2022

 

24) Demetz M, Abramovic A, Krigers A et al:Cadaveric study of ergonomics and performance using a robotic exoscope with a head-mounted display in spine surgery. J Robot Surg 18:6, 2024

 

P.267 掲載の参考文献

25) Milani D, Zaed I, Ricciardi L et al:Defining the learning curve of the exoscope in spine surgery. World Neurosurg 182:e1-e4, 2024

 

26) Iqbal J, Covell MM, Jabeen S et al:Comparative analysis of exoscope-assisted spine surgery versus operating microscope:a systematic review. World Neurosurg X 21:100258, 2024

 

P.268 掲載の参考文献

1) Branco LMT, Rezende TJR, Reis F et al:Advanced structural magnetic resonance imaging of the spinal cord:technical aspects and clinical use. Semin Ultrasound CT MR 44:464-468, 2023

 

P.269 掲載の参考文献

2) Kinany N, Pirondini E, Micera S et al:Spinal cord fMRI:a new window into the central nervous system. Neuroscientist 29:715-731, 2023

 

P.270 掲載の参考文献

3) He B, Sheldrick K, Das A et al:Clinical and research MRI techniques for assessing spinal cord integrity in degenerative cervical myelopathy-a scoping review. Biomedicines 10:2621, 2022

 

P.271 掲載の参考文献

4) Rau A, Straehle J, Stein T et al:Photon-counting computed tomography (PC-CT) of the spine:impact on diagnostic confidence and radiation dose. Eur Radiol 33:5578-5586, 2023

 

5) Mull M, Dafotakis M, Schubert GA et al:Arteriovenous malformations of the filum terminale:clinical characteristics, angioarchitecture, and management of a rare spinal vascular pathology. Neurosurg Focus 53:E16, 2022

 

P.272 掲載の参考文献

6) Takai K, Endo T, Yasuhara T et al:Microsurgical versus endovascular treatment of spinal epidural arteriovenous fistulas with intradural venous drainage:a multicenter study of 81 patients. J Neurosurg Spine 33:381-391, 2020

 

P.273 掲載の参考文献

7) Krebs S, Barasch JG, Young RJ et al:Positron emission tomography and magnetic resonance imaging in primary central nervous system lymphoma-a narrative review. Ann Lymphoma 5:15, 2021

 

VII章 水頭症

P.276 掲載の参考文献

1) Constantinescu C, Wikkelso C, Westman E et al:Prevalence of possible idiopathic normal pressure hydrocephalus in Sweden:a population-based MRI study in 791 70-year-old participants. Neurology 102:e208037, 2024

 

2) Manet R, Czosnyka Z, Czosnyka M et al:Managing idiopathic normal pressure hydrocephalus:need for a change of mindset. World Neurosurg 178:e6-e12, 2023

 

P.277 掲載の参考文献

3) Bo SH, Lundqvist C:Cerebrospinal fluid opening pressure in clinical practice - a prospective study. J Neurol 267:3696-3701, 2020

 

4) Tipton PW, Elder BD, Cogswell PM et al:Normal pressure hydrocephalus, or Hakim syndrome:review and update. Neurol Neurochir Pol 58:8-20, 2024

 

5) Tullberg M, Toma AK, Yamada S et al:Classification of chronic hydrocephalus in adults:a systematic review and analysis. World Neurosurg 183:113-122, 2024

 

P.278 掲載の参考文献

6) Johannsdottir AM, Pedersen CB, Munthe S et al:Idiopathic normal pressure hydrocephalus:validation of the DESH score as a prognostic tool for shunt surgery response. Clin Neurol Neurosurg 241:108295, 2024

 

7) Hattori T, Ohara M, Yuasa T et al:Correlation of callosal angle at the splenium with gait and cognition in normal pressure hydrocephalus. J Neurosurg 139:481-491, 2023

 

8) Carlsen JF, Backlund ADL, Mardal CA et al:Can shunt response in patients with idiopathic normal pressure hydrocephalus be predicted from preoperative brain Imaging? A retrospective study of the diagnostic use of the normal pressure hydrocephalus radscale in 119 patients. AJNR Am J Neuroradiol 43:223-229, 2022

 

9) Petrella G, Ciarlo S, Elia S et al:Idiopathic normal pressure hydrocephalus:the real social and economic burden of a possibly enormous underdiagnosis problem. Tomography 9:2006-2015, 2023

 

P.279 掲載の参考文献

10) Iseki C, Takahashi Y, Adachi M et al:Prevalence and development of idiopathic normal pressure hydrocephalus:a 16-year longitudinal study in Japan. Acta Neurol Scand 146:680-689, 2022

 

11) Courville E, Rumalla K, Kazim SF et al:Risk Analysis Index as a preoperative frailty tool for elective ventriculoperitoneal shunt surgery for idiopathic normal pressure hydrocephalus. J Neurosurg 140:1110-1116, 2024

 

12) Luciano M, Holubkov R, Williams MA et al;PENS Co-investigators and AHCRN Site PIs:Placebo-controlled effectiveness of idiopathic normal pressure hydrocephalus shunting:a randomized pilot trial. Neurosurgery 92:481-489, 2023

 

P.280 掲載の参考文献

13) Chidiac C, Sundstrom N, Tullberg M et al:Waiting time for surgery influences the outcome in idiopathic normal pressure hydrocephalus - a population-based study. Acta Neurochir (Wien) 164:469-478, 2022

 

14) Grasso G, Torregrossa F:The impact of cerebrospinal fluid shunting on quality of life in idiopathic normal pressure hydrocephalus:a long-term analysis. Neurosurg Focus 54:E7, 2023

 

15) Ebel F, Amstutz S, Wanderer S et al:Effect of cranial entry site on the rate of proximal catheter misplacement in ventriculoperitoneal shunt insertion. J Neurosurg, 2024. doi:10.3171/2024.2.JNS232978

 

16) Chiu CD, Chiu PF, Wu CY et al:Comparing the long-term cardiovascular outcomes of lumbo-peritoneal, ventriculo-peritoneal, or non-shunting treatment after idiopathic normal pressure hydrocephalus:a nationwide retrospective cohort study. Int J Med Sci 21:656-663, 2024

 

17) Tseng PH, Huang WT, Wang JH et al:Cerebrospinal fluid shunt surgery reduces the risk of developing dementia and Alzheimer's disease in patients with idiopathic normal pressure hydrocephalus:a nationwide population-based propensity-weighted cohort study. Fluids Barriers CNS 21:16, 2024

 

P.281 掲載の参考文献

18) Gold D, Wisialowski C, Piryatinsky I et al:Longitudinal post-shunt outcomes in idiopathic normal pressure hydrocephalus with and without comorbid Alzheimer's disease. J Int Neuropsychol Soc 29:751-762, 2023

 

19) Sakurai A, Tsunemi T, Ishiguro Y et al:Comorbid alpha synucleinopathies in idiopathic normal pressure hydrocephalus. J Neurol 269:2022-2029, 2022

 

20) Giannini G, Baiardi S, Dellavalle S et al:In vivo assessment of Lewy body and beta-amyloid copathologies in idiopathic normal pressure hydrocephalus:prevalence and associations with clinical features and surgery outcome. Fluids Barriers CNS 19:71, 2022

 

21) Sakurai A, Tsunemi T, Shimada T et al:Effect of comorbid Parkinson's disease and Parkinson's disease dementia on the course of idiopathic normal pressure hydrocephalus. J Neurosurg 137:1302-1309, 2022

 

P.282 掲載の参考文献

22) Atbas E, Gaydecki P, Callaghan M:A wearable gait-analysis device for idiopathic normal-pressure hydrocephalus (INPH) monitoring. Biomed Phys Eng Express, 2024. doi:10.1088/2057-1976/ad2a1a

 

23) Iseki C, Hayasaka T, Yanagawa H et al:Artificial intelligence distinguishes pathological gait:the analysis of markerless motion capture gait data acquired by an iOS application (TDPT-GT). Sensors (Basel) 23:6217, 2023

 

24) Ferrari A, Milletti D, Palumbo P et al:Gait apraxia evaluation in normal pressure hydrocephalus using inertial sensors. Clinical correlates, ventriculoperitoneal shunt outcomes, and tap-test predictive capacity. Fluids Barriers CNS 19:51, 2022

 

P.283 掲載の参考文献

1) Duy PQ, Weise SC, Marini C et al:Impaired neurogenesis alters brain biomechanics in a neuroprogenitor-based genetic subtype of congenital hydrocephalus. Nat Neurosci 25:458-473, 2022

 

P.284 掲載の参考文献

2) Munch TN, Hedley PL, Hagen CM et al:The genetic background of hydrocephalus in a population-based cohort:implication of ciliary involvement. Brain Commun 5:fcad004, 2023

 

3) Singh AK, Allington G, Viviano S et al:A novel SMARCC1 BAFopathy implicates neural progenitor epigenetic dysregulation in human hydrocephalus. Brain 147:1553-1570, 2023

 

4) Greenberg ABW, Mehta NH, Allington G et al:Molecular diagnostic yield of exome sequencing in patients with congenital hydrocephalus:a systematic review and meta-analysis. JAMA Netw Open 6:e2343384, 2023

 

5) Mallucci CL, Jenkinson MD, Conroy EJ et al:Antibiotic or silver versus standard ventriculoperitoneal shunts (BASICS):a multicentre, single-blinded, randomised trial and economic evaluation. Lancet 394:1530-1539, 2019

 

6) Sunderland GJ, Conroy EJ, Nelson A et al:Factors affecting ventriculoperitoneal shunt revision:a post hoc analysis of the British Antibiotic and Silver Impregnated Catheter Shunt multicenter randomized controlled trial. J Neurosurg 138:483-493, 2023

 

7) Chu J, Jensen H, Holubkov R et al:The Hydrocephalus Clinical Research Network quality improvement initiative:the role of antibiotic-impregnated catheters and vancomycin wound irrigation. J Neurosurg:Pediatr 29:711-718, 2022

 

8) Tamber MS, Jensen H, Clawson J et al:Shunt infection prevention practices in Hydrocephalus Clinical Research Network-Quality:a new quality improvement network for hydrocephalus management. J Neurosurg Pediatr 33:157-164, 2023

 

9) Podkovik S, Zhou C, Coffin SE et al:Utilization trends in cerebrospinal fluid shunt infection prevention techniques in the United States from 2007 to 2015. J Neurosurg Pediatr 33:349-358, 2024

 

P.285 掲載の参考文献

10) Naik A, Ramsy N, Krist DT et al:Anterior versus posterior ventricular catheter placement in pediatric patients:a systematic review and meta-analysis. World Neurosurg 167:e10-e18, 2022

 

11) Black HG, Woolard EA, Stuebe CM et al:Postconception age at surgery as a predictor of ventriculoperitoneal shunt failure. J Neurosurg Pediatr 33:444-451, 2024

 

12) Chiarelli PA, Chapman N, Flyer BE et al:Shunt timing in low-weight infants in the treatment of hydrocephalus. J Neurosurg Pediatr 33:564-573, 2024

 

13) Khalid SI, Hunter BM, Shah P et al:The Impact of social determinants of health in pediatric shunted hydrocephalus. Neurosurgery 92:1066-1072, 2023

 

14) Verhey LH, Kulkarni AV, Reeder RW et al:A re-evaluation of the Endoscopic Third Ventriculostomy Success Score:a Hydrocephalus Clinical Research Network study. J Neurosurg:Pediatr 33:417-427, 2024

 

P.286 掲載の参考文献

15) Issa M, Younsi A, Paggetti F et al:Heidelberg ETV score to assess success of ETV in patients with occlusive hydrocephalus:a retrospective single-center study. Neurosurg Rev 46:214, 2023

 

16) Black H, Succop B, Stuebe CM et al:Low surgical weight associated with ETV failure in pediatric hydrocephalus patients. Neurosurg Rev 47:176, 2024

 

17) Ben-Israel D, Mann JA, Yang MMH et al:Clinical outcomes in pediatric hydrocephalus patients treated with endoscopic third ventriculostomy and choroid plexus cauterization:a systematic review and meta-analysis. J Neurosurg Pediatr 30:18-30, 2022

 

18) Guida L, Grenier-Chartrand F, Benichi S et al:Predicting endoscopic third ventriculostomy success in pediatric shunt dysfunction:a monocentric retrospective case series of 70 consecutive children, systematic review, and meta-analysis. J Neurosurg Pediatr 32:638-648, 2023

 

19) Lee KS, Chari A, Gillespie CS et al:Endoscopic third ventriculostomy for shunt malfunction in the pediatric population:a systematic review, meta-analysis, and meta-regression analysis. J Neurosurg Pediatr 31:423-432, 2023

 

20) Arynchyna-Smith A, Rozzelle CJ, Jensen H et al;Hydrocephalus Clinical Research Network:Endoscopic third ventriculostomy revision after failure of initial endoscopic third ventriculostomy and choroid plexus cauterization. J Neurosurg Pediatr 30:8-17, 2022

 

P.287 掲載の参考文献

21) Minta KJ, Kannan S, Kaliaperumal C:Outcomes of endoscopic third ventriculostomy (ETV) and ventriculoperitoneal shunt (VPS) in the treatment of paediatric hydrocephalus:systematic review and meta-analysis. Childs Nerv Syst 40:1045-1052, 2024

 

22) Yang M, Kim S, Sung SI et al:Current status and associated factors of posthemorrhagic hydrocephalus in infants of 22 to 28 weeks gestation with severe intraventricular hemorrhage in Korea:a nationwide cohort study. J Korean Med Sci 39:e139, 2024

 

23) Park J, Park SH, Kwon YR et al:Long-term outcomes of very low birth weight infants with intraventricular hemorrhage:a nationwide population study from 2011 to 2019. World J Pediatr, 2024. doi:10.1007/s12519-024-00799-x

 

24) Falsaperla R, Lo Bianco M, Palmeri A et al:short efficacy evaluation of external ventricular drains versus ventriculosubgaleal shunt in the management of neonatal posthemorrhagic hydrocephalus:a retrospective single-center cohort study. Neurosurgery 93:622-627, 2023

 

P.288 掲載の参考文献

25) Cabacungan E, Adams S, Best B et al:Variability in neurosurgical management and associated comorbidities and complications among preterm patients with posthemorrhagic hydrocephalus in the United States. J Neurosurg Pediatr, 2023. doi:10.3171/2023.1.peds22461

 

26) Serebin M, Zhang J, Yan K et al:Prediction of short- and long-term outcomes using pre-operative ventricular size in infants with post-hemorrhagic ventricular dilation. Child's Nerv Syst, 2024. doi:10.1007/s00381-024-06371-2

 

27) Mahaney KB, Buddhala C, Paturu M et al:Elevated cerebrospinal fluid iron and ferritin associated with early severe ventriculomegaly in preterm posthemorrhagic hydrocephalus. J Neurosurg Pediatr 30:169-176, 2022

 

28) Garcia-Bonilla M, Yahanda AT, Isaacs AM et al:Pro-inflammatory cerebrospinal fluid profile of neonates with intraventricular hemorrhage:clinical relevance and contrast with CNS infection. Fluids Barriers CNS 21:17, 2024

 

29) Karuparti S, Dunbar A, Varagur K et al:Predictors and timing of hydrocephalus treatment in patients undergoing prenatal versus postnatal surgery for myelomeningocele. J Neurosurg Pediatr 33:544-533, 2024

 

30) Peralta CFA, Medrado AP, Botelho RD et al:Percutaneous fetal endoscopic third ventriculostomy for severe isolated cerebral ventriculomegaly. Prenat Diagn 43:1614-1621, 2023

 

VIII章 感染症

P.290 掲載の参考文献

1) Zeggay A, Patry I, Chirouze C et al:Characteristics and outcomes of cerebrospinal fluid shunt and drain-associated infections. Infect Dis Now 53:104665, 2023

 

P.291 掲載の参考文献

2) Gatos C, Fotakopoulos G, Chatzi M et al:Investigation of risk factors for external ventricular drainage-associated central nervous system infections in patients undergoing neurosurgery. Med Int (Lond) 29:44, 2023

 

P.292 掲載の参考文献

3) Ponnambath DK, Divakar G, Mamachan J et al:Epidemiology, clinical profile, and outcomes of CSF-diversion catheter-related infections - prospective cohort study results from a single quaternary neurosurgery referral centre. Indian J Med Microbiol 48:100534, 2024

 

4) Li MT, Wu QQ, Li JB et al:Intrathecal or intraventricular antimicrobial therapy for post-neurosurgical Gram-negative bacillary meningitis or ventriculitis:a systematic review and meta-analysis. Int J Antimicrob Agents 63:107033, 2024

 

P.293 掲載の参考文献

5) Li Z, Yang W, Ye X et al:Early intraventricular antibiotic therapy improved in-hospital-mortality in neurocritical patients with multidrug-resistant bacterial nosocomial meningitis and ventriculitis. Neurocrit Care 40:612-620, 2024

 

6) Georgakopoulou VE, Spandidos DA, Papalexis P et al:Outcomes in meningitis-ventriculitis treated with intravenous or intrathecal plus intravenous colistin:a meta-analysis. Exp Ther Med 25:293, 2023

 

P.294 掲載の参考文献

7) Li C, Zhou P, Liu Y et al:Treatment of ventriculitis and meningitis after neurosurgery caused by carbapenem-resistant Enterobacteriaceae (CRE):a challenging topic. Infect Drug Resist 16:3807-3818, 2023

 

8) Huang YH, Lee TH:Health care-associated infections after surgical treatment of ruptured intracranial aneurysms. J Stroke Cerebrovasc Dis 33:107725, 2024

 

P.295 掲載の参考文献

9) Hawkes MT, McAlpine A, Barton M et al;Paediatric Investigators Collaborative Network on Infections in Canada (PICNIC):Association of cerebrospinal fluid parameters with treatment and complications among children with cerebrospinal fluid shunt infections:a multicenter study. J Neurosurg Pediatr 33:35-43, 2023

 

P.296 掲載の参考文献

1) 金谷康平, 堀内哲吉:中枢神経における感染性疾患. 脳神経外科 50:933-941, 2022

 

P.297 掲載の参考文献

2) Kameda-Smith MM, Ragulojan M, Hart S et al:A Canadian national survey of the neurosurgical management of intracranial abscesses. Can J Neurol Sci 50:679-686, 2023

 

3) Singla A, Gautam A, Goyal A et al:Paradoxical septic embolism in an Ebstein's anomaly patient leading to brain abscess:a case report. J Cardiol Cases 29:161-164, 2024

 

4) Sangi R, Ahsan AK, Shaikh AS et al:Incidence, clinical profile and short term outcome of cerebral abscess in cyanotic congenital heart diseases. Heliyon 9:e22198, 2023

 

P.298 掲載の参考文献

5) Spencer EE, Nostrand SV, Arya S:Group B streptococcus brain abscess in a neonate with bilateral otorrhea. AJP Rep 14:e106-e110, 2024

 

6) Rivera K, Truckner R, Furiato A et al:The diagnostic challenge of the pediatric brain abscess. Cureus 13:e15402, 2021

 

P.299 掲載の参考文献

7) Virtanen PS, Jimenez MJD, Horak VJ et al:Concomitant brain abscess and spinal cord abscess in an immunocompetent teenage male:illustrative case. J Neurosurg Case Lessons 5:CASE22458, 2023

 

8) Accorsi EK, Chochua S, Moline HL et al:Pediatric brain abscesses, epidural empyemas, and subdural empyemas associated with Streptococcus species - United States, January 2016-August 2022. MMWR Morb Mortal Wkly Rep 71:1169-1173, 2022

 

9) Khuon D, Ogrin S, Engels J et al:Notes from the field:increase in pediatric intracranial infections during the COVID-19 pandemic - eight pediatric hospitals, United States, March 2020-March 2022. MMWR Morb Mortal Wkly Rep 71:1000-1001, 2022

 

P.300 掲載の参考文献

10) Massimi L, Cinalli G, Frassanito P et al:Intracranial complications of sinogenic and otogenic infections in children:an ESPN survey on their occurrence in the pre- COVID and post-COVID era. Childs Nerv Syst 40:1221-1237, 2024

 

P.301 掲載の参考文献

11) Nakamura M, Maruo T, Hashimoto H et al:Brain abscess in a patient with generalized dystonia after deep brain stimulation:illustrative case. J Neurosurgery Case Lessons 5:CASE22239, 2023

 

12) Tabaja H, Yuen J, Tai DBG et al:Deep brain stimulator device infection:the Mayo Clinic Rochester experience. Open Forum Infect Dis 10:ofac631, 2023

 

P.302 掲載の参考文献

13) Bodilsen J, D'Alessandris QG, Humphreys H et al:European Society of Clinical Microbiology and Infectious Diseases guidelines on diagnosis and treatment of brain abscess in children and adults. Clin Microbiol Infect 30:66-89, 2024

 

14) Dyckhoff-Shen S, Koedel U, Brouwer MC et al:ChatGPT fails challenging the recent ESCMID brain abscess guideline. J Neurol 271:2086-2101, 2024

 

15) Hirata S, Kobayashi M, Ujihara M et al:Aspiration surgery with appropriate antibiotic treatment yields favorable outcomes for bacterial brain abscess. World Neurosurg 165:e317-e324, 2022

 

IX章 神経科学

P.305 掲載の参考文献

1) Yoshida S, Kato TM, Sato Y et al:A clinical-grade HLA haplobank of human induced pluripotent stem cells matching approximately 40% of the Japanese population. Med 4:51-66. e10, 2023

 

2) Xu H, Wang B, Ono M et al:Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility. Cell Stem Cell 24:566-578. e7, 2019

 

3) Sugita S, Mandai M, Hirami Y et al:HLAmatched allogeneic iPS cells-derived RPE transplantation for macular degeneration. J Clin Med 9:2217, 2020

 

P.306 掲載の参考文献

4) Watari K, Yamasaki S, Tu HY et al:Selforganization, quality control, and preclinical studies of human iPSC-derived retinal sheets for tissue-transplantation therapy. Commun Biol 6:164, 2023

 

5) Hirami Y, Mandai M, Sugita S et al :Safety and stable survival of stem-cell-derived retinal organoid for 2 years in patients with retinitis pigmentosa. Cell Stem Cell 30:1585-1596. e6, 2023

 

6) Yamasaki S, Tu HY, Matsuyama T et al:A genetic modification that reduces ON-bipolar cells in hESC-derived retinas enhances functional integration after transplantation. iScience 25:103657, 2022

 

P.307 掲載の参考文献

7) Kirkeby A, Nelander J, Hoban DB et al:Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD. Cell Stem Cell 30:1299-1314. e9, 2023

 

8) Park S, Park CW, Eom JH et al:Preclinical and dose-ranging assessment of hESC-derived dopaminergic progenitors for a clinical trial on Parkinson's disease. Cell Stem Cell 31:25-38. e8, 2024

 

9) Hiller BM, Marmion DJ, Thompson CA et al:Optimizing maturity and dose of iPSC-derived dopamine progenitor cell therapy for Parkinson's disease. NPJ Regen Med 7:24, 2022

 

10) Gantner CW, de Luzy IR, Kauhausen JA et al:Viral delivery of GDNF promotes functional integration of human stem cell grafts in Parkinson's disease. Cell Stem Cell 26:511-526. e5, 2020

 

11) Torikoshi S, Morizane A, Shimogawa T et al:Exercise promotes neurite extensions from grafted dopaminergic neurons in the direction of the dorsolateral striatum in Parkinson's disease model rats. J Parkinsons Dis 10:511-521, 2020

 

12) Adachi H, Morizane A, Torikoshi S et al:Pretreatment with perlecan-conjugated laminin-E8 fragment enhances maturation of grafted dopaminergic progenitors in Parkinson's disease model. Stem Cells Transl Med 11:767-777, 2022

 

P.308 掲載の参考文献

13) McKenna SL, Ehsanian R, Liu CY et al:Ten-year safety of pluripotent stem cell transplantation in acute thoracic spinal cord injury. J Neurosurg Spine 37:321-330, 2022

 

14) Fessler RG, Ehsanian R, Liu CY et al:A phase 1/2a dose-escalation study of oligodendrocyte progenitor cells in individuals with subacute cervical spinal cord injury. J Neurosurg Spine 37:812-820, 2022

 

15) Sugai K, Sumida M, Shofuda T et al:First-in-human clinical trial of transplantation of iPSC-derived NS/PCs in subacute complete spinal cord injury:study protocol. Regen Ther 18:321-333, 2021

 

16) Shibata T, Tashiro S, Shibata S et al:Rehabilitative training enhances therapeutic effect of human-iPSC-derived neural stem/progenitor cells transplantation in chronic spinal cord injury. Stem Cells Transl Med 12:83-96, 2023

 

17) Hashimoto S, Nagoshi N, Shinozaki M et al:Microenvironmental modulation in tandem with human stem cell transplantation enhances functional recovery after chronic complete spinal cord injury. Biomaterials 295:122002, 2023

 

18) Saijo Y, Nagoshi N, Kawai M et al:Human-induced pluripotent stem cell-derived neural stem/progenitor cell ex vivo gene therapy with synaptic organizer CPTX for spinal cord injury. Stem Cell Reports 19:383-398, 2024

 

P.309 掲載の参考文献

19) Kitahara T, Sakaguchi H, Morizane A et al:Axonal extensions along corticospinal tracts from transplanted human cerebral organoids. Stem Cell Reports 15:467-481, 2020

 

20) Tsuchimochi R, Yamagami K, Kubo N et al:Viral delivery of L1CAM promotes axonal extensions by embryonic cerebral grafts in mouse brain. Stem Cell Reports 18:899-914, 2023

 

21) Zhu Q, Mishra A, Park JS et al:Human cortical interneurons optimized for grafting specifically integrate, abort seizures, and display prolonged efficacy without over-inhibition. Neuron 111:807-823. e7, 2023

 

P.310 掲載の参考文献

1) Niizuma K, Osawa SI, Endo H et al:Randomized placebo-controlled trial of CL2020, an allogenic muse cell-based product, in subacute ischemic stroke. J Cereb Blood Flow Metab 43:2029-2039, 2023

 

P.311 掲載の参考文献

2) Houkin K, Osanai T, Uchiyama S et al:Allogeneic stem cell therapy for acute ischemic stroke:the phase 2/3 TREASURE randomized clinical trial. JAMA Neurol 81:154-162, 2024

 

3) Saini R, Pahwa B, Agrawal D et al:Efficacy and outcome of bone marrow derived stem cells transplanted via intramedullary route in acute complete spinal cord injury - a randomized placebo controlled trial. J Clin Neurosci 100:7-14, 2022

 

P.312 掲載の参考文献

4) Yamaki T, Oka S, Iyama S et al:Intravenous infusion of auto-serum-expanded autologous mesenchymal stem cells into chronic severe brain injury patients. Interdisciplinary Neurosurgery 36:101927, 2024

 

P.313 掲載の参考文献

5) Terada K, Sasaki M, Nagahama H et al:Therapeutic efficacy of intravenous infusion of mesenchymal stem cells in rat perinatal brain injury. Pediatr Res 94:1921-1928, 2023

 

P.314 掲載の参考文献

6) Hirota R, Sasaki M, Kataoka-Sasaki Y et al:Enhanced network in corticospinal tracts after infused mesenchymal stem cells in spinal cord injury. J Neurotrauma 39:1665-1677, 2022

 

P.315 掲載の参考文献

7) Yamashita T, Sasaki M, Sasaki Y et al:Rehabilitation facilitates functional improvement following intravenous infusion of mesenchymal stem cells in the chronic phase of cerebral ischemia in rats. Brain Res 1825:148709, 2024

 

P.318 掲載の参考文献

1) Louis DN, Perry A, Wesseling P et al:The 2021 WHO Classification of Tumors of the Central Nervous System:a summary. Neuro Oncol 23:1231-1251, 2021

 

P.319 掲載の参考文献

2) Brastianos PK, Twohy E, Geyer S et al:BRAF-MEK inhibition in newly diagnosed papillary craniopharyngiomas. N Engl J Med 389:118-126, 2023

 

3) Brastianos PK, Taylor-Weiner A, Manley PE et al:Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nat Genet 46:161-165, 2014

 

4) Reardon DA, Brandes AA, Omuro A et al:Effect of nivolumab vs bevacizumab in patients with recurrent glioblastoma:the CheckMate 143 phase 3 randomized clinical trial. JAMA Oncol 6:1003-1010, 2020

 

5) Marabelle A, Fakih M, Lopez J et al:Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab:prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study. Lancet Oncol 21:1353-1365, 2020

 

P.320 掲載の参考文献

6) Natsume A, Aoki K, Ohka F et al;Members of Japan Clinical Oncology Group Brain Tumor Study Group (JCOGBTSG):Genetic analysis in patients with newly diagnosed glioblastomas treated with interferon-beta plus temozolomide in comparison with temozolomide alone. J Neurooncol 148:17-27, 2020

 

7) Touat M, Li YY, Boynton AN et al:Mechanisms and therapeutic implications of hypermutation in gliomas. Nature 580:517-523, 2020

 

8) Doebele RC, Drilon A, Paz-Ares L et al:Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours:integrated analysis of three phase 1-2 trials. Lancet Oncol 21:271-282, 2020

PubMed

9) Drilon A, Laetsch TW, Kummar S et al:Efficacy of larotrectinib in TRK fusionpositive cancers in adults and children. N Engl J Med 378:731-739, 2018

 

P.321 掲載の参考文献

10) Boyer J, Birzu C, Bielle F et al:Dramatic response of STRN-NTRK-fused malignant glioneuronal tumor to larotrectinib in adult. Neuro Oncol 23:1200-1202, 2021

 

11) Kaley T, Touat M, Subbiah V et al:BRAF inhibition in BRAFV600-mutant gliomas:results from the VE-BASKET study. J Clin Oncol 36:3477-3484, 2018

 

12) Wen PY, Stein A, van den Bent M et al:Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR):a multicentre, open-label, single-arm, phase 2, basket trial. Lancet Oncol 23:53-64, 2022

 

P.322 掲載の参考文献

13) Mellinghoff IK, Ellingson BM, Touat M et al:Ivosidenib in isocitrate dehydrogenase 1-mutated advanced glioma. J Clin Oncol 38:3398-3406, 2020

 

14) Natsume A, Arakawa Y, Narita Y et al:The first-in-human phase I study of a brain penetrant mutant IDH1 inhibitor DS-1001 in patients with recurrent or progressive IDH1-mutant gliomas. Neuro Oncol 25:326-336, 2022

 

15) Amankulor NM, Kim Y, Arora S et al:Mutant IDH1 regulates the tumor-associated immune system in gliomas. Genes Dev 31:774-786, 2017

 

16) Bunse L, Pusch S, Bunse T et al:Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate. Nat Med 24:1192-1203, 2018

 

17) Mellinghoff IK, Penas-Prado M, Peters KB et al:Vorasidenib, a dual inhibitor of mutant IDH1/2, in recurrent or progressive glioma;results of a first-in-human phase I trial. Clin Cancer Res 27:4491-4499, 2021

 

18) Mellinghoff IK, van den Bent MJ, Blumenthal DT et al:Vorasidenib in IDH1- or IDH2-mutant low-grade glioma. N Engl J Med 389:589-601, 2023

 

P.323 掲載の参考文献

19) Di Stefano AL, Picca A, Saragoussi E et al:Clinical, molecular, and radiomic profile of gliomas with FGFR3-TACC3 fusions. Neuro Oncol 22:1614-1624, 2020

 

20) Picca A, Berzero G, Bielle F et al;TARGET study group:FGFR1 actionable mutations, molecular specificities, and outcome of adult midline gliomas. Neurology 90:e2086-e2094, 2018

 

21) Lassman AB, Sepulveda-Sanchez JM, Cloughesy TF et al:Infigratinib in patients with recurrent gliomas and FGFR alterations:a multicenter phase II study. Clin Cancer Res 28:2270-2277, 2022

 

P.324 掲載の参考文献

1) Zhu J, Wen G, Tang C et al:One-and-a-half nostril versus binostril endoscopic transsphenoidal approach to the pituitary adenomas:a prospective randomized controlled trial. Front Surg 9:1007883, 2022

 

2) Ferreli F, Lasagna C, Canali L et al:A randomized prospective comparative study on sinonasal morbidity and quality of life of transsphenoidal endoscopic surgery for pituitary adenomas:endonasal versus trans-septal approach. Eur Arch Otorhinolaryngol 281:257-266, 2024

 

P.325 掲載の参考文献

3) Aziz Baban MI, Hadi SJ, Mahmoud AA et al:Preservation versus resection of middle turbinate in endoscopic transnasal transsphenoidal pituitary surgery. Am J Otolaryngol 44:103826, 2023

 

4) Fuse Y, Takeuchi K, Hashimoto N et al:Deep learning based identification of pituitary adenoma on surgical endoscopic images:a pilot study. Neurosurg Rev 46:291, 2023

 

5) Ishida A, Shiramizu H, Yoshimoto H et al:Resection of the cavernous sinus medial wall improves remission rate in functioning pituitary tumors:retrospective analysis of 248 consecutive cases. Neurosurgery 91:775-781, 2022

 

6) Serioli S, Plou P, Leonel LCPC et al:The "candy wrapper" of the pituitary gland:a road map to the parasellar ligaments and the medial wall of the cavernous sinus. Acta Neurochir (Wien) 165:3431-3444, 2023

 

7) Deng S, Morisako H, Beniwal M et al:Usefulness of opening the diaphragma sellae before transecting interclinoidal ligament for endoscopic endonasal transoculomotor triangle approach:technical nuances and surgical outcomes. World Neurosurg 185:e731-e740, 2024

 

P.326 掲載の参考文献

8) Tanoue Y, Morisako H, Sasaki T et al:Endoscopic endonasal approach to remove pediatric intraventricular tumors of the third ventricle. Childs Nerv Syst 39:3397-3406, 2023

 

9) Cao L, Wu W, Kang J et al:Feasibility of endoscopic endonasal resection of intrinsic third ventricular craniopharyngioma in adults. Neurosurg Rev 45:1-13, 2022

 

10) d'Avella E, Vitulli F, Berardinelli J et al:Systematic review of transcranial and endoscopic endonasal approaches for craniopharyngiomas in children:is there an evolution? J Neurosurg Pediatr 33:73-84, 2023

 

11) Makino R, Fujio S, Sugata J et al:Indocyanine green endoscopic evaluation of pituitary stalk and gland blood flow in craniopharyngiomas. Neurosurg Rev 46:312, 2023

 

12) Dadario NB, Zaman A, Pandya M et al:Endoscopic-assisted surgical approach for butterfly glioma surgery. J Neurooncol 156:635-644, 2022

 

13) Li K, Liang J, Niu H et al:Effect comparison of neuroendoscopy versus microsurgery in the treatment of lateral ventricular tumors. Front Oncol 13:1008291, 2023

 

P.327 掲載の参考文献

14) Watanabe T, Iwami K, Kishida Y et al:Combined exoscopic and endoscopic twostep keyhole approach for intracranial meningiomas. Curr Oncol 29:5370-5382, 2022

 

15) Robinow ZM, Peterson C, Waldau B et al:Supraorbital keyhole craniotomy via eyebrow incision:a systematic review and meta-analysis. World Neurosurg 158:e509-e542, 2022

 

16) Zoli M, Sollini G, Rustici A et al:Endoscopic transorbital approach for sphenoorbital tumors:case series and systematic review of literature. World Neurosurg 177:e239-e253, 2023

 

P.328 掲載の参考文献

17) De Simone M, Zoia C, Choucha A et al:The transorbital approach:a comprehensive review of targets, surgical techniques, and multiportal variants. J Clin Med 13:2712, 2024

 

18) Zheng B, Xu S, Guo C et al:Efficacy and safety of unilateral biportal endoscopy versus other spine surgery:a systematic review and meta-analysis. Front Surg 9:911914, 2022

 

19) Vattipally VN, Jiang K, Weber-Levine C et al:Exoscope use in spine surgery:a systematic review of applications, benefits, and limitations. World Neurosurg 184:283-292. e3, 2024

 

P.329 掲載の参考文献

20) Guida L, Grenier-Chartrand F, Benichi S et al:Predicting endoscopic third ventriculostomy success in pediatric shunt dysfunction:a monocentric retrospective case series of 70 consecutive children, systematic review, and meta-analysis. J Neurosurg Pediatr 32:638-648, 2023

 

21) Omar AT, Espiritu AI, Spears J:Endoscopic third ventriculostomy with or without choroid plexus coagulation for myelomeningocele-associated hydrocephalus:systematic review and meta-analysis. J Neurosurg Pediatr 29:435-443, 2022

 

22) Phillips HW, Miller TA, Liu HY et al:Utility of minimally invasive endoscopic skull base approaches for the treatment of drug-resistant mesial temporal lobe epilepsy:a review of current techniques and trends. J Neurosurg 139:1604-1612, 2023

 

P.330 掲載の参考文献

23) Yindeedej V, Uda T, Kawashima T et al:Total corpus callosotomy via posterior approach with endoscopic-alone technique. World Neurosurg 188:77, 2024

 

P.331 掲載の参考文献

1) Aungaroon G, Vedala K, Byars AW et al:Comparing electrical stimulation functional mapping with subdural electrodes and stereoelectroencephalography. Epilepsia 64:1527-1540, 2023

 

2) Reecher HM, Bearden DJ, Koop JI et al:The changing landscape of electrical stimulation language mapping with subdural electrodes and stereoelectroencephalography for pediatric epilepsy:a literature review and commentary. Epilepsia, 2024. doi:10.1111/epi.18009

 

P.332 掲載の参考文献

3) Arya R, Frink C, Kargol C et al:Neuropsychological outcomes after epilepsy surgery:a comparison of stereo electroencephalography and subdural electrodes. Eur J Neurol 30:2986-2998, 2023

 

4) Kamada C, Enatsu R, Imataka S et al:Functional brain mapping using depth electrodes. World Neurosurg, 2024. doi:10.1016/j.wneu.2024.05.098

 

5) Schmid W, Danstrom IA, Echevarria MC et al:A biophysically constrained brain connectivity model based on stimulation-evoked potentials. J Neurosci Methods 405:110106, 2024

 

6) Piastra MC, Oostenveld R, Homolle S et al:How to assess the accuracy of volume conduction models? A validation study with stereotactic EEG data. Front Hum Neurosci 18:1279183, 2024

 

P.333 掲載の参考文献

7) Hermosillo RJM, Moore LA, Feczko E et al:A precision functional atlas of personalized network topography and probabilities. Nat Neurosci 27:1000-1013, 2024

 

8) Oota SR, Yadav A, Dash A et al:Attention-based fusion of multiple graphheat networks for structural to functional brain mapping. Sci Rep 14:1184, 2024

 

9) Schreiner L, Jordan M, Sieghartsleitner S et al:Mapping of the central sulcus using non-invasive ultra-high-density brain recordings. Sci Rep 14:6527, 2024

 

10) Liu Y, Ge E, Kang Z et al:Spatial-temporal convolutional attention for discovering and characterizing functional brain networks in task fMRI. Neuroimage 287:120519, 2024

 

11) Liang J, Yu ZL, Gu Z et al:Electromagnetic source imaging with a combination of sparse Bayesian learning and deep neural network. IEEE Trans Neural Syst Rehabil Eng 31:2338-2348, 2023

 

P.334 掲載の参考文献

12) Aqil M, Knapen T, Dumoulin SO:Computational model links normalization to chemoarchitecture in the human visual system. Sci Adv 10:eadj6102, 2024

 

13) Schindler H, Jawinski P, Arnatkeviciute A et al:Molecular signatures of attention networks. Hum Brain Mapp 45:e26588, 2024

 

14) Tariq R, Aziz HF, Paracha S et al:Intraoperative mapping and preservation of executive functions in awake craniotomy:a systematic review. Neurol Sci, 2024. doi:10.1007/s10072-024-07475-y

 

P.335 掲載の参考文献

15) Ille S, Zhang H, Stassen N et al:Noninvasive-and invasive mapping reveals similar language network centralities - a unction-based connectome analysis. Cortex 174:189-200, 2024

 

16) Fukuma R, Yanagisawa T, Nishimoto S et al:Voluntary control of semantic neural representations by imagery with conflicting visual stimulation. Commun Biol 5:214, 2022

 

17) Fukuma R, Majima K, Kawahara Y et al:Fast, accurate, and interpretable decoding of electrocorticographic signals using dynamic mode decomposition. Commun Biol 7:595, 2024

 

18) Tripathy K, Fogarty M, Svoboda AM et al:Mapping brain function in adults and young children during naturalistic viewing with high-density diffuse optical tomography. Hum Brain Mapp 45:e26684, 2024

 

P.336 掲載の参考文献

19) Giraud M, Zapparoli L, Basso G et al:Mapping the emotional homunculus with fMRI. iScience 27:109985, 2024

 

20) Liu B, Guo J, Chen CLP et al:Finegrained interpretability for EEG emotion recognition:Concat-aided Grad-CAM and systematic brain functional network. IEEE Trans Affect Comput 15:671-684, 2024

 

21) Lee DH, Chung CK, Kim JS et al:Unraveling tactile categorization and decision-making in the subregions of supramarginal gyrus via direct cortical stimulation. Clin Neurophysiol 158:16-26, 2024

 

22) Wischnewski M, Berger TA, Opitz A et al:Causal functional maps of brain rhythms in working memory. Proc Natl Acad Sci U S A 121:e2318528121, 2024

 

23) Iwata T, Yanagisawa T, Ikegaya Y et al:Hippocampal sharp-wave ripples correlate with periods of naturally occurring self-generated thoughts in humans. Nat Commun 15:4078, 2024

 

24) Keil J, Kiiski H, Doherty L et al:Artificial sharp-wave-ripples to support memory and counter neurodegeneration. Brain Res 1822:148646, 2024

 

P.338 掲載の参考文献

1) Chiocca EA, Gelb AB, Chen CC et al:Combined immunotherapy with controlled interleukin-12 gene therapy and immune checkpoint blockade in recurrent glioblastoma:an open-label, multi-institutional phase I trial. Neuro Oncol 24:951-963, 2022

 

2) Faisal SM, Castro MG, Lowenstein PR:Combined cytotoxic and immune-stimulatory gene therapy using Ad-TK and Ad-Flt3L:translational developments from rodents to glioma patients. Mol Ther 31:2839-2860, 2023

 

3) Kitzberger C, Spellerberg R, Han Y et al:Mesenchymal stem cell-mediated image-guided sodium iodide symporter (NIS) gene therapy improves survival of glioblastoma-bearing mice. Clin Cancer Res 29:930-942, 2023

 

4) Kitzberger C, Shehzad K, Morath V et al:Interleukin-6-controlled, mesenchymal stem cell-based sodium/iodide symporter gene therapy improves survival of glioblastoma-bearing mice. Mol Ther Oncolytics 30:238-253, 2023

 

P.339 掲載の参考文献

5) Oraee-Yazdani S, Tavanaei R, Rostami F et al:Suicide gene therapy using allogeneic adipose tissue-derived mesenchymal stem cell gene delivery vehicles in recurrent glioblastoma multiforme:a first-in-human, dose-escalation, phase I clinical trial. J Transl Med 21:350, 2023

 

6) Yao M, Luo Y, Li H et al:LncRNA Tug1 contributes post-stroke NLRP3 inflammasome-dependent pyroptosis via miR-145a-5p/Tlr4 axis. Mol Neurobiol 59:6701-6712, 2022

 

7) Zheng K, Zhang Y, Zhang C et al:PRMT8 attenuates cerebral ischemia/reperfusion injury via modulating microglia activation and polarization to suppress neuroinflammation by upregulating Lin28a. ACS Chem Neurosci 13:1096-1104, 2022

 

8) Zhang Y, Chen Q, Chen D et al:SerpinA3N attenuates ischemic stroke injury by reducing apoptosis and neuroinflammation. CNS Neurosci Ther 28:566-579, 2022

 

9) Zhang X, Gong P, Zhao Y et al:Endothelial caveolin-1 regulates cerebral thrombo-inflammation in acute ischemia/reperfusion injury. EBioMedicine 84:104275, 2022

 

P.340 掲載の参考文献

10) Yang J, He W, Gu L et al:CircFOXP1 alleviates brain injury after acute ischemic stroke by regulating STAT3/apoptotic signaling. Transl Res 257:15-29, 2023

 

11) Jin W, Zhao J, Yang E et al:Neuronal STAT3/HIF-1α/PTRF axis-mediated bioenergetic disturbance exacerbates cerebral ischemia-reperfusion injury via PLA2G4A. Theranostics 12:3196-3216, 2022

 

12) Wang J, Cai Y, Sun J et al:Administration of intramuscular AAV-BDNF and intranasal AAV-TrkB promotes neurological recovery via enhancing corticospinal synaptic connections in stroke rats. Exp Neurol 359:114236, 2023

 

13) Chen Y, Hong Z, Wang J et al:Circuit-specific gene therapy reverses core symptoms in a primate Parkinson's disease model. Cell 186:5394-5410. e18, 2023

 

P.341 掲載の参考文献

14) Bettegazzi B, Cattaneo S, Simonato M et al:Viral vector-based gene therapy for epilepsy:what does the future hold? Mol Diagn Ther 28:5-13, 2024

 

15) Blaszkiewicz M, Tao T, Mensah-Arhin K et al:Gene therapy approaches for obesity-induced adipose neuropathy:device-targeted AAV-mediated neurotrophic factor delivery to adipocytes in subcutaneous adipose. Mol Ther 32:1407-1424, 2024

 

16) Bharucha-Goebel DX, Todd JJ, Saade D et al:Intrathecal gene therapy for giant axonal neuropathy. N Engl J Med 390:1092-1104, 2024

 

P.342 掲載の参考文献

17) Gomez K, Stratton HJ, Duran P et al:Identification and targeting of a unique NaV1.7 domain driving chronic pain. Proc Natl Acad Sci U S A 120:e2217800120, 2023

 

18) Stavrou M, Kagiava A, Choudury SG et al:A translatable RNAi-driven gene therapy silences PMP22/Pmp22 genes and improves neuropathy in CMT1A mice. J Clin Invest 132:e159814, 2022

 

19) Bouras M, Asehnoune K, Roquilly A:Immune modulation after traumatic brain injury. Front Med (Lausanne) 9:995044, 2022

 

20) Wang W, Gong QY, Cai L et al:Knockout of Sirt2 alleviates traumatic brain injury in mice. Neural Regen Res 18:350-356, 2023

 

21) Imai R, Tamura R, Yo M et al:Neuroprotective effects of genome-edited human iPS cell-derived neural stem/progenitor cells on traumatic brain injury. Stem Cells 41:603-616, 2023

 

X章 手術・手技

P.344 掲載の参考文献

1) Wu J, Zhang B, Shao D et al:Analysis of neuroendoscopy for the treatment of macroadenomas and giant pituitary adenomas. Front Surg;9:956345 2022

 

P.345 掲載の参考文献

2) Wang XB, Han TY, Ma JG et al:Pseudocapsule and pseudocapsule-based extracapsular resection in pituitary neuroendocrine tumors. Front Endocrinol (Lausanne) 13:1056327, 2022

 

3) Costello RT:Subclinical adenoma of the pituitary gland. Am J Pathol 12:205-216. 1, 1936

 

4) Solari D, Mastantuoni C, Cavallo LM et al:Endoscopic endonasal treatment of craniopharyngiomas:current management strategies and future perspectives. J Neurosurg Sci 67:26-35, 2023

 

5) Solari D, d'Avella E, Agresta G et al:Endoscopic endonasal approach for infradiaphragmatic craniopharyngiomas:a multicentric Italian study. J Neurosurg 138:522-532, 2023

 

6) Bobeff EJ, Mathios D, Mistry AA et al:Predictors of extent of resection and recurrence following endoscopic endonasal resection of craniopharyngioma. J Neurosurg 139:1235-1246, 2023

 

7) Patel TD, Rullan-Oliver B, Ungerer H et al:Outcomes of endoscopic endonasal resection of pediatric craniopharyngiomas. Int Forum Allergy Rhinol 12:1517-1526, 2022

 

P.346 掲載の参考文献

8) Mo C, Li M, Li Y et al:A simple scoring system for predicting the risk of delayed hyponatremia after endoscopic transsphenoidal surgery for pituitary adenomas. World Neurosurg, 2024. doi:10.1016/j.wneu.2024.03.073

 

9) Rajan R, Chacko AG, Verma S et al:Predictors of delayed hyponatraemia after surgery for pituitary tumour. Horm Metab Res 55:395-401, 2023

 

10) Lin K, Lu L, Pei Z et al:Predictive factors for delayed hyponatremia after transsphenoidal surgery in patients with pituitary adenomas. Endocr Connect 11:e210497, 2022

 

11) Tomita Y, Kurozumi K, Inagaki K et al:Delayed postoperative hyponatremia after endoscopic transsphenoidal surgery for pituitary adenoma. Acta Neurochir (Wien) 161:707-715, 2019

 

P.347 掲載の参考文献

12) Makino R, Fujio S, Hanada T et al:Delayed postoperative hyponatremia in patients with acromegaly:incidence and predictive factors. Pituitary 26:42-50, 2023

 

13) Zhao J, Wang S, Zhao X et al:Risk factors of cerebrospinal fluid leakage after neuroendoscopic transsphenoidal pituitary adenoma resection:a systematic review and meta-analysis. Front Endocrinol (Lausanne) 14:1263308, 2023

 

14) Wang X, Wang B, Cheng G et al:Intradural fat graft packing is not indispensable in preventing postoperative cerebrospinal fluid leakage in endoscopic endonasal pituitary adenoma surgeries. Front Oncol 13:1222581, 2023

 

15) 日本脳卒中学会脳卒中ガイドライン委員会編:脳卒中治療ガイドライン2021〔改訂2023〕. 協和企画, 2023

 

16) Noiphithak R, Yindeedej V, Ratanavinitkul W et al:Treatment outcomes between endoscopic surgery and conventional craniotomy for spontaneous supratentorial intracerebral hemorrhage:a randomized controlled trial. Neurosurg Rev 46:136, 2023

 

P.348 掲載の参考文献

17) Zhan Y, Zou X, Wu J et al:Neuroendoscopy surgery for hypertensive intracerebral hemorrhage with concurrent brain herniation:a retrospective study of comparison with craniotomy. Front Neurol 14:1238283, 2023

 

18) Monteiro GA, Marinheiro G, Mutarelli A et al:Efficacy and safety of neuroendoscopy surgery versus craniotomy for supratentorial intracerebral hemorrhage:an updated meta-analysis of randomized controlled trials. Neurosurg Rev 47:255, 2024

 

19) Li Q, Duan F, Luo M et al:Neuronavigation-assisted neuroendoscopy versus conventional craniotomy for hypertensive cerebellar hemorrhage:a comparative analysis of efficacy and outcomes. Clin Neurol Neurosurg 233:107960, 2023

 

20) Wang L, Zhou T, Wang P et al:Efficacy and safety of NeuroEndoscopic Surgery for IntraCerebral Hemorrhage:a randomized, controlled, open-label, blinded endpoint trial (NESICH). Int J Stroke 19:587-592, 2024

 

P.349 掲載の参考文献

21) Montemurro N:Clinical and surgical outcome of endoscopic third ventriculostomy (ETV) and ventriculoperitoneal shunt (VPS) in patients with Long-Standing Overt Ventriculomegaly in Adults (LOVA):a systematic review. Neurol Res 46:81-88, 2024

 

22) Gillespie CS, Fang WYS, Lee KS et al:Long-standing overt ventriculomegaly in adults:a systematic review and meta-analysis of endoscopic third ventriculostomy versus ventriculoperitoneal shunt as first-line treatment. World Neurosurg 174:213-220. e2, 2023

 

23) Minta KJ, Kannan S, Kaliaperumal C:Outcomes of endoscopic third ventriculostomy (ETV) and ventriculoperitoneal shunt (VPS) in the treatment of paediatric hydrocephalus:systematic review and meta-analysis. Childs Nerv Syst 40:1045-1052, 2024

 

24) Li C, Gui S, Zhang Y:Compare the safety and efficacy of endoscopic third ventriculostomy and ventriculoperitoneal shunt placement in infants and children with hydrocephalus:a systematic review and meta-analysis. Int J Neurosci 134:1-10, 2024

 

25) Lee KS, Chari A, Gillespie CS et al:Endoscopic third ventriculostomy for shunt malfunction in the pediatric population:a systematic review, meta-analysis, and meta-regression analysis. J Neurosurg Pediatr 31:423-432, 2023

 

P.350 掲載の参考文献

26) Yamamoto KK, Brumfiel TA, Qi R et al:Preclinical evaluation of a novel steerable robotic neuroendoscope tool. Oper Neurosurg (Hagerstown) 26:389-395, 2024

 

27) Koizumi S, Shiraishi Y, Makita I et al:A novel technique for fence-post tube placement in glioma using the robot-guided frameless neuronavigation technique under exoscope surgery:patient series. J Neurosurg Case Lessons 2:CASE21466, 2021

 

28) Tan K, Peng Y, Li J et al:Long-term outcomes and cost-effectiveness evaluation of robot-assisted stereotactic hematoma drainage for spontaneous intracerebral hemorrhage. Front Neurol 14:1291634, 2023

 

P.351 掲載の参考文献

1) Zhang JF, Okai B, Iovoli A et al:Bevacizumab and gamma knife radiosurgery for first-recurrence glioblastoma. J Neurooncol 166:89-98, 2024

 

P.352 掲載の参考文献

2) Tsien CI, Pugh SL, Dicker AP et al:NRG Oncology/RTOG1205:a randomized phase II trial of concurrent bevacizumab and reirradiation versus bevacizumab alone as treatment for recurrent glioblastoma. J Clin Oncol 41:1285-1295, 2023

 

3) Moore-Palhares D, Chen H, Keith J et al:Re-irradiation for recurrent high-grade glioma:an analysis of prognostic factors for survival and predictors of radiation necrosis. J Neurooncol 163:541-551, 2023

 

4) Wei Z, Pease M, Tang LW et al:Radiosurgery outcomes in infratentorial juvenile pilocytic astrocytomas. J Neurooncol 162:157-165, 2023

 

P.353 掲載の参考文献

5) Lehrer EJ, Gurewitz J, Bernstein K et al:Concurrent administration of immune checkpoint inhibitors and stereotactic radiosurgery is well tolerated in patients with melanoma brain metastases:an international multicenter study of 203 patients. Neurosurgery 91:872-882, 2022

 

6) Lehrer EJ, Gurewitz J, Bernstein K et al:Radiation necrosis in renal carcinoma brain metastases treated with checkpoint inhibitors and radiosurgery:an international multicenter study. Cancer 128:1429-1438, 2022

 

7) Mehkri Y, Windermere SA, Still MEH et al:The safety and efficacy of concurrent immune checkpoint blockade and stereotactic radiosurgery therapy with practitioner and researcher recommendations. World Neurosurg 181:e133-e153, 2024

 

P.354 掲載の参考文献

8) Hall J, Lui K, Tan X et al:Factors associated with radiation necrosis and intracranial control in patients treated with immune checkpoint inhibitors and stereotactic radiotherapy. Radiother Oncol 189:109920, 2023

 

9) Yomo S, Oda K, Oguchi K:Synergistic effects of immune checkpoint inhibitors in combination with stereotactic radiosurgery for patients with lung cancer and brain metastases:a propensity score-matched analysis. J Neurosurg 139:1628-1637, 2023

 

10) Yang Y, Deng L, Yang Y et al:Efficacy and safety of combined brain radiotherapy and immunotherapy in non-small-cell lung cancer with brain metastases:a systematic review and meta-analysis. Clin Lung Cancer 23:95-107, 2022

 

11) Botticella A, Dhermain F:Combination of radiosurgery and immunotherapy in brain metastases:balance between efficacy and toxicities. Curr Opin Neurol 36:587-591, 2023

 

12) Badrigilan S, Meola A, Chang SD et al:Stereotactic radiosurgery with immune checkpoint inhibitors for brain metastases:a meta-analysis study. Br J Neurosurg 37:1533-1543, 2023

 

P.355 掲載の参考文献

13) Shrivastava M, Emmanouil B, Mathew R et al:Stereotactic radiosurgery and radiotherapy for vestibular schwannoma in NF2-related schwannomatosis. Laryngoscope, 2023. doi:10.1002/lary.31180

 

14) Puataweepong P, Dhanacha M, Ruangkanchanasetr R et al:Long-term clinical outcomes of stereotactic radiotherapy for bilateral vestibular schwannomas in neurofibromatosis type 2 patients. J Neurooncol 164:587-595, 2023

 

15) Pikis S, Mantziaris G, Dumot C et al:Third stereotactic radiosurgery for residual arteriovenous malformations:a retrospective multicenter study. Neurosurgery, 2023. doi:10.1227/neu.0000000000002805

 

P.356 掲載の参考文献

16) Karlsson B, Johansson AV, Jokura H et al:Risk for brain arteriovenous malformation rupture during pregnancy and puerperium. Neurosurgery 93:918-923, 2023

 

P.357 掲載の参考文献

1) Rabbin-Birnbaum C, Wiggan DD, Sangwon KL et al:Learning curve of robotic end-to-side microanastomoses. Oper Neurosurg (Hagerstown), 2024. doi:10.1227/ons.0000000000001187

 

P.358 掲載の参考文献

2) Cekic E, Pinar E, Pinar M et al:Deep learning-assisted segmentation and classification of brain tumor types on magnetic resonance and surgical microscope images. World Neurosurg 182:e196-e204, 2024

 

3) Sharma N, Mallela AN, Khan T et al:Evolution of the meta-neurosurgeon:a systematic review of the current technical capabilities, limitations, and applications of augmented reality in neurosurgery. Surg Neurol Int 15:146, 2024

 

4) Ma L, Pruitt K, Fei B:A hyperspectral surgical microscope with super-resolution reconstruction for intraoperative image guidance. Proc SPIE Int Soc Opt Eng 12930:129300Z, 2024

 

5) Goldberg J, Miller DR, Dimanche A et al:Intraoperative laser speckle contrast imaging to assess vessel flow in neurosurgery:a pilot study. Neurosurgery, 2023. doi:10.1227/neu.0000000000002776

 

P.359 掲載の参考文献

6) Mohtasebi M, Huang C, Zhao M et al:A wearable fluorescence imaging device for intraoperative identification of human brain tumors. IEEE J Transl Eng Health Med 12:225-232, 2024

 

7) Ma R, Livermore LJ, Taylor L et al:Endoscopic 5-aminolevulinic acid-induced fluorescence-guided intraparenchymal brain tumor resection - can the endoscope detect more fluorescence than the microscope? World Neurosurg 185:e1268-e1279, 2024

 

8) Vattipally VN, Jiang K, Weber-Levine C et al:Exoscope use in spine surgery:a systematic review of applications, benefits, and limitations. World Neurosurg 184:283-292. e3, 2023

 

P.360 掲載の参考文献

9) Iqbal J, Covell MM, Jabeen S et al:Comparative analysis of exoscope-assisted spine surgery versus operating microscope:a systematic review. World Neurosurg X 21:100258, 2024

 

10) Ferreira T, Roy S, Tan JK et al:Exoscope-assisted spine surgery:current applications and future directions. World Neurosurg X 23:100335, 2024

 

11) Cunningham CM, Nawabi N, Saway BF et al:Exoscope efficacy and feasibility in pediatric spinal neurosurgery:a single-institution cohort case series. World Neurosurg 183:e314-e320, 2024

 

P.361 掲載の参考文献

12) Demetz M, Abramovic A, Krigers A et al:Cadaveric study of ergonomics and performance using a robotic exoscope with a head-mounted display in spine surgery. J Robot Surg 18:6, 2024

 

13) Garcia A, Shave S, Cheng YS et al:Initial experience with robotic-assisted otologic and lateral skull base surgery. Otolaryngol Head Neck Surg 170:1190-1194, 2024

 

14) Kimura H, Shigeyasu M, Mori T et al:Next-generation exoscopic surgery featuring a head-mounted 3-dimensional display for carotid endarterectomy:2-dimensional operative video. Oper Neurosurg (Hagerstown), 2024. doi:10.1227/ons.0000000000001189

 

15) Zulbaran-Rojas A, Rouzi MD, Zahiri M et al:Objective assessment of postural ergonomics in neurosurgery:integrating wearable technology in the operating room. J Neurosurg Spine, 2024. doi:10.3171/2024.1.SPINE231001

 

P.363 掲載の参考文献

1) Picart T, Pallud J, Berthiller J et al;Members of RESECT study group:Use of 5-ALA fluorescence-guided surgery versus white-light conventional microsurgery for the resection of newly diagnosed glioblastomas (RESECT study):a French multicenter randomized phase III study. J Neurosurg 140:987-1000, 2024

 

P.364 掲載の参考文献

2) Eatz TA, Eichberg DG, Lu VM et al:Intraoperative 5ALA fluorescenceguided resection of highgrade glioma leads to greater extent of resection with better outcomes:a systematic review. J Neurooncol 156:233-256, 2022

 

3) Mirza AB, Lavrador JP, Christodoulides I et al:5-aminolevulinic acid-guided resection in grade III tumors - a comparative cohort study. Oper Neurosurg 22:215-223, 2022

 

4) McCracken DJ, Schupper AJ, Lakomkin N et al:Turning on the light for brain tumor surgery:a 5-aminolevulinic acid story. Neuro Oncol 24(Suppl 6):S52-S61, 2022

 

5) Watts C, Dayimu A, Matys T et al:Refining the intraoperative identification of suspected high-grade glioma using a surgical fluorescence biomarker:GALA BIDD study report. J Pers Med 13:514, 2023

 

6) Hosmann A, Jaber M, Roetzer-Pejrimovsky T et al:CD34 microvascularity in low-grade glioma:correlation with 5-aminolevulinic acid fluorescence and patient prognosis in a multicenter study at three specialized centers. J Neurosurg 138:1281-1290, 2022

 

7) Pacioni S, D'Alessandris QG, Giannetti S et al:5-aminolevulinic acid (5-ALA)-induced protoporphyrin IX fluorescence by glioma cells-a fluorescence microscopy clinical study. Cancers (Basel)14:2844, 2022

 

P.365 掲載の参考文献

8) Bianconi A, Bonada M, Zeppa P et al:How reliable is fluorescence-guided surgery in low-grade gliomas? A systematic review concerning different fluorophere. Cancers (Basel) 15:4130, 2023

 

9) Molina ES, Black D, Kaneko S et al:Double dose of 5-aminolevulinic acid and its effect on protoporphyrin IX accumulation in low-grade glioma. J Neurosurg 137:943-952, 2022

 

10) Liu Z, Mela A, Argenziano MG et al:Single-cell analysis of 5-aminolevulinic acid intraoperative labeling specificity for glioblastoma. J Neurosurg 140:968-978, 2023

 

P.366 掲載の参考文献

11) Zeppa P, De Marco R, Monticelli M et al:Fluorescence-guided surgery in glioblastoma:5-ALA, SF or both? Differences between fluorescent dyes in 99 consecutive cases. Brain Sci 12:555, 2022

 

12) Smith EJ, Gohil K, Thompson CM et al:Fluorescein-guided resection of high grade gliomas:a meta-analysis. World Neurosurg 155:181-188. e7, 2021

 

13) Naik A, Smith EJ, Barreau A et al:Comparison of fluorescein sodium, 5-ALA, and intraoperative MRI for resection of high-grade gliomas:a systematic review and network meta-analysis. J Clin Neurosci 98:240-247, 2022

 

14) de Laurentis C, Beuriat PA, Bteich F et al:Pediatric low-grade glioma surgery with sodium fluorescein:efficient localization for removal and association with intraoperative pathological sampling. Diagnostics (Basel) 12:2927, 2022

 

15) Falco J, Broggi M, Schiariti M et al:The role of sodium fluorescein in pediatric supratentorial intra-axial tumor resection:new insights from a monocentric series of 33 consecutive patients. Childs Nerv Syst 39:1463-1471, 2023

 

16) Chen ZH, Zhang XH, Lin FH et al:The application of fuorescein sodium for the resection of medulloblastoma. J Neurooncol 158:463-470, 2022

 

P.367 掲載の参考文献

17) Cheng X, Chen J, Tang R et al:Sodium fluorescein-guided surgery for resection of brain metastases from lung cancer:a consecutive case series study and literature review. Cancers (Basel) 15:882, 2023

 

18) Kerschbaumer J, Demetz M, Krigers A et al:Mind the gap - the use of sodium fuoresceine for resection of brain metastases to improve the resection rate. Acta Neurochir (Wien) 165:225-230, 2023

 

19) Schebesch KM, Hohne J, Noeva E et al:Brain metastasis resection:the impact of fluorescence guidance (MetResect study). Neurosurg Focus 55:E10, 2023

 

20) Cristofori AD, Carone G, Rocca A et al:Fluorescence and intraoperative ultrasound as surgical adjuncts for brain metastases resection:what do we know? A systematic review of the literature. Cancers (Basel) 15:2047, 2023

 

21) Narducchi A, Ronchetti G, Minardi M et al:Sodium fluorescein application in brain tumor biopsy. J Neurosurg Sci 67:439-445, 2023

 

22) Klint E, Richter J, Wardell K:Combined use of frameless neuronavigation and in situ optical guidance in brain tumor needle biopsies. Brain Sci 13:809, 2023

 

P.368 掲載の参考文献

23) Ruzevick J, Cardinal T, Pangal DJ et al:From white to blue light:evolution of endoscope-assisted intracranial tumor neurosurgery and expansion to intraaxial tumors. J Neurosurg 139:59-64, 2023

 

24) Witten AJ, Ben-Sharom N, Ellis JA et al:Optimization of novel exoscopic blue light filter during fluorescenceguided resection of Glioblastoma. J Neurooncol 161:617-623, 2023

 

25) Molina ES, Hellwig SJ, Walke A et al:Development and validation of a triple-LED surgical loupe device for fluorescence-guided resections with 5-ALA. J Neurosurg 137:582-590, 2022

 

26) Zhang X, Habib A, Jaman E et al:Headlight and loupe-based fluorescein detection system in brain tumor surgery:a first-inhuman experience. J Neurosurg Sci 67:374-379, 2023

 

27) Muto J, Mine Y, Nishiyama Y et al:Intraoperative real-time near-infrared image-guided surgery to identify intracranial meningiomas via microscope. Front Neurosci 16:837349, 2022

 

P.369 掲載の参考文献

1) Gharios M, El-Hajj VG, Frisk H et al:The use of hybrid operating rooms in neurosurgery, advantages, disadvantages, and future perspectives:a systematic review. Acta Neurochir (Wien) 165:2343-2358, 2023

 

2) Spenkelink IM, Heidkamp J, Futterer JJ et al:Image-guided procedures in the hybrid operating room:a systematic scoping review. PLoS One 17:e0266341, 2022

 

P.370 掲載の参考文献

3) Scarone P, Chatterjea A, Jenniskens I et al:Percutaneous thoraco-lumbar-sacral pedicle screw placement accuracy results from a multi-center, prospective clinical study using a skin marker-based optical navigation system. Eur Spine J 31:3098-3108, 2022

 

4) Soenens G, Marchand B, Doyen B et al:Surgeons' leadership style and team behavior in the hybrid operating room:prospective cohort study. Ann Surg 278:e5-e12, 2023

 

P.371 掲載の参考文献

5) Roder C, Stummer W, Coburger J et al:Intraoperative MRI-guided resection is not superior to 5-aminolevulinic acid guidance in newly diagnosed glioblastoma:a prospective controlled multicenter clinical trial. J Clin Oncol 41:5512-5523, 2023

 

6) Aichholzer M, Rauch P, Kastler L et al:Tailored intraoperative MRI strategies in high-grade glioma surgery:a machine learning-based radiomics model highlights selective benefits. Oper Neurosurg (Hagerstown), 2023. doi:10.1227/ons.0000000000001023

 

7) Tsuzuki S, Muragaki Y, Nitta M et al:Information-guided surgery centered on intraoperative magnetic resonance imaging guarantees surgical safety with low mortality. Neurol Med Chir (Tokyo) 64:57-64, 2024

 

8) Sharma M, Wang D, Palmisciano P et al:Is intraoperative MRI use in malignant brain tumor surgery a health care burden? A matched analysis of MarketScan Database. J Neurooncol 160:331-339, 2022

 

P.372 掲載の参考文献

9) Picart T, Pallud J, Berthiller J et al:Use of 5-ALA fluorescence-guided surgery versus white-light conventional microsurgery for the resection of newly diagnosed glioblastomas (RESECT study):a French multicenter randomized phase III study. J Neurosurg 140:987-1000, 2024

 

10) Stummer W, Pichlmeier U, Meinel T et al;ALA-Glioma Study Group:Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma:a randomised controlled multicentre phase III trial. Lancet Oncol 7:392-401, 2006

 

11) Zhang JJY, Lim JX, Lee KS et al:Impact of intraoperative magnetic resonance imaging on short-term and long-term outcomes after transsphenoidal resection of pituitary adenoma:a systematic review and meta-analysis. World Neurosurg 167:184-194. e16, 2022

 

12) Pal'a A, Etzrodt-Walter G, Karpel-Massler G et al:Characterization of tumor remnants in intraoperative MRI-assisted microscopic and endoscopic transsphenoidal resection of less invasive pituitary adenomas. Neurosurg Rev 45:1701-1708, 2022

 

13) Dhawan S, Chen CC:Comparison meta-analysis of intraoperative MRI-guided needle biopsy versus conventional stereotactic needle biopsies. Neurooncol Adv 6:vdad129, 2024

 

P.373 掲載の参考文献

14) Herta J, Cho A, Roetzer-Pejrimovsky T et al:Optimizing maximum resection of glioblastoma:Raman spectroscopy versus 5-aminolevulinic acid. J Neurosurg 139:334-343, 2023

 

15) Wagner A, Brielmaier MC, Kampf C et al:Fluorescein-stained confocal laser endomicroscopy versus conventional frozen section for intraoperative histopathological assessment of intracranial tumors. Neuro Oncol 26:922-932, 2024

 

16) He Z, Zhu YN, Chen Y et al:A deep unrolled neural network for real-time MRI-guided brain intervention. Nat Commun 14:8257, 2023

 

17) Zhao Y, Ding Y, Lau V et al:Whole-body magnetic resonance imaging at 0.05 Tesla. Science 384:eadm7168, 2024

 

P.374 掲載の参考文献

1) Shimamoto T, Sano Y, Yoshimitsu K et al:Precise brain-shift prediction by new combination of W-Net deep learning for neurosurgical navigation. Neurol Med Chir (Tokyo) 63:295-303, 2023

 

2) Mazzucchi E, La Rocca G, Hiepe P et al:Intraoperative integration of multimodal imaging to improve neuronavigation:a technical note. World Neurosurg 164:330-340, 2022

 

P.375 掲載の参考文献

3) Tomaiuolo F, Raffa G, Morelli A et al:Sulci and gyri are topological cerebral landmarks in individual subjects:a study of brain navigation during tumour resection. Eur J Neurosci 55:2037-2046, 2022

 

4) Furuse M, Ikeda N, Kawabata S et al:Influence of surgical position and registration methods on clinical accuracy of navigation systems in brain tumor surgery. Sci Rep 13:2644, 2023

 

5) Habib A, Jovanovich N, Hoppe M et al:Navigated 3D ultrasound-guided resection of high-grade gliomas:a case series and review. Surg Neurol Int 13:356, 2022

 

6) Aleo D, Elshaer Z, Pfnur A et al:Evaluation of a navigated 3D ultrasound integration for brain tumor surgery:first results of an ongoing prospective study. Curr Oncol 29:6594-6609, 2022

 

P.376 掲載の参考文献

7) Yamaguchi T, Kuwano A, Koyama T et al:Construction of brain area risk map for decision making using surgical navigation and motor evoked potential monitoring information. Int J Comput Assist Radiol Surg 18:269-278, 2023

 

8) Harwick E, Singhal I, Conway B et al:Pinless electromagnetic neuronavigation during awake craniotomies:technical pearls, pitfalls, and nuances. World Neurosurg 175:e159-e166, 2023

 

9) Bopp MHA, SaB B, Pojskic M et al:Use of neuronavigation and augmented reality in transsphenoidal pituitary adenoma surgery. J Clin Med 11:5590, 2022

 

P.377 掲載の参考文献

10) de Macedo Filho LJM, Diogenes AVG, Barreto EG et al:Endoscopic endonasal resection of the medial wall of the cavernous sinus and its impact on outcomes of pituitary surgery:a systematic review and meta-analysis. Brain Sci 12:1354, 2022

 

11) Han S, Qin X, Zhang W et al:Advantages of computed tomography-based navigation in clipping distal anterior cerebral artery aneurysms:a retrospective cohort study. Quant Imaging Med Surg 13:8326-8335, 2023

 

12) Steineke TC, Barbery D:Extended reality platform for minimally invasive endoscopic evacuation of deep-seated intracerebral hemorrhage:illustrative case. J Neurosurg Case Lessons 4:CASE21390, 2022

 

13) Zhou Z, Yang Z, Jiang S et al:Surgical navigation system for hypertensive intracerebral hemorrhage based on mixed reality. J Digit Imaging 35:1530-1543, 2022

 

P.378 掲載の参考文献

14) Golubovsky JL, Liao J, Hogue O et al:Complications associated with ventriculoperitoneal shunt surgery for normal pressure hydrocephalus using stereotactic navigation and abdominal laparoscopy:a single-institution case series. Oper Neurosurg (Hagerstown) 23:188-193, 2022

 

15) Vanstrum EB, Borzage MT, Ha J et al:Development of an ultrafast brain MR neuronavigation protocol for ventricular shunt placement. J Neurosurg 138:367-373, 2022

 

16) Belal A, Allmen GV, Kommuru I et al:Complete corpus callosotomy using a frameless navigation probe through a minicraniotomy in children with medically refractory epilepsy:a case series and technical note. Surg Neurol Int 13:585, 2022

 

P.379 掲載の参考文献

17) Wang J, Zhang W, Wang X et al:Application of neuronavigation in microvascular decompression:optimizing craniotomy and 3D reconstruction of neurovascular compression. J Craniofac Surg 34:e620-e623, 2023

 

P.380 掲載の参考文献

1) Sasaki T, Murakami K, Saito A et al:Usefulness of transcranial motor evoked potential in clipping surgery for cerebral aneurysms - introduction of a new protocol for stable monitoring. Neurol Med Chir (Tokyo) 63:409-419, 2023

 

P.381 掲載の参考文献

2) Yamada S, Enatsu R, Ishikawa S et al:Transcranial electrical stimulation technique for induction of unilateral motor evoked potentials. Clin Neurophysiol 150:194-196, 2023

 

3) Sasaki R, Tamura K, Yamazaki S et al:Effects of intraoperative motor evoked potential amplification following tetanic stimulation of the pudendal nerve in pediatric craniotomy. J Neurosurg Pediatr 31:488-495, 2023

 

P.382 掲載の参考文献

4) Olmsted ZT, Ryu B, Phayal G et al:Direct wave intraoperative neuromonitoring for spinal tumor resection:a focused review. World Neurosurg X 17:100139, 2023

 

5) Skrap B, Tramontano V, Faccioli F et al:Surgery for intramedullary spinal cord ependymomas in the neuromonitoring era:results from a consecutive series of 100 patients. J Neurosurg Spine 36:858-868, 2022

 

P.383 掲載の参考文献

6) Niedermeyer S, Szelenyi A, Schichor C et al:Intramedullary spinal cord cavernous malformations - association between intraoperative neurophysiological monitoring changes and neurological outcome. Acta Neurochir (Wien) 164:2595-2604, 2022

 

7) Antkowiak L, Putz M, Sordyl R et al:Relevance of intraoperative motor evoked potentials and D-wave monitoring for the resection of intramedullary spinal cord tumors in children. Neurosurg Rev 45:2723-2731, 2022

 

8)Tropeano MP, Rossini Z, Franzini A et al:Multimodal intraoperative neurophysiological monitoring in intramedullary spinal cord tumors:a 10-year single center experience. Cancers (Basel) 16:111, 2024

 

P.384 掲載の参考文献

9) Sen RD, Martinez V, Eaton J et al:Intraoperative neuromonitoring for pediatric Chiari decompression:when is it useful? Neurosurg Focus 54:E9, 2023

 

10) Karre B, Sasidharan GM, Bidkar PU:Trigeminal somatosensory evoked potentials during neurosurgical procedures using electrical stimulation of the lips under general anesthesia. Cureus 15:e37601, 2023

 

P.385 掲載の参考文献

11) Kawajiri S, Isozaki M, Komori O et al:Visual evoked potential can predict deterioration of visual function after direct clipping of paraclinoid aneurysm with anterior clinoidectomy. Neurosurgery 92:1276-1285, 2023

 

12) Mattogno PP, D'Alessandris QG, Rigante M et al:Reliability of intraoperative visual evoked potentials (iVEPs) in monitoring visual function during endoscopic transsphenoidal surgery. Acta Neurochir (Wien) 165:3421-3429, 2023

 

13) Yamada S, Hayamizu K, Akiyama Y et al:Effect of remimazolam on intraoperative neurophysiology monitoring of visual-evoked potential:a case series. J Anesth 37:311-314, 2023

 

14) Park SK, Lee HS, Cho KR et al:Recent advances in intraoperative brainstem auditory evoked potential monitoring during microvascular decompression surgery for hemifacial spasm. Life (Basel) 13:1789, 2023

 

P.386 掲載の参考文献

15) Vega-Zelaya L, Pulido P, Sola RG et al:Intraoperative cortico-cortical evoked potentials for monitoring language function during brain tumor resection in anesthetized patients. J Integr Neurosci 22:17, 2023

 

16) Morota N, Sakamoto H:Surgery for spina bifida occulta:spinal lipoma and tethered spinal cord. Childs Nerv Syst 39:2847-2864, 2023

 

17) Morota N:Intraoperative neurophysiological monitoring of the bulbocavernosus reflex during surgery for conus spinal lipoma:what are the warning criteria? J Neurosurg Pediatr 23:693-647, 2019

 

P.387 掲載の参考文献

18) Nonaka M, Itakura T, Iwamura H et al:Comparison of intraoperative neurophysiological monitoring methods for lumbosacral lipoma surgery in infants. Childs Nerv Syst 39:1603-1610, 2023

 

19) Kojima A, Saga I, Fukumura M:Intraoperative neuromonitoring of hypoglossal nerves using transcranial and direct electrical stimulation during extracranial internal carotid artery surgery. World Neurosurg 172:E701-E707, 2023

 

XI章 画像診断

P.390 掲載の参考文献

1) Horiuchi D, Tatekawa H, Shimono T et al:Accuracy of ChatGPT generated diagnosis from patient's medical history and imaging findings in neuroradiology cases. Neuroradiology 66:73-79, 2024

 

P.391 掲載の参考文献

2) Suthar P, Kounsal A, Chhetri L et al:Artificial Intelligence (AI) in radiology:a deep dive into ChatGPT 4.0's accuracy with the American Journal of Neuroradiology's (AJNR) "Case of the Month". Cureus 15:e43958, 2023

 

3) Food and Drug Administration:Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices. https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-and-machine-learning-aiml-enabled-medical-devices?utm_medium=email&utm_source=govdelivery

 

4) 越野沙織:ディープラーニングを用いた未破裂脳動脈瘤検出CADソフトウエアの開発. INNERVISION 34:22-24, 2019

 

5) Koshino S, Choppin A, Suzuki M et al:Deep learning-based automated detection of cerebral aneurysms:a comparison of reading performance between radiologists and neurosurgeons. Insights into Imaging 11 (Suppl 1):183, 2020

 

6) Ishihara M, Shiiba M, Maruno H et al:Detection of intracranial aneurysms using deep learning-based CAD system:usefulness of the scores of CNN's final layer for distinguishing between aneurysm and infundibular dilatation. Jpn J Radiol 41:131-141, 2023

 

7) Tajima T, Akai H, Yasaka K et al:Comparison of 1.5 T and 3 T magnetic resonance angiography for detecting cerebral aneurysms using deep learning-based computer-assisted detection software. Neuroradiology 65:1473-1482, 2023

 

P.392 掲載の参考文献

8) Chen G, Yifang B, Jiajun Z et al:Automated unruptured cerebral aneurysms detection in TOF MR angiography images using dual-channel SE-3D UNet:a multicenter research. Eur Radiol 33:3532-3543, 2023

 

9) Claux F, Baudouin M, Bogey C et al:Dense, deep learning-based intracranial aneurysm detection on TOF MRI using two-stage regularized U-Net. J Neuroradiol 50:9-15, 2023

 

10) Gibson E, Georgescu B, Ceccaldi P et al:Artificial intelligence with statistical confidence scores for detection of acute or subacute hemorrhage on noncontrast CT head scans. Radiol Artif Intell 4:e210115, 2022

 

11) Nijiati M, Tuersun A, Zhang Y et al:A symmetric prior knowledge based deep learning model for intracerebral hemorrhage lesion segmentation. Front Physiol 13:977427, 2022

 

P.393 掲載の参考文献

12) Vacek A, Mair G, White P et al:Evaluating artificial intelligence software for delineating hemorrhage extent on CT brain imaging in stroke:AI delineation of ICH on CT. J Stroke Cerebrovasc Dis 33:107512, 2024

 

13) Pedro T, Sousa J, Fonseca L et al:Exploring the use of ChatGPT in predicting anterior circulation stroke functional outcomes after mechanical thrombectomy:a pilot study. J Neurointerv Surg, 2024. doi:10.1136/jnis-2024-021556

 

14) Ganesh A, Luengo-Fernandez R, Wharton R et al:Ordinal vs dichotomous analyses of modified Rankin Scale, 5-year outcome, and cost of stroke. Neurology 91:e1951-e1960, 2018

 

15) Khalighi S, Reddy K, Midya A et al:Artificial intelligence in neuro-oncology:advances and challenges in brain tumor diagnosis, prognosis, and precision treatment. NPJ Precis Oncol 8:80, 2024

 

16) Li G, Li L, Li Y et al:An MRI radiomics approach to predict survival and tumour-infiltrating macrophages in gliomas. Brain 145:1151-1161, 2022

 

P.394 掲載の参考文献

17) Iyer S, Ismail M, Tamrazi B et al:Novel MRI deformation-heterogeneity radiomic features are associated with molecular subgroups and overall survival in pediatric medulloblastoma:preliminary findings from a multi-institutional study. Front Oncol 12:915143, 2022

 

18) Long H, Zhang P, Bi Y et al:MRI radiomic features of peritumoral edema may predict the recurrence sites of glioblastoma multiforme. Front Oncol 12:1042498, 2022

 

19) Zhou T, Noeuveglise A, Modzelewski R et al:Prediction of brain tumor recurrence location based on multi-modal fusion and nonlinear correlation learning. Comput Med Imaging Graph 106:102218, 2023

 

P.395 掲載の参考文献

1) Agarwal N, Lewis LD, Hirschler L et al:Current understanding of the anatomy, physiology, and magnetic resonance imaging of neurofluids:update from the 2022 "ISMRM imaging neurofluids study group" workshop in Rome. J Magn Reson Imaging 59:431-449, 2024

 

P.396 掲載の参考文献

2) Charidimou A, Boulouis G, Frosch MP et al:The Boston criteria version 2.0 for cerebral amyloid angiopathy:a multicenter, retrospective, MRI-neuropathology diagnostic accuracy study. Lancet Neurol 21:714-725, 2022

 

3) Benson JC, Madhavan AA, Cutsforth-Gregory JK, et al:The Monro-Kellie Doctrine:a review and call for revision. AJNR Am J Neuroradiol 44:2-6, 2023

 

4) Wardlaw JM, Smith C, Dichgans M:Small vessel disease:mechanisms and clinical implications. Lancet Neurol 18:684-696, 2019

 

5) Markus HS, de Leeuw FE:Cerebral small vessel disease:recent advances and future directions. Int J Stroke 18:4-14, 2023

 

P.397 掲載の参考文献

6) Lahna D, Schwartz DL, Woltjer R et al:Venous collagenosis as pathogenesis of white matter hyperintensity. Ann Neurol 92:992-1000, 2022

 

7) Jochems ACC, Arteaga C, Chappell F et al:Longitudinal changes of white matter hyperintensities in sporadic small vessel disease:a systematic review and meta-analysis. Neurolgy 99:e2454-e2463, 2022

 

P.398 掲載の参考文献

8) Benveniste H, Nedergaard M:Cerebral small vessel disease:a glymphopathy? Curr Opin Neurobiol 72:15-21, 2022

 

P.399 掲載の参考文献

9) Van den Brink H, Doubal FN, Duering M:Advanced MRI in cerebral small vessel disease. Int J Stroke 18:28-35, 2023

 

10) Sun F, Huang Y, Wang J et al:Research progress in diffusion spectrum imaging. Brain Sci 13:1497, 2023

 

11) Feng M, Wen H, Xin H et al:Decreased local specialization of brain structural networks associated with cognitive dysfunction revealed by probabilistic diffusion tractography for different cerebral small vessel disease burdens. Mol Neurobiol 61:326-339, 2024

 

12) 増谷佳孝:拡散MRI解析における数理的基礎と応用. 医用画像情報会誌 33:22-27, 2016

 

13) Konieczny MJ, Dewenter A, ter Telgte A et al:Multi-shell diffusion MRI models for white matter characterization in cerebral small vessel disease. Neurology 96:e698-e708, 2021

 

14) Wang X, Wang Y, Gao D et al:Characterizing the penumbras of white matter hyperintensities in patients with cerebral small vessel disease. Jpn J Radiol 41:928-937, 2023

 

15) Chekhonin I, Cohen O, Otazo R et al:Magnetic resonance relaxometry in quantitative imaging of brain gliomas:a literature review. Neuroradiol J 37:267-275, 2024

 

16) Fujita S, Cencini M, Bounincontri G et al:Simultaneous relaxometry and morphometry of human brain structures with 3D magnetic resonance fingerprinting:a multicenter, multiplatform, multifield-strength study. Cereb Cortex 33:729-739, 2023

 

P.400 掲載の参考文献

17) Uchida Y, Kan H, Sakurai K et al:Iron leakage owing to blood-brain barrier disruption in small vessel disease CADASIL. Neurology 95:e1188-e1198, 2020

 

18) Perosa V, Rotta J, Yakpov R et al:Implications of quantitative susceptibility mapping at 7 Tesla MRI for microbleeds detection in small vessel disease. Fron Neurol 14:11123112, 2023

 

19) Rudilosso S, Stringer MS, Thrippleton M et al:Blood-brain barrier leakage hotspots collocating with brain lesions due to sporadic and monogenic small vessel disease. J Cereb Blood Flow Metab 43:1490-1502, 2023

 

20) Bae J, Li C, Masurkar A et al:Improving measurement of blood-brain barrier permeability with reduced scan time using deep-learning-derived capillary input function. Neuroimage 278:120284, 2023

 

21) Huang F, Guo Y, Chen R et al:Visualization of the lenticulostriate artery with 3-dimensional time-of-light magnetic resonance angiography combined with the compressed sensing technique using a 3-T magnetic resonance imaging system. Magn Reson Imaging 102:38-42, 2023

 

22) 福島啓太, 町田治彦, 苅安俊哉他:高性能3テスラMRIの最新技術と臨床応用. 杏林医会誌 52:133-140, 2021

 

23) Shi Z, Zhao X, Zhu S et al:Time-of-flight intracranial MRA at 3T versus 5T versus 7T:visualization of distal small cerebral arteries. Radiology 306:207-217, 2023

 

24) Perosa V, Arts T, Assmann A et al:Pulsatility index in the basal ganglia arteries increases with age in elderly with and without cerebral small vessel disease. AJNR Am J Neuroradiol 43:540-546, 2022

 

25) Van Den Brink H, Pham S, Siero JC et al:Assessment of small vessel function using 7T MRI in patients with sporadic cerebral small vessel disease:the ZOOM@SVDs study. Neurology 102:e209136, 2024

 

26) Natsumeda M, Matsuzawa H, Watanabe M et al:SWI by 7T MR imaging for the microscopic imaging diagnosis of astrocytic and oligodendroglial tumors. AJNR Am J Neuroradiol 43:1575-1581, 2022

 

27) Okada T, Fujimoto K, Fushimi Y et al:Neuroimaging at 7 Tesla:a pictorial narrative review. Quant Imaging Med Surg 12:3406-3435, 2022

 

P.401 掲載の参考文献

28) Feinberg DA, Beckett AJS, Vu AT et al:Next-generation MRI scanner designated for ultra-high-resolution human brain imaging at 7 Tesla. Nat Methods 20:2048-2057, 2023

 

29) Alipour A, Seifert AC, Delman BN et al:Enhancing the brain MRI at ultra-high filed system using a meta-array structure. Med Phys 50:7606-7618, 2023

 

30) Arnold TC, Freeman CW, Litt B et al:Low-field MRI:clinical promise and challenges. J Magn Reson Imaging 57:25-44, 2023

 

P.403 掲載の参考文献

1) Lindner T, Bolar DS, Achten E et al;on behalf of the ISMRM Perfusion Study Group:Current state and guidance on arterial spin labeling perfusion MRI in clinical neuroimaging. Magn Reson Med 89:2024-2047, 2023

 

2) Ozpar R, Dinc Y, Nas OF et al:Arterial transit artifacts observed on arterial spin labeling perfusion imaging of carotid artery stenosis patients:what are counterparts on symptomatology, dynamic susceptibility contrast perfusion, and digital subtraction angiography? J Neuroradiol 50:407-414, 2023

 

P.404 掲載の参考文献

3) van Grinsven EE, Guichelaar J, Philippens ME et al:Hemodynamic imaging parameters in brain metastases patients - agreement between multi-delay ASL and hypercapnic BOLD. J Cereb Blood Flow Metab 43:2072-2084, 2023

 

4) Woodward OB, Driver I, Schwarz ST et al:Assessment of brainstem function and haemodynamics by MRI:challenges and clinical prospects. Br J Radiol 96:20220940, 2023

 

P.405 掲載の参考文献

5) Lee TJ, Roh HG, Kim HJ et al:Prognostic value of collateral perfusion estimation by arterial spin labeling for acute anterior circulation ischemic stroke. Neuroradiology 65:1695-1705, 2023

 

6) Gao F, Cong J, Duan Y et al:Screening of postoperative cerebral hyperperfusion syndrome in moyamoya disease:a three-dimensional pulsed arterial-spin labeling magnetic resonance imaging approach. Front Neurosci 17:1274038, 2023

 

7) Peer S, Singh P:Intraluminal arterial transit artifact as a predictor of intracranial large artery stenosis on 3D time of flight MR angiography:expanding the application of arterial spin labeling MRI in ischemic stroke. J Clin Imaging Sci 13:17, 2023

 

P.406 掲載の参考文献

8) Kochi R, Endo H, Uchida H et al:Efficacy of arterial spin labeling for detection of the ruptured micro-arteriovenous malformation:illustrative cases. J Neurosurg Case Lessons 3:CASE21597, 2022

 

9) Yoo DH, Sohn CH, Kang HS et al:Arterial spin-labeling MR imaging for the differential diagnosis of venous-predominant AVMs and developmental venous anomalies. AJNR Am J Neuroradiol 44:916-921, 2023

 

10) Stotesbury H, Hales PW, Koelbel M et al:Venous cerebral blood flow quantification and cognition in patients with sickle cell anemia. J Cereb Blood Flow Metab 42:1061-1077, 2022

 

P.407 掲載の参考文献

11) Hirschler L, Sollmann N, Schmitz-Abecassis B et al:Advanced MR techniques for preoperative glioma characterization:part 1. J Magn Reson Imaging 57:1655-1675, 2023

 

12) Henssen D, Meijer F, Verburg FA et al:Challenges and opportunities for advanced neuroimaging of glioblastoma. Br J Radiol 96:20211232, 2023

 

P.408 掲載の参考文献

13) De Silvestro AA, Kellenberger CJ, Gosteli M et al:Postnatal cerebral hemodynamics in infants with severe congenital heart disease:a scoping review. Pediatr Res 94:931-943, 2023

 

14) Uher D, Drenthen GS, Schijns OEMG et al:Advances in image processing for epileptogenic zone detection with MRI. Radiology 307:e220927, 2023

 

P.409 掲載の参考文献

15) Agarwal N, Lewis LD, Hirschler L et al:Current understanding of the anatomy, physiology, and magnetic resonance imaging of neurofluids:update from the 2022 "ISMRM Imaging Neurofluids Study group" workshop in Rome. J Magn Reson Imaging 59:431-449, 2024

 

P.410 掲載の参考文献

16) Wang DJ, Hua J, Cao D et al:Neurofluids and the glymphatic system:anatomy, physiology, and imaging. Br J Radiol 96:20230016, 2023

 

17) Mollgard K, Beinlich FRM, Kusk P et al:A mesothelium divides the subarachnoid space into functional compartments. Science 379:84-88, 2023

 

18) 三浦真弘, 内野哲哉, 山田茂樹:最新のNeurofluidの吸収機序-脈管外通路と髄膜リンパ管の連関吸収メカニズムを中心にして-. 自律神経 59:110-124, 2022

 

19) Garic D, McKinstry RC, Rutsohn J et al;Infant Brain Imaging Study (IBIS) Network:Enlarged perivascular spaces in infancy and autism diagnosis, cerebrospinal fluid volume, and later sleep problems. JAMA Netw Open 6:e2348341, 2023

 

P.411 掲載の参考文献

20) Yamada S, Hiratsuka S, Otani T et al:Usefulness of intravoxel incoherent motion MRI for visualizing slow cerebrospinal fluid motion. Fluids Barriers CNS 20:16, 2023

 

P.412 掲載の参考文献

21) Liu P, Fall S, Baledent O:Use of real-time phase-contrast MRI to quantify the effect of spontaneous breathing on the cerebral arteries. Neuroimage 258:119361, 2022

 

22) Petitclerc L, Hirschler L, Orzsik B et al:Arterial spin labeling signal in the CSF:implications for partial volume correction and blood-CSF barrier characterization. NMR Biomed 36:e4852, 2023

 

23) Yang HS, Inglis B, Talavage TM et al:Coupling between cerebrovascular oscillations and CSF flow fluctuations during wakefulness:an fMRI study. J Cereb Blood Flow Metab 42:1091-1103, 2022

 

P.413 掲載の参考文献

24) Lilius TO, Mortensen KN, Deville C et al:Glymphatic-assisted perivascular brain delivery of intrathecal small gold nanoparticles. J Control Release 355:135-148, 2023

 

25) Sennfalt S, Thrippleton MJ, Stringer M et al:Visualising and semi-quantitatively measuring brain fluid pathways, including meningeal lymphatics, in humans using widely available MRI techniques. J Cereb Blood Flow Metab 43:1779-1795, 2023

 

P.415 掲載の参考文献

1) Kitakami K, Kubo Y, Yabuki M et al:Five-year outcomes of medical management alone for adult patients with ischemic moyamoya disease without cerebral misery perfusion. Cerebrovasc Dis 51:158-164, 2022

 

2) Ogasawara K, Takahashi T, Igarashi S et al:Effect of the addition of 123I-iomazenil single-photon emission computed tomography to brain perfusion single-photon emission computed tomography on the detection accuracy of misery perfusion in adult patients with ischemic moyamoya disease. Ann Nucl Med 37:280-288, 2023

 

P.416 掲載の参考文献

3) Kikuchi T, Takagi Y, Nakagawara J et al;COSMO-Japan Study Group:Neuronal loss in the bilateral medial frontal lobe revealed by 123I-iomazenil single-photon emission computed tomography in patients with moyamoya disease:the first report from cognitive dysfunction survey of Japanese patients with moyamoya disease (COSMO-Japan Study). Neurol Med Chir (Tokyo) 63:334-342, 2023

 

4) Onodera K, Ooigawa H, Tabata S et al:Effect of revascularization surgery on cerebral hemodynamics in adult moyamoya disease. Clin Neurol Neurosurg 239:108180, 2024

 

5) Shimizu T, Aihara M, Yamaguchi R et al:Impact of craniotomy area on improvement of cerebral blood flow in combined revascularization surgery for moyamoya disease. J Stroke Cerebrovasc Dis 32:107110, 2023

 

6) Araki Y, Mamiya T, Fujita N et al:Changes in cerebral blood flow in the postoperative chronic phase after combined cerebral revascularization for moyamoya disease with ischaemic onset. Neurosurg Rev 45:2471-2480, 2022

 

P.417 掲載の参考文献

7) Kimura K, Kubo Y, Dobashi K et al:Angiographic, cerebral hemodynamic, and cognitive outcomes of indirect revascularization surgery alone for adult patients with misery perfusion due to ischemic moyamoya disease. Neurosurgery 90:676-683, 2022

 

8) Yasuda S, Katakura Y, Kubo Y et al:Recovery of cortical neurotransmitter receptor function and its impact on cognitive improvement after indirect revascularization surgery alone for adult patients with ischemic moyamoya disease:123I-iomazenil single-photon emission computed tomography study. World Neurosurg 164:e1135-e1142, 2022

 

9) Shimonaga K, Hama S, Furui A et al:Increased cerebrovascular reactivity in selected brain regions after extracranial-intracranial bypass improves the speed and accuracy of visual cancellation in patients with severe steno-occlusive disease:a preliminary study. Neurosurg Rev 45:2257-2268, 2022

 

10) Nishimoto T, Oka F, Okazaki K et al:Relationship between cerebral hyperperfusion syndrome and the immediate change of cerebral blood flow after carotid artery stenting evaluated by single-photon emission computed tomography. Neuroradiology 64:1157-1164, 2022

 

P.418 掲載の参考文献

11) Kanemaru K, Yoshioka H, Hashimoto K et al:Neuronal dysfunction and hemodynamic disturbance due to venous congestionin dural arteriovenous fistula revealed by 123I-iomazenil SPECT. J Neurosurg 138:760-767, 2022

 

12) Kato H, Nakagawara J, Hachisuka K et al:Impaired neuronal integrity in traumatic brain injury detected by 123I-iomazenil single photon emission computed tomography and MRI. J Cereb Blood Flow Metab 42:2245-2254, 2022

 

P.419 掲載の参考文献

13) Suzuki Y, Iseki C, Igari R et al:Reduced cerebral blood flow of lingual gyrus associated with both cognitive impairment and gait disturbance in patients with idiopathic normal pressure hydrocephalus. J Neurol Sci 437:120266, 2022

 

14) Galiana A, Ruiz S, Alen JF et al:Effects of cranioplasty in cerebral blood perfusion using quantification with 99m-Tc HMPAO SPECT-CT. J Neuroimaging 33:174-183, 2023

 

15) Hayashi Y, Mishima T, Fujioka S et al:Unilateral GPi-DBS improves ipsilateral and axial motor symptoms in Parkinson's disease as evidenced by a brain perfusion single photon emission computed tomography study. Front Hum Neurosci 16:888701, 2022

 

P.421 掲載の参考文献

1) Filimonov A, Zeiger J, Goldrich D et al:Virtual reality surgical planning for endoscopic endonasal approaches to the craniovertebral junction. Am J Otolaryngol 43:103219, 2022

 

2) Kan I, Oishi H, Hyodo A et al:A novel braided stent with customized simulation software for treatment of intracranial aneurysms:multicenter prospective trial before unrestricted clinical application. Oper Neurosurg (Hagerstown) 26:180-187, 2024

 

3) Wu ZB, Zeng Y, Zhang HQ et al:Virtual simulation with AneuShape(TM) software for microcatheter shaping in intracranial aneurysm coiling:a validation study. Front Neurol 14:1095266, 2023

 

4) Abdulateef AA, Morita S, Ismail M et al:Supraorbital keyhole approach for paraclinoid aneurysms clipping:a case series with literature review. Surg Neurol Int 14:167, 2023

 

P.422 掲載の参考文献

5) Li L, Fang B, Zhang H et al:Reducing the incidence of persistent headache attributed to retrosigmoid craniotomy:the role of 3D computed tomography venography image-guided technique and bone defects minimization. Int J Neurosci 14:1-7, 2024

 

6) Dogu H, Abdallah A, Mucuoglu AO et al:Comparing three-dimensional and two-dimensional preoperative planning for lumbar transpedicular screw placement:a retrospective study. J Neurol Surg A Cent Eur Neurosurg, 2023. doi:10.1055/a-2175-3215

 

7) Goto Y, Kawaguchi A, Inoue Y et al:Efficacy of a novel augmented reality navigation system using 3D computer graphic modeling in endoscopic transsphenoidal surgery for sellar and parasellar tumors. Cancers (Basel) 15:2148, 2023

 

P.423 掲載の参考文献

8) Koike T, Tanaka S, Kin T et al:Accurate preoperative identification of motor speech area as termination of arcuate fasciculus depicted by Q-ball imaging tractography. World Neurosurg 164:e764-e771, 2022

 

9) Watanabe N, Watanabe K, Fujimura S et al:Real stiffness and vividness reproduction of anatomic structures into the 3-dimensional printed models contributes to improved simulation and training in skull base surgery. Oper Neurosurg (Hagerstown) 24:548-555, 2023

 

10) Gonzalez-Lopez P, Kuptsov A, Gomez-Revuelta C et al:The integration of 3D virtual reality and 3D printing technology as innovative approaches to preoperative planning in neuro-oncology. J Pers Med 14:187, 2024

 

11) Haruma J, Sugiu K, Hoshika M et al:A new method of intracranial aneurysm modeling for stereolithography apparatus 3D printer:the "wall-carving technique" using digital imaging and communications in medicine data. World Neurosurg 159:e113-e119, 2022

 

12) Zhou L, Wang W, Li Z et al:Clinical application of 3D-Slicer + 3D printing guide combined with transcranial neuroendoscopic in minimally invasive neurosurgery. Sci Rep 12:20421, 2022

 

13) Jimenez JE, Shaffer AD, Hammersley E et al:Use of patient-specific 3D printed models in pre-operative counseling for pediatric skull base surgery. Int J Pediatr Otorhinolaryngol 171:111655, 2023

 

P.424 掲載の参考文献

14) Hou X, Xu R, Chen L et al:3D color multimodality fusion imaging as an augmented reality educational and surgical planning tool for extracerebral tumors. Neurosurg Rev 46:280, 2023

 

15) 境浩康, 熊田恵介, 石原拓磨他:偶発所見の見落とし症例における画像診断報告書様式の特徴に関する検討. 医療の質・安全会誌 17:144-148, 2022

 

16) Singh S, Singh R, Kumar S et al:A narrative review on 3D visualization techniques in neurosurgical education, simulation and planning. World Neurosurg 187:46-64, 2024

 

17) Hastreiter P, Maliachova O, Fahlbusch R et al:Comparing 1.5 T and 3.0 T MR data for 3D visualization of neurovascular relationships in the posterior fossa. Acta Neurochir (Wien) 165:3853-3386, 2023

 

18) Inoue A, Watanabe H, Suehiro S et al:Clinical utility of new bone imaging using zero-echo-time sequence in neurosurgical procedures:can zero-echo-time be used in clinical practice in neurosurgery? Neuroradiol J 36:289-296, 2023

 

P.425 掲載の参考文献

19) Ruparelia J, Manjunath N, Nachiappan DS et al:Virtual reality in preoperative planning of complex cranial surgery. World Neurosurg 180:e11-e18, 2023

 

20) 厚生労働省:医科診療報酬点数表. https://www.mhlw.go.jp/content/12404000/000907834.pdf

 

21) 富田博信:画像等手術支援認定診療放射線技師制度の現状報告. JART 69:732-736, 2022

 

22) Jean WC, Piper K, Felbaum DR et al:The inaugural "century" of mixed reality in cranial surgery:virtual reality rehearsal/augmented reality guidance and its learning curve in the first 100-case, single-surgeon series. Oper Neurosurg (Hagerstown) 26:28-37, 2024

 

P.426 掲載の参考文献

23) 内閣府:医療分野の研究開発に資するための匿名加工医療情報及び仮名加工医療情報に関する法律についてのガイドライン. p133, 2024

 

24) Uchida T, Kin T, Sato K et al:Reproducibility of facial information in three-dimensional reconstructed head images:an exploratory study. Curr Med Imaging 19:1387-1393, 2023

 

書評を投稿する